triiodothyronine has been researched along with Graves Disease in 935 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In spite of previous conflicting results, an adjuvant role of selenium in the treatment of Graves' disease (GD) hyperthyroidism has been proposed." | 9.24 | Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial. ( Bartalena, L; Di Cera, M; Ionni, I; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Masiello, E; Piantanida, E; Premoli, P; Rotondo Dottore, G; Sassi, L; Tanda, ML; Vitti, P, 2017) |
| "Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 9.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
| "Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses." | 9.12 | Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. ( Fukata, S; Hamada, N; Itoh, K; Miyauchi, A; Nakamura, H; Noh, JY, 2007) |
| " This study evaluated the effect of methimazole pretreatment on the efficacy of 131I therapy in Graves' hyperthyroidism." | 9.09 | The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. ( Andrade, VA; Gross, JL; Maia, AL, 2001) |
| "To investigate the effect of thyroxine upon the prevention of recurrence of Graves disease after treatment by antithyroid drugs." | 9.09 | [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs]. ( Jie, Y; Situ, Y; Wu, G, 2001) |
| " To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 9.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 9.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| " We, therefore, evaluated the effect of colestipol-hydrochloride administration on clinical and biochemical indices of patients with hyperthyroidism." | 9.08 | Role of colestipol in the treatment of hyperthyroidism. ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| "In 28 patients with Graves' disease showing a wide range of thyroid function between the extremes of hypothyroidism and hyperthyroidism, the following parameters of peripheral thyroid function were measured: serum thyroxine concentration, serum-free thyroxine concentration, serum triiodothyronine concentration, and serum-free triiodothyronine concentration." | 9.04 | The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. ( Burke, G; Clifton-Bligh, P, 1975) |
| "There is insufficient information about the appetite-related hormones orexin-A, nesfatin-1, agouti-related peptide (AgRP), and neuropeptide Y (NPY) in hyperthyroidism." | 7.81 | Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism. ( Akturk, M; Altinova, A; Arslan, M; Cerit, ET; Gulbahar, O; Sanlier, N; Tohma, Y; Toruner, F; Yassibas, E, 2015) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 7.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 7.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 7.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 7.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
| "In eight female patients with diagnosed Graves disease and 8 healthy control subjects (7 females and one male) several parameters of oxidative stress (the level of conjugated dienes [CD], malondialdehyde [MDA] and Schiff bases [SB]) were estimated before and during the treatment with methimazole (Metizol -POLFA) as well as by hormonal and immunological tests." | 7.70 | Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. ( Lewinski, A; Nowak, D; Sewerynek, J; Wiktorska, J, 2000) |
| "In order to differentiate silent thyroiditis (SLT) from Graves' disease, the usefulness of the measurement of the urinary concentration of iodine was evaluated in this study." | 7.69 | [Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease]. ( Iino, S; Ito, K; Momotani, N; Sugimoto, T, 1994) |
| " In this report we describe a patient with Graves' disease diagnosed in early pregnancy and treated with propylthiouracil, which resulted in a large fetal goitre and fetal hypothyroidism." | 7.69 | In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. ( Bos, AF; Derksen, JT; Rouwé, CW; Van Loon, AJ, 1995) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 7.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "Hypothyroxinemia and hypertriiodothyroninemia may occur in the course of antithyroid drug or 131I treatment for hyperthyroid Graves' disease and toxic multinodular goiter." | 7.68 | Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter. ( Akalin, S; Gedik, O; Ozdemir, T, 1991) |
| "Serum fructosamine was measured in patients with Graves' disease and primary hypothyroidism." | 7.68 | [The significance of serum fructosamine measurement in patients with thyroid diseases]. ( Ban, Y; Hara, H; Ito, K; Kaihara, M; Kushima, K; Nagakura, H; Sato, R; Taniyama, M, 1990) |
| "Serum concentrations of total thyroxine (T4) and total triiodothyronine (T3) were measured in a group of patients (n = 113) presenting with untreated hyperthyroidism due to Graves' disease and in subjects receiving oral T4 replacement (n = 93) in whom the total T4 concentration was supraphysiological (greater than 150 nmol/l)." | 7.67 | Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement. ( Himsworth, RL; Pearce, CJ, 1984) |
| "Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma." | 7.67 | Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986) |
| "In an attempt to study the effects of methimazole treatment on immunologic abnormality of hyperthyroidism of Graves' disease, TSH receptor antibody (TRab), anti-DNA antibody and HLA-DR were measured in untreated patients with hyperthyroidism of Graves' disease and treated patients with methimazole for 2 years, using peripheral blood." | 7.67 | Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment. ( Aizawa, T; Hasegawa, Y; Ishihara, M; Kamoi, K; Kaneko, K; Koizumi, Y; Murakami, M; Ogata, H; Yamada, T, 1988) |
| "We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 7.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
| " Documented triiodothyronine thyrotoxicosis developed in a patient with a six-year history of primary hypothyroidism that was left untreated." | 7.66 | Triiodothyronine thyrotoxicosis complicating primary hypothyroidism in a patient with autoimmune thyroiditis. ( Anderson, MW; Gharib, H; Kohut, WD, 1982) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 7.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 7.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
| "The serum triiodothyronine concentration is superior to the serum thyroxine concentration, the resin uptake test and the free thyroxine index in the diagnosis of hyperthyroidism." | 7.65 | Serum triiodothyronine concentration in the diagnosis of hyperthyroidism. ( Marsden, P; McKerron, CG, 1975) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 6.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "We studied the influence of TSH suppressive therapy combined with carbimazole (CBZ) on treatment outcome in Graves' disease." | 6.69 | TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates. ( Baldet, L; Boegner, C; Bringer, J; Daurès, JP; Galtier-Dereure, F; Grabar, S; Jaffiol, C; Osman, A; Pujol, P; Raye, R, 1998) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 6.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "Methimazole dose, pretreatment serum T3 levels, and goitre size are the main determinants of the therapeutic response to methimazole in Graves' disease, at least in areas comprising low, subnormal and normal iodine supply." | 6.68 | Response to methimazole in Graves' disease. The European Multicenter Study Group. ( Benker, G; Hirche, H; Kahaly, G; Raue, F; Reinwein, D; Tegler, L; Vitti, P, 1995) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 6.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 6.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| "38 patients with Graves' disease were treated at random with the glucocorticosteroid betamethasone or with placebo." | 6.66 | Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease. ( Gamstedt, A; Kågedal, B; Tegler, L, 1988) |
| "Group II (18 patients) received no treatment." | 6.65 | Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease. ( Beck, JS; Crooks, J; Gunn, A; Isles, TE; Wilkin, TJ, 1979) |
| "Biotin is a water-soluble vitamin that acts as a cofactor for carboxylase, and is often used as a component in several immunoassays." | 5.91 | Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report. ( Emoto, M; Fujiwara, N; Hamaoka, A; Inami, M; Kamei, N; Morioka, T; Shimmaru, K, 2023) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 5.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "A 31-year-old woman had unstable thyroid function during the third trimester of pregnancy, making it impossible to reduce her dosage of antithyroid medication." | 5.56 | Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report. ( Adachi, H; Ariake, C; Fujishima, A; Fukuoka, Y; Kameyama, S; Miura, H; Sato, A; Shimoda, Y; Terada, Y, 2020) |
| "Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment." | 5.56 | Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis. ( Han, X; Ji, L; Li, M; Liu, W; Ren, Q; Wang, C; Wu, Z; Yang, W; Zhang, M; Zhang, S; Zhou, L; Zhu, Y, 2020) |
| "Severe hyperthyroidism, with particularly high TRAb concentrations at diagnosis, may facilitate the identification of patients requiring regular serum fT3 determinations and potentially needing higher doses of ATD dosage during follow-up." | 5.42 | Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications. ( Alberti, C; Boizeau, P; Carel, JC; Chevenne, D; Guilmin Crepon, S; Harvengt, J; Léger, J; Paulsen, A; Simon, D; Zenaty, D, 2015) |
| "3,5,3'-triiodothyronine-predominant Graves' disease (T(3)-P-GD) is characterized by a persistently high serum T(3) level and normal or even lower serum thyroxine (T(4)) level during antithyroid drug therapy." | 5.37 | Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease. ( Amino, N; Ito, M; Iwasaka, T; Miyauchi, A; Nishikawa, M; Nomura, E; Takamatsu, J; Takamura, Y; Toyoda, N, 2011) |
| "Methimazole treatment resulted in all markers being normalized in the patients without infiltrative ophthalmopathy, yet oxidative stress was still present in the ophthalmopathy group." | 5.33 | Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. ( Bednarek, J; Sowiński, J; Wysocki, H, 2005) |
| "The diagnosis of thyrotoxicosis due to Graves' disease was made." | 5.32 | Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report. ( Agarwal, A; Dhiraaj, S; Pandey, CK; Raza, M; Singh, PK, 2004) |
| "On follow-up 1 year after treatment for Graves' disease, we repeated the measurement of the levels of sHLA-1 in 21 patients." | 5.31 | Levels of soluble human leukocyte antigen class 1 are increased in Graves' disease and toxic multinodular goiter and correlate with the levels of triiodothyronine. ( McDonald, J; Yaturu, S, 2002) |
| "Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI." | 5.29 | Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994) |
| "No ipodate was discontinued in the eight patients who did not respond, and they were then treated with MMI." | 5.29 | Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| "Patients with T3-predominant Graves' disease have an increased serum T3 level despite a normal or even lower level of serum T4 caused by antithyroid drug treatment." | 5.28 | Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease. ( Katayama, S; Kuma, K; Morita, S; Ohsawa, N; Sakane, S; Takamatsu, J; Takeda, K, 1992) |
| " The dose-response curves of inhibition of binding of [125I]T3S to anti-T3S antibody by serial dilutions of serum extracts were essentially parallel to the standard curve." | 5.28 | A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. ( Chopra, IJ; Santini, F; Teco, GN; Wu, SY, 1992) |
| "Sera of 63 patients with Graves' disease, and 49 control subjects were assayed for T3 autoantibodies by a sensitive radioimmunoassay after being stripped of the endogenous thyroid hormone." | 5.28 | Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies. ( Chen, CD; Huang, MJ; Liu, RT; Wang, PW, 1990) |
| "The other 22 patients with Graves' disease were followed while in remission during the observation period of up to 48 months." | 5.28 | Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. ( Furuya, H; Kato, Y; Masaki, Y; Notsu, K; Oka, N, 1991) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 5.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "The performed studies covered 48 subjects, inhabiting the Western Pomerania, therein 40 patients with hyperthyroidism in the course of Graves-Basedow's disease (32 females and 8 males, aged 21-64 years) as well as 8 healthy individuals (5 females and 3 males, aged 23-36 years, with negative anamnesis towards thyroid diseases), who made up the control group at determining the pharmacokinetic parameters after a single oral dose containing 60 mg of thiamazole." | 5.28 | [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics]. ( Syrenicz, A, 1990) |
| " For several years following treatment, the patient displayed clinical hypothyroidism and persistently low serum thyroxine (T4) and triiodothyronine (T3) levels despite large T4 replacement dosage (0." | 5.28 | Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy. ( Bregant, R; Burman, KD; Burns, TW; Premachandra, BN; Williams, IK, 1989) |
| "In 50 consecutive patients with Graves' disease treated with PTU, 7 (group 1) developed increasing goitre in spite of unmeasurable TSH." | 5.27 | Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment. ( Andersen, E; Bech, K; Bliddal, H; Hansen, JM; Hansen, P; Hegedüs, L; Jensen, K; Kampmann, JP; Karstrup, S, 1984) |
| "Propranolol was also given for the first 3 weeks." | 5.27 | Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. ( Beardwell, CG; Davies, D; Longson, D; MacFarlane, IA; Shalet, SM, 1983) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 5.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "In 49 patients with Graves' disease, the 20-min thyroidal uptake of 99mTc and serum levels of thyroid stimulating hormone (TSH) receptor antibody were estimated at presentation and at intervals during a 1-yr course of carbimazole and triiodothyronine." | 5.27 | Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. ( Cuthbert, GF; McKillop, JH; Pearson, DW; Thomson, JA; Wilson, R, 1985) |
| "Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs." | 5.27 | Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. ( Hosoya, T; Kohno, Y; Kuma, K; Mozai, T; Naito, N; Sakane, S; Takamatsu, J; Takeda, K; Tarutani, O; Yoshimura, H, 1988) |
| "The iodine content of Tg was 28 +/- 3." | 5.27 | Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. ( Laurberg, P, 1987) |
| "Of 47 patients with hyperthyroid Graves' disease, 37 patients had a serum T3 to T4 ratio greater than 20 ng/micrograms before therapy (normal range, 12-20; mean, 16." | 5.27 | Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. ( Kuma, K; Mozai, T; Takamatsu, J, 1986) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 5.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "A case of Graves' disease with high serum thyroxine (T4) and low triiodothyronine (T3) levels which was therefore initially diagnosed as a T4-thyrotoxicosis is reported." | 5.27 | A case of Graves' disease with anti-triiodothyronine antibodies. ( Kametani, M; Kamikubo, K; Komaki, T; Miura, K; Nakamura, S; Sakata, S; Takakuwa, K; Tokimitsu, N, 1985) |
| "In 272 patients with Graves' disease, 209 of 240 (87%) untreated patients without complications had high T3 to T4 ratios (nanograms per micrograms) of more than 20." | 5.26 | Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. ( Amino, N; Iwatani, Y; Kumahara, Y; Miki, T; Miyai, K; Mori, H; Morimoto, S; Nakatani, K; Nishi, K; Yabu, Y, 1981) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 5.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| " High pretreatment T3 values were comparatively common among patients in whom a fixed CMI dosage had a insufficient effect." | 5.26 | Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen. ( Dahlberg, PA; Karlsson, FA; Lindström, B; Wide, L, 1981) |
| "Seventy-seven patients with Graves' disease, with an average of 56 years of age were treated with carbimazole in the period 1968-1975." | 5.26 | Outcome of long-term antithyroid treatment of graves' disease in relation to iodine intake. ( Friis, T; Hansen, JM; Kirkegaard, C; Lumholtz, IB; Poulsen, DL; Rogowski, P; Siersbaek-Nielsen, K, 1977) |
| "In Tg from patients with treated Graves' disease, iodine, T(3), and T(4) were reduced, but the reduction in the latter was more substantial, resulting in a T(4)/T(3) molar ratio of 3." | 5.26 | Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. ( Izumi, M; Larsen, PR, 1977) |
| " Lithium carbonate was administered for 4-7 weeks in a dosage (900 mg/day) which maintained serum lithium levels between 0." | 5.26 | Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. ( Burman, KD; Dimond, RC; Earll, JM; Wartofsky, L; Wright, FD, 1976) |
| "The 13 patients with Graves' disease were divided into three groups." | 5.25 | Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. ( Larsen, PR, 1975) |
| "In four patients with hyperthyroid Graves' disease V(H) ranged from 3." | 5.25 | The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease. ( Cavalieri, RR; Searle, GL; Steinberg, M, 1970) |
| "In the patients with untreated hyperthyroidism, values for all these functions were greatly increased." | 5.25 | The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. ( Ingbar, SH; Sobel, RJ; Sterling, K; Woeber, KA, 1970) |
| "In spite of previous conflicting results, an adjuvant role of selenium in the treatment of Graves' disease (GD) hyperthyroidism has been proposed." | 5.24 | Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial. ( Bartalena, L; Di Cera, M; Ionni, I; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Masiello, E; Piantanida, E; Premoli, P; Rotondo Dottore, G; Sassi, L; Tanda, ML; Vitti, P, 2017) |
| "Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 5.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
| "Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses." | 5.12 | Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. ( Fukata, S; Hamada, N; Itoh, K; Miyauchi, A; Nakamura, H; Noh, JY, 2007) |
| " In view of the increased enterohepatic circulation of thyroxine (T4) and triiodothyronine (T3) in thyrotoxicosis, and metabolic effects of konjac glucomannan in gastrointestinal system, we aimed to determine the activity of glucomannan in treatment of hyperthyroidism." | 5.12 | The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. ( Azezli, AD; Bayraktaroglu, T; Orhan, Y, 2007) |
| "To test whether thyroid hormone regulates MBL levels, we studied eight patients with Graves' hyperthyroidism before and after methimazole therapy, eight healthy subjects before and after short-term experimental hyperthyroidism, and eight hypothyroid patients with chronic auto-immune thyroiditis before and after L-thyroxine substitution." | 5.11 | Thyroid hormone increases mannan-binding lectin levels. ( Gjedde, S; Gormsen, LC; Gravholt, CH; Hansen, TK; Jørgensen, JO; Møller, N; Riis, AL; Thiel, S; Weeke, J, 2005) |
| " This study evaluated the effect of methimazole pretreatment on the efficacy of 131I therapy in Graves' hyperthyroidism." | 5.09 | The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. ( Andrade, VA; Gross, JL; Maia, AL, 2001) |
| "To investigate the effect of thyroxine upon the prevention of recurrence of Graves disease after treatment by antithyroid drugs." | 5.09 | [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs]. ( Jie, Y; Situ, Y; Wu, G, 2001) |
| " To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 5.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 5.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| " We, therefore, evaluated the effect of colestipol-hydrochloride administration on clinical and biochemical indices of patients with hyperthyroidism." | 5.08 | Role of colestipol in the treatment of hyperthyroidism. ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| "In 28 patients with Graves' disease showing a wide range of thyroid function between the extremes of hypothyroidism and hyperthyroidism, the following parameters of peripheral thyroid function were measured: serum thyroxine concentration, serum-free thyroxine concentration, serum triiodothyronine concentration, and serum-free triiodothyronine concentration." | 5.04 | The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. ( Burke, G; Clifton-Bligh, P, 1975) |
| "" If eradication of thyroid hormone excess suffices for the label "cure," then all patients can be cured because total thyroidectomy or high doses of ¹³¹I will abolish hyperthyroidism albeit at the expense of creating another disease (hypothyroidism) requiring lifelong medication with levothyroxine." | 5.01 | Graves' Disease: Can It Be Cured? ( Wiersinga, WM, 2019) |
| " The male infant who was born by spontaneous delivery at 35 weeks of gestational age presented with fever, tachycardia and tachypnea at rest on day 11 after birth, and developed severe apnea on day 14." | 4.89 | [Neonatal hyperthyroidism: a case report and literature review]. ( Li, N; Li, XH; Yao, YM, 2013) |
| "The major clinical role for total triiodothyronine (TT3) and (or) free T3 (FT3) is the assessment of hyperthyroidism in patients with suppressed sensitive thyrotropin (sTSH) concentrations." | 4.79 | Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. ( Klee, GG, 1996) |
| " The patient complained of myalgia two weeks after methimazole treatment." | 4.02 | Myopathy Associated with Treatment of Graves' Disease. ( Ji, YK; Kim, SH, 2021) |
| "There is insufficient information about the appetite-related hormones orexin-A, nesfatin-1, agouti-related peptide (AgRP), and neuropeptide Y (NPY) in hyperthyroidism." | 3.81 | Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism. ( Akturk, M; Altinova, A; Arslan, M; Cerit, ET; Gulbahar, O; Sanlier, N; Tohma, Y; Toruner, F; Yassibas, E, 2015) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 3.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| " All patients received the measurements of Zung Self-Rating Depression Scale (SDS) and serum thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and TSH receptor antibodies (TRAb)." | 3.80 | [Relationship between depression and thyroid hormone levels in patients with Graves disease]. ( Huang, H; Yan, YR; Yan, Z; Zeng, J, 2014) |
| "To characterize thyroid hormone levels at the time of diagnosis in the nosological types of thyrotoxicosis diagnosed in the population and to analyze determinants for serum thyroxine (T4) and tri-iodothyronine (T3)." | 3.79 | Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. ( Carlé, A; Knudsen, N; Laurberg, P; Ovesen, L; Pedersen, IB; Perrild, H; Rasmussen, LB, 2013) |
| " We assessed the subjects according to the Simplified Menopause Index, menstrual status, thyroid hormone measurements (thyroid stimulating hormone, free thyroxine, free triiodothyronine), the presence of Hashimoto's disease antibodies (anti-thyroid peroxidase antibody or anti-thyroglobulin antibody), the presence of Grave's disease (anti-TSH receptor antibody), markers of thyroid tumor (high thyroglobulin), and thyroid ultrasonography studies." | 3.79 | Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years. ( Ohi, K; Oi, N, 2013) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 3.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 3.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
| "To examine the natural history of a subnormal serum thyroid-stimulating hormone (TSH) concentration with normal concentrations of both serum free thyroxine (FT4) and free triiodothyronine (FT3) (subclinical hyperthyroidism)." | 3.73 | Observations concerning the natural history of subclinical hyperthyroidism. ( Woeber, KA, 2005) |
| "The objective of the study was to describe the clinical and biochemical findings of four patients with chronic hypothyroidism, previously euthyroid on fixed doses of L-T4 for several years, in whom the metformin was initiated." | 3.73 | Thyrotropin suppression by metformin. ( Filmore-Nassar, A; Glass, AR; Vigersky, RA, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| " Three months later hypothyroidism was observed requiring treatment with levothyroxine." | 3.71 | [Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report]. ( Bogner, S; Maschek, W; Pichler, R; Shamiyeh, A; Sulzbacher, H; Wölfl, S, 2002) |
| "In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 3.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
| "In eight female patients with diagnosed Graves disease and 8 healthy control subjects (7 females and one male) several parameters of oxidative stress (the level of conjugated dienes [CD], malondialdehyde [MDA] and Schiff bases [SB]) were estimated before and during the treatment with methimazole (Metizol -POLFA) as well as by hormonal and immunological tests." | 3.70 | Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. ( Lewinski, A; Nowak, D; Sewerynek, J; Wiktorska, J, 2000) |
| "Thyroid cells obtained from 21 normal human thyroid tissue samples and 17 tissue samples from diseased thyroid, including one of Graves disease, 4 with follicular adenoma, 11 with papillary carcinoma, and 1 with follicular carcinoma, were cultured in collagen gel, and ability to produce thyroglobulin (Tg), triiodothyronine (T3) and thyroxine (T4) was determined." | 3.69 | Productivity of thyroglobulin and thyroid hormone on human thyroid cell in collagen gel culture. ( Koezuka, M; Kusunoki, T; Murata, K; Nishida, S; Tomura, T, 1995) |
| "In order to differentiate silent thyroiditis (SLT) from Graves' disease, the usefulness of the measurement of the urinary concentration of iodine was evaluated in this study." | 3.69 | [Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease]. ( Iino, S; Ito, K; Momotani, N; Sugimoto, T, 1994) |
| " To evaluate this hypothesis, the density of TSH receptors and the activity of adenylate cyclase were determined in the thyroid membranes from hyperthyroid and hypothyroid adult male rats; they were rendered hyperthyroid either with bovine TSH, TRH, or T3 for 7 days and hypothyroid by propylthiouracil treatment or by hypophysectomy." | 3.69 | Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland. ( Denereaz, N; Lemarchand-Beraud, T, 1995) |
| " In this report we describe a patient with Graves' disease diagnosed in early pregnancy and treated with propylthiouracil, which resulted in a large fetal goitre and fetal hypothyroidism." | 3.69 | In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. ( Bos, AF; Derksen, JT; Rouwé, CW; Van Loon, AJ, 1995) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 3.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "Twenty-nine patients (22 female) aged 2 to 17 years were followed with serial measurements of serum triiodothyronine, thyroxine, and thyrotropin during medical therapy for Graves disease." | 3.68 | Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood. ( Horlick, MN; Rapaport, R; Sills, IN, 1992) |
| "Hypothyroxinemia and hypertriiodothyroninemia may occur in the course of antithyroid drug or 131I treatment for hyperthyroid Graves' disease and toxic multinodular goiter." | 3.68 | Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter. ( Akalin, S; Gedik, O; Ozdemir, T, 1991) |
| " During a first pregnancy that ended by miscarriage in the 3rd month, the titer of anti-thyroxine autoantibodies decreased by about 30%." | 3.68 | Changes in serum thyroid hormone autoantibody concentrations during pregnancy: a case report. ( Abs, R; Blockx, P; Martin, M, 1991) |
| "Serum fructosamine was measured in patients with Graves' disease and primary hypothyroidism." | 3.68 | [The significance of serum fructosamine measurement in patients with thyroid diseases]. ( Ban, Y; Hara, H; Ito, K; Kaihara, M; Kushima, K; Nagakura, H; Sato, R; Taniyama, M, 1990) |
| "Serum concentrations of total thyroxine (T4) and total triiodothyronine (T3) were measured in a group of patients (n = 113) presenting with untreated hyperthyroidism due to Graves' disease and in subjects receiving oral T4 replacement (n = 93) in whom the total T4 concentration was supraphysiological (greater than 150 nmol/l)." | 3.67 | Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement. ( Himsworth, RL; Pearce, CJ, 1984) |
| "Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma." | 3.67 | Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986) |
| "We compared fetal and maternal serum indexes of thyroid status at delivery in 70 patients with Graves' disease who required therapy with thionamides (such as propylthiouracil) during pregnancy." | 3.67 | Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. ( Ishikawa, N; Ito, K; Momotani, N; Noh, J; Oyanagi, H, 1986) |
| "We examined 25 patients with untreated, newly diagnosed Graves' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI)." | 3.67 | Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. ( Greenhouse, J; Klein, I; Levey, GS; Roberts, M; Trzepacz, PT, 1989) |
| "T-lymphocyte subpopulations, anti-thyroid microsomal antibody titres, and free triiodothyronine and free thyroxine levels were investigated in 10 patients with Graves' disease before, during and after pregnancy." | 3.67 | T-lymphocyte subsets in pregnant women with Graves' disease. ( Bizzarro, A; Daponte, A; De Bellis, A; Fontana, A; Iacono, G; Peluso, G, 1987) |
| "In an attempt to study the effects of methimazole treatment on immunologic abnormality of hyperthyroidism of Graves' disease, TSH receptor antibody (TRab), anti-DNA antibody and HLA-DR were measured in untreated patients with hyperthyroidism of Graves' disease and treated patients with methimazole for 2 years, using peripheral blood." | 3.67 | Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment. ( Aizawa, T; Hasegawa, Y; Ishihara, M; Kamoi, K; Kaneko, K; Koizumi, Y; Murakami, M; Ogata, H; Yamada, T, 1988) |
| "We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 3.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
| "Appropriate dosage of levothyroxine for the treatment of hypothyroidism is assessed by determining the serum thyroxine (T4) concentration in secondary and tertiary types." | 3.66 | Laboratory tests for evaluating thyroid therapy. ( Kabadi, UM, 1982) |
| " Homogenates of human thyroid follicular adenoma and carcinomas were incubated with [125I]T4 and dithiothreitol (DTT) at 37 C for 60 min under N2 gas." | 3.66 | Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. ( Imura, H; Inada, M; Ishii, H; Mashio, Y; Naito, K; Nishikawa, M; Tanaka, K, 1981) |
| " Documented triiodothyronine thyrotoxicosis developed in a patient with a six-year history of primary hypothyroidism that was left untreated." | 3.66 | Triiodothyronine thyrotoxicosis complicating primary hypothyroidism in a patient with autoimmune thyroiditis. ( Anderson, MW; Gharib, H; Kohut, WD, 1982) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 3.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 3.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
| "Serum concentrations of thyroxine (T4) and triiodothyronine (T3) were measured in 74 untreated hyperthyroid patients." | 3.65 | Thyroxine toxicosis in patients with iodine induced thyrotoxicosis. ( Limbert, ES; Santos, MA; Sobrinho, LG, 1977) |
| "158 patients with physiological and pathological triiodothyronine values were studied: 118 normal subjects, 33 hyperthyroid patients and 7 hypo- patients." | 3.65 | [Clinical significance in radioimmunologic determination of triiodothyronine]. ( Betti, E; Sanguineti, M, 1975) |
| "The serum triiodothyronine concentration is superior to the serum thyroxine concentration, the resin uptake test and the free thyroxine index in the diagnosis of hyperthyroidism." | 3.65 | Serum triiodothyronine concentration in the diagnosis of hyperthyroidism. ( Marsden, P; McKerron, CG, 1975) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 2.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "The majority of patients with Graves' disease gradually enter remission of TSH-receptor autoimmunity during medical or after surgical therapy, with no difference between the types of therapy." | 2.73 | TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. ( Abraham-Nordling, M; Laurberg, P; Lundell, G; Tallstedt, L; Tørring, O; Wallin, G, 2008) |
| "Subacute thyroiditis, autoimmune thyroiditis and an atypical form of thyroiditis are complications of COVID-19." | 2.72 | Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). ( Somogyi, P; Speer, G, 2021) |
| "TSH has been incriminated in Graves' disease for increasing the production of antibodies against TSH receptor (TRAb)." | 2.71 | T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy. ( Doufas, AG; Koutras, DA; Mantzos, E; Mantzos, J; Mastorakos, G, 2003) |
| "The degree of amelioration of diplopia did not significantly differ between the two groups (P = 0." | 2.70 | Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. ( Barbesino, G; Bartalena, L; Bartolomei, MP; Cartei, F; Dell'Unto, E; Lepri, P; Manetti, L; Marcocci, C; Mazzi, B; Nardi, M; Pinchera, A; Rocchi, R; Tanda, ML, 2001) |
| "We studied the influence of TSH suppressive therapy combined with carbimazole (CBZ) on treatment outcome in Graves' disease." | 2.69 | TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates. ( Baldet, L; Boegner, C; Bringer, J; Daurès, JP; Galtier-Dereure, F; Grabar, S; Jaffiol, C; Osman, A; Pujol, P; Raye, R, 1998) |
| "Methimazole was interrupted 4 days before 131I therapy." | 2.69 | Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. ( Andrade, VA; Gross, JL; Maia, AL, 1999) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 2.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "Methimazole dose, pretreatment serum T3 levels, and goitre size are the main determinants of the therapeutic response to methimazole in Graves' disease, at least in areas comprising low, subnormal and normal iodine supply." | 2.68 | Response to methimazole in Graves' disease. The European Multicenter Study Group. ( Benker, G; Hirche, H; Kahaly, G; Raue, F; Reinwein, D; Tegler, L; Vitti, P, 1995) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 2.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "There was no difference between the recurrence rates in the two groups, despite the fact that serum thyrotropin concentrations were undetectable in 73 percent of patients in the carbimazole-T4 group on at least 75 percent of their visits." | 2.68 | Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. ( Beckett, G; Gold, A; McIver, B; Rae, P; Toft, A; Wilkinson, E, 1996) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 2.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| " These treatment regimens were continued for 24 weeks, and physicians were allowed to adjust MMI dosage during follow-up visits." | 2.68 | Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. ( Abe, Y; Fukawa, E; Kawakami-Tani, T; Makino, I; Tanaka, H, 1997) |
| "To explore the therapeutic effect and its mechanism mainly using traditional Chinese medicine (TCM) of replenishing Qi and nourishing Yin (RQNY) with a small dosage of Tapazol for treatment of Graves disease (GD)." | 2.68 | [Therapeutic effect and its mechanism exploration on mainly using traditional Chinese medicine of replenishing qi and nourishing yin in treating Graves disease]. ( Zha, LL, 1997) |
| "Dysbiosis has not only been found in AITDs, but has also been reported in thyroid carcinoma, in which an increased number of carcinogenic and inflammatory bacterial strains were observed." | 2.66 | Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? ( Amrein, K; Knezevic, J; Starchl, C; Tmava Berisha, A, 2020) |
| "38 patients with Graves' disease were treated at random with the glucocorticosteroid betamethasone or with placebo." | 2.66 | Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease. ( Gamstedt, A; Kågedal, B; Tegler, L, 1988) |
| " These results support the hypothesis that large antithyroid drug doses may have greater immunosuppressive effects than low dosage regimens." | 2.65 | Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. ( Bromberg, N; Farah, CS; Reis, LC; Rodrigues, HF; Romaldini, JH; Tanaka, LM; Werner, MC; Werner, RS, 1983) |
| "Group II (18 patients) received no treatment." | 2.65 | Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease. ( Beck, JS; Crooks, J; Gunn, A; Isles, TE; Wilkin, TJ, 1979) |
| " In patients with a high TSH despite being clinically euthyroid, the use of thyroid extract in low dosage (50 mg/day) would appear to be desirable in avoiding the subsequent development of hypothyroidism." | 2.64 | [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine]. ( Brunelle, P; Courtois, H; Nouel, JP; Poirier, A; Schrub, JC; Segond, G, 1976) |
| "Recurrence of hyperthyroidism of Graves' disease is generally associated with re-appearance of TRab in the blood in most of the recurrent patients after discontinuation of antithyroid drugs." | 2.38 | [TSH receptor antibody in hyperthyroid patients due to Graves' disease treated with antithyroid drugs]. ( Yamada, T, 1991) |
| "Biotin is a water-soluble vitamin that acts as a cofactor for carboxylase, and is often used as a component in several immunoassays." | 1.91 | Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report. ( Emoto, M; Fujiwara, N; Hamaoka, A; Inami, M; Kamei, N; Morioka, T; Shimmaru, K, 2023) |
| "Graves disease (GD) and type 2 diabetes mellitus (T2DM) both impair liver function; we therefore explored the possibility of a relationship among diabetic control, thyroid function, and liver function." | 1.72 | Clinical significance of hepatic function in Graves disease with type 2 diabetic mellitus: A single-center retrospective cross-sectional study in Taiwan. ( Hsieh, YS; Hsu, CH; Huang, CL; Lee, YW; Lin, YP; Lin, YY; Weng, SF, 2022) |
| "He had Graves' disease and underwent total thyroidectomy about 4 years before." | 1.72 | Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia. ( Dan, K; Iwamoto, Y; Kaku, K; Kaneto, H; Katakura, Y; Kimura, T; Mune, T; Nakanishi, S; Shimoda, M; Tatsumi, F; Wamata, R, 2022) |
| "Although Graves' disease is a common autoimmune thyroid disorder, the coexistence of these two diseases is extremely rare and makes the diagnosis and treatment complicated, leading to the delayed diagnosis of resistance to thyroid hormone." | 1.62 | Graves' disease coexisted with resistance to thyroid hormone: a case report. ( Akahori, H; Usuda, R, 2021) |
| "Neutropenia was defined as ANC <1500 cells/μL." | 1.62 | Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism ( Alvarez, AG; Litao, MKS; Shah, B, 2021) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 1.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
| "Radioiodine (RAI) treatment for hyperthyroidism is a very common modality, chosen by physicians worldwide." | 1.56 | Predictors of euthyreosis in hyperthyroid patients treated with radioiodine ( Budlewski, T; Franek, E; Gryn, T; Kałuża, B; Stachura, A, 2020) |
| "A 31-year-old woman had unstable thyroid function during the third trimester of pregnancy, making it impossible to reduce her dosage of antithyroid medication." | 1.56 | Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report. ( Adachi, H; Ariake, C; Fujishima, A; Fukuoka, Y; Kameyama, S; Miura, H; Sato, A; Shimoda, Y; Terada, Y, 2020) |
| " There was no statistical correlation between drug dosage and increased serum CK level." | 1.56 | Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs. ( Cheng, Y; Ren, L; Sun, Z; Yang, H; Zhong, D, 2020) |
| "Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment." | 1.56 | Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis. ( Han, X; Ji, L; Li, M; Liu, W; Ren, Q; Wang, C; Wu, Z; Yang, W; Zhang, M; Zhang, S; Zhou, L; Zhu, Y, 2020) |
| "Graves' Disease is a representative autoimmune thyroid disease that presents with hyperthyroidism." | 1.51 | Serum autotaxin levels are associated with Graves' disease. ( Aoki, J; Araki, O; Igarashi, K; Kano, K; Kihara, S; Kurano, M; Murakami, M; Nakawatari, K; Nishikawa, M; Nojiri, T; Shimamoto, S; Yatomi, Y, 2019) |
| "Weight gain during treatment for Graves' disease is common in children, and many children become overweight or obese during treatment." | 1.48 | Weight gain after treatment of Graves' disease in children. ( Alonso, GT; Rabon, S; White, PC, 2018) |
| "Our data suggest that Graves' disease patients with elevated immunoglobulin G4 levels at diagnosis have a phenotype characterized by higher anti-thyroglobulin antibody and antithyroid peroxidase antibody titers, less severe T3 hyperthyroidism, younger age at ophthalmopathy onset and require a shorter duration of the first methimazole treatment cycle." | 1.46 | Serum immunoglobulin G4 levels and Graves' disease phenotype. ( Barbu, CG; Betivoiu, MA; Fica, SV; Florea, S; Martin, CS; Sirbu, AE, 2017) |
| "Ten patients with thyrotoxicosis due to Graves' disease were treated with a rapid thyroid hormone blocking protocol of Lugol's solution, dexamethasone and a beta-blocker." | 1.43 | Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease. ( Fischli, S; Henzen, C; Lucchini, B; Müller, W; Slahor, L, 2016) |
| "Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades." | 1.43 | The management of Graves' disease in New Zealand 2014. ( Conaglen, JV; Cox, SC; Elston, MS; Tamatea, JA, 2016) |
| "Severe hyperthyroidism, with particularly high TRAb concentrations at diagnosis, may facilitate the identification of patients requiring regular serum fT3 determinations and potentially needing higher doses of ATD dosage during follow-up." | 1.42 | Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications. ( Alberti, C; Boizeau, P; Carel, JC; Chevenne, D; Guilmin Crepon, S; Harvengt, J; Léger, J; Paulsen, A; Simon, D; Zenaty, D, 2015) |
| "Relapse was most common during the first year, and prognosis was excellent after 4 years without relapse." | 1.40 | Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010. ( Eliasson, M; Filipsson Nyström, H; Mohlin, E, 2014) |
| "Onset of thyrotoxicosis was distributed from 2 to 12 months postpartum." | 1.40 | Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. ( Amino, N; Ide, A; Ito, M; Kang, S; Kudo, T; Miyauchi, A; Nakamura, H; Nishihara, E; Yoshioka, W, 2014) |
| "Subjects were 25 Graves' disease patients visiting Metabolic Endocrinology Clinic at Dr." | 1.40 | Immunologic and hormonal effects of prophylthiouracil treatment using maintenance dose in Graves' disease patients. ( Decroli, E; Manaf, A; Syahbuddin, S, 2014) |
| "Twenty patients with Graves' disease, 21 patients with Hashimoto hypothyroidism, 21 euthyroid Hashimoto patients, and 27 control subjects were recruited to this study." | 1.39 | Increased serum interleukin-33 levels in patients with Graves' disease. ( Abusoglu, S; Avcikucuk, M; Burnik, SF; Celik, HT; Ceylan, B; Ercan, M; Serdar, MA; Sezer, S; Uguz, N; Yildirimkaya, M, 2013) |
| "3,5,3'-triiodothyronine-predominant Graves' disease (T(3)-P-GD) is characterized by a persistently high serum T(3) level and normal or even lower serum thyroxine (T(4)) level during antithyroid drug therapy." | 1.37 | Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease. ( Amino, N; Ito, M; Iwasaka, T; Miyauchi, A; Nishikawa, M; Nomura, E; Takamatsu, J; Takamura, Y; Toyoda, N, 2011) |
| "Stimulatory autoantibodies in Graves' disease activate the thyroid-stimulating hormone receptor leading to thyroid hyperplasia and unregulated thyroid hormone production and secretion." | 1.37 | Graves' disease: diagnostic and therapeutic challenges (multimedia activity). ( Grebe, SK; Kahaly, GJ; Lupo, MA; McDonald, N; Sipos, JA, 2011) |
| "Prednisone was started 1 d after RAI and withdrawn after 6 wk." | 1.36 | Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. ( Bartalena, L; Compri, E; Lai, A; Marino, F; Piantanida, E; Sassi, L; Sivelli, P; Tanda, ML, 2010) |
| "The development of Graves' disease (GD) from Hashimoto's thyroiditis (HT) has sporadically been reported, but no data are available concerning the prevalence of this sequence of events in GD patients." | 1.36 | Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. ( Arrigo, T; Corrias, A; De Luca, F; Lombardo, F; Mussa, A; Salerno, M; Vigone, MC; Wasniewska, M, 2010) |
| "These results indicated that Graves' disease (GD) caused primary hyperthyroidism." | 1.36 | Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). ( Sato, H, 2010) |
| "Thymic hyperplasia is associated with Graves' disease, particularly in young patients." | 1.36 | Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. ( Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA, 2010) |
| "The pleural effusions were transudates." | 1.36 | Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis. ( Fujita, H; Furumoto, Y; Inoshita, S; Kaneko, S; Kinoshita, H; Maruyama, Y; Suenaga, M; Susa, K; Tomiyama, J; Usui, R; Yakushiji, F; Yasuda, M, 2010) |
| "In subjects with Graves' disease, we propose using a pre-determined 131I activity, which is higher than that derived from the guidelines." | 1.35 | Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up. ( Condorelli, A; Latina, A; Marturano, I; Pezzino, V; Regalbuto, C, 2009) |
| "Thirty patients with untreated hyperthyroidism and 25 age- and sex-matched healthy controls were included in the study." | 1.35 | Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. ( Erem, C; Ersoz, HO; Kocak, M; Nuhoglu, İ; Ucuncu, O; Yilmaz, M, 2009) |
| "We report a patient with Graves' disease who developed myalgias with elevated creatine kinase levels after total thyroidectomy." | 1.35 | Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome? ( Kim, CS; Shaheen, D, 2009) |
| "In an individual patient with Graves' disease, the serum TSH level may be more reflective of the circulating TSI concentration than is thyroid gland function as expressed by free T4 and T3 concentrations and therefore may be as reliable a predictor of remission as TSI." | 1.34 | Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function? ( Kabadi, UM; Premachandra, BN, 2007) |
| "Methimazole treatment resulted in all markers being normalized in the patients without infiltrative ophthalmopathy, yet oxidative stress was still present in the ophthalmopathy group." | 1.33 | Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. ( Bednarek, J; Sowiński, J; Wysocki, H, 2005) |
| "Therefore, the diagnostic accuracy for Graves' disease might be increased by using the three parameters in combination." | 1.33 | Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. ( Kato, Y; Sato, K; Shimizu, S; Takano, K; Yanagisawa, T, 2005) |
| "An association between Graves' disease (GD) and chronic hepatitis C (C-HC) has been observed both in the presence and the absence of recombinant interferon-alpha (rIFN-alpha) treatment." | 1.33 | Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. ( Barilli, AL; Bertoni, R; Coiro, V; Delsignore, R; Di Seclì, C; Ferrari, C; Finardi, L; Jotti, GS; La Gioia, D; Minelli, R; Valli, MA, 2005) |
| "Women with a past history of Graves' disease and no current treatment display a normal thyroid function and adaptation during pregnancy." | 1.33 | Thyroid function during pregnancy in women with past Graves' disease. ( Guibourdenche, J; Le Gac, I; Luton, D; Noel, M; Polak, M, 2005) |
| "Forty-five patients were treated for active hyperthyroidism, 161 were euthyroid (85 immediately before withdrawal of antithyroid drug at maintenance doses, 76 in stable remission after withdrawal of antithyroid treatment)." | 1.33 | Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease. ( Baldini, M; Bonfanti, MT; Cantalamessa, L; Castagnone, D; Orsatti, A, 2005) |
| "Post-partum thyrotoxicosis due to Graves' disease may be treated with radioiodine but it requires radiation safety measurements for infant and is contraindicated if the mother is breast-feeding." | 1.33 | Treatment of post-partum thyrotoxicosis. ( Azizi, F, 2006) |
| "Hyperthyroidism is in a sympathovagal imbalanced state, characterized by both increased sympathetic and decreased vagal modulation of the heart rate." | 1.33 | Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. ( Chen, JL; Chiu, HW; Chu, WC; Tseng, YJ, 2006) |
| "Eighty-five patients with Graves' disease (males : females ratio 1:5." | 1.33 | Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status. ( Dimitrakov, DY; Dimov, RS; Mateva, NG; Nonchev, BI; Terzieva, DD; Tsvetkova, TZ, 2005) |
| "Incidence of the hyperthyroidism is continuously increasing, whereas our knowledge concerning the facilitating or etiologic factors of this increase are still partial." | 1.33 | HLA class II distribution in Congolese with hyperthyroidism: preliminary results. ( Bidingija, M; Buzzetti, R; Ditu, M; Galgani, A, 2006) |
| "The diagnosis of thyrotoxicosis due to Graves' disease was made." | 1.32 | Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report. ( Agarwal, A; Dhiraaj, S; Pandey, CK; Raza, M; Singh, PK, 2004) |
| "Sixty-one thyroid cancers with concurrent Graves disease were retrospectively reviewed." | 1.32 | Surgical treatment of thyroid cancers with concurrent Graves disease. ( Chao, TC; Chen, MF; Lin, JD, 2004) |
| "An 18-year-old woman being treated for Graves disease underwent elective thyroidectomy." | 1.32 | Intraoperative thyroid storm: a case report. ( Goh, YS; Grimes, CM; Montgomery, WH; Muniz, H, 2004) |
| "The restoration of hyperthyroid Graves' disease to euthyroidism is rapidly accomplished with IOP and DEX, beta-blockers, and, when possible, antithyroid drugs." | 1.32 | Rapid preoperative preparation for severe hyperthyroid Graves' disease. ( Beazley, R; Braverman, L; Panzer, C, 2004) |
| "On follow-up 1 year after treatment for Graves' disease, we repeated the measurement of the levels of sHLA-1 in 21 patients." | 1.31 | Levels of soluble human leukocyte antigen class 1 are increased in Graves' disease and toxic multinodular goiter and correlate with the levels of triiodothyronine. ( McDonald, J; Yaturu, S, 2002) |
| "The prevalence of postpartum recurrence or exacerbation of GH within 1 year after delivery was examined." | 1.31 | Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Yamamoto, M; Yoshida, K, 2002) |
| "Patients with Graves' disease are more susceptible to calcium and vitamin D deficiency during the winter than during the summer, resulting in the tendency toward a higher incidence of postoperative tetany in winter." | 1.31 | Seasonal changes in calcium homeostasis affect the incidence of postoperative tetany in patients with Graves' disease. ( Kawamoto, H; Murakami, T; Noguchi, S; Ohshima, A; Toda, M; Uchino, S; Watanabe, S; Yamashita, H, 2000) |
| "Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology most commonly affecting young females." | 1.31 | A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland. ( Blichert-Toft, M; Christensen, L; Feldt-Rasmussen, U; Hansen, HS; Kirkegaard, J; Zimmermann-Belsing, T, 2000) |
| "Nevertheless, very few cases of Graves' disease, occurred in such condition, have been reported in literature." | 1.31 | Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. ( Amato, G; Biondi, B; Carella, C; Del Buono, AD; di Cristofaro, M; Di Iorio, G; Manganella, G; Mazziotti, G; Montella, P; Rotondi, M, 2000) |
| "In hyperthyroid Graves' disease, short-term methimazole is sufficient to induce lasting remission in some patients, but even long-term treatment fails to do so in others." | 1.31 | An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. ( Eto, S; Ito, Y; Komiya, I; Nishimori, T; Sato, A; Tanaka, Y; Terao, A; Yamada, T, 2000) |
| "Seven patients with Graves' disease, eight with toxic nodular goiter and seven with non-toxic nodular goiter, were followed after 131I-treatment." | 1.31 | Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter. ( Faber, J; Jarløv, AE; Kristensen, LO; Nygaard, B, 2000) |
| "The serum IL-18 levels in Graves' disease were significantly increased in the hyperthyroid state and were decreased during treatment with methimazole or propylthiouracil." | 1.31 | Increased levels of serum interleukin-18 in Graves' disease. ( Matsuura, B; Miyauchi, S; Onji, M, 2000) |
| "However, of patients with Graves' disease (GD) maintained on antithyroid drug (ATD) treatment, some exhibit persistent suppression of TSH long after normalization of their serum free T3 (FT3) and free T4 (FT4) levels." | 1.31 | Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. ( Inaba, M; Ishikawa, T; Kumeda, Y; Kurioka, Y; Morii, H; Nishizawa, Y; Tahara, H, 2000) |
| "Retrospective study on serum samples of Graves' disease patients treated by antithyroid drugs for 18 months." | 1.31 | Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. ( Massart, C; Maugendre, D, 2001) |
| " The beginning of therapy, dosage of drugs, length of application and results of treatment are critically evaluated, with special emphasis on the rate and time of remission, on the frequency of recurrences and on the success of additional treatments such as surgery and/or radioiodine application." | 1.31 | [Graves' disease. Clinical features and treatment results]. ( Amor, H; Crivellaro, C; Leimgruber, K; Oberhofer, R, 2001) |
| "In patients with Graves' disease, APA were not associated with thyroid status." | 1.31 | Detection of antipituitary antibodies in patients with autoimmune thyroid disease. ( Kanda, T; Kobayashi, I; Murakami, M; Nishino, M; Yabe, S, 2001) |
| "Sevoflurane was discontinued and dantrolene was given by intravenous bolus." | 1.31 | Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. ( Genma, R; Kitahara, A; Matsushita, A; Nakamura, H; Nakano, K; Natsume, H; Nishiyama, K; Sasaki, S; Yamamoto, Y, 2001) |
| "Spontaneous remission of Graves' disease during pregnancy is thought to be due to a reduction of thyroid-stimulating antibody activity." | 1.31 | Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. ( Kohn, LD; Kung, AW; Lau, KS, 2001) |
| "Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism." | 1.31 | Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. ( Faber, J; Mehlsen, J; Schifter, S; Wiinberg, N, 2001) |
| "400 consecutive patients (300 with Graves' disease and 100 with silent thyroiditis) who underwent radioiodine scanning of the thyroid." | 1.31 | Association between lithium use and thyrotoxicosis caused by silent thyroiditis. ( Daniels, GH; Miller, KK, 2001) |
| "Some patients with Graves' disease who select surgical therapy so they can discontinue antithyroid medication require lifelong levo-thyroxin (l-T4) replacement therapy because of irreversible postoperative hypothyroidism." | 1.31 | Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease. ( Akasu, H; Kitagawa, W; Kitamura, Y; Kumasaki, T; Kumita, S; Nagahama, M; Oshina, T; Shimizu, K; Tanaka, S, 2002) |
| "However, in predicting the recurrence of thyrotoxicosis after discontinuing ATD it has been of little value." | 1.31 | Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. ( Feldt-Rasmussen, U; Nygaard, B; Rasmussen, AK; Zimmermann-Belsing, T, 2002) |
| "In patients with Graves' disease, the anti-thyroid treatment resulted in significant reductions of plasma thyroxine and triiodothyronine levels." | 1.31 | Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. ( Hoffstedt, J; Wahrenberg, H; Wennlund, A, 2002) |
| "Four patients with Graves' disease presented elevated plasma concentrations of calcitonin, but none of these patients also had an elevated serum gastrin." | 1.31 | Prevalence of hypergastrinemia in patients with hyper- and hypothyroidism: impact for calcitonin? ( Bieglmayer, Ch; Gessl, A; Nowotny, P; Vierhapper, H, 2002) |
| "With the diagnosis of neonatal Graves' disease established, both twins were treated with propranolol (2 mg/kg." | 1.30 | [Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism]. ( Grüters, A; Hüfner, M; Lakomek, M; Roth, C; Siggelkow, H, 1997) |
| "Total thyroidectomy for Graves' disease is an effective and safe therapy." | 1.30 | Total thyroidectomy for Graves' disease. ( Lippes, HA; Lore, JM; Rassael, H; Razack, MS; Schaefer, DP, 1997) |
| "Though spontaneous switch to Graves' disease cannot be excluded in patients with toxic nodules, the massive release of thyroid materials from follicular cells, among these TSH-receptor antigenic components partially denatured by ethanol, may indeed trigger an autoimmune response to the TSH-receptor, thus accounting for this observation." | 1.30 | Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. ( Caraccio, N; Casolaro, A; Del Guerra, P; Goletti, O; Lippolis, PV; Monzani, F, 1997) |
| "Whether Graves' disease and Moyamoya coexist because of an aggressive autoimmune mechanism is a concept that remains to be settled." | 1.30 | Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. ( Duckrow, R; MacGillivray, D; Malchoff, C; Ramsby, GR; Shoukri, K; Talmadge, T; Tendler, BE, 1997) |
| "To determine whether Graves' disease or primary hypothyroidism influence platelet function, we evaluated platelet aggregation in the platelet-rich plasma (PRP) from such patients." | 1.30 | Alteration of platelet aggregation in patients with thyroid disorders. ( Hagiwara, M; Hayakawa, N; Hidaka, H; Hirano, E; Kato, R; Kotake, M; Masunaga, R; Mokuno, T; Nagasaka, A; Nakai, A; Oda, N; Sawai, Y; Shimazaki, K, 1997) |
| "In patients showing hyperthyreosis or a TRAK value > 11 U/l at the beginning of RIT, a significantly lower therapeutic dosage and effective iodine half-life were found than in non-hyperthyreotic patients or patients with TRAK < or = 11 U/l." | 1.30 | [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]. ( Bares, R; Büll, U; Dohmen, BM; Kaiser, HJ; Sabri, O; Schreckenberger, M; Schulz, G; Wagenknecht, G; Zimny, D; Zimny, M, 1998) |
| "The outcome of Graves' disease depends on the individual changes of the TRAb levels rather than on their absolute values." | 1.30 | [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease]. ( Garth, H; Holle, LH; Rink, T; Schroth, HJ, 1998) |
| "Eighteen patients with Graves' disease, 24 patients with Hashimoto's thyroiditis and 32 sex- and age-matched healthy control subjects were studied." | 1.30 | Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease. ( Aguilar, M; Escobar, L; Gavilán, I; Girón, JA; Rojano, J; Sasián, S, 1998) |
| "In untreated hyperthyroid patients with Graves' disease, the CV(R-R) and HF values were significantly lower than in healthy controls." | 1.30 | Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism. ( Aso, Y; Fujiwara, Y; Inukai, T; Kobayashi, H; Takanashi, K; Takemura, Y; Tayama, K, 1998) |
| "Euthyroid Graves' disease is defined as Graves' ophthalmopathy without hyperthyroidism, and the thyroid-stimulating antibody (TSAb) has been known to be a good marker for diagnosis." | 1.30 | Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease. ( Amino, N; Fujikado, T; Hidaka, Y; Kashiwai, T; Shimaoka, Y; Tada, H; Watanabe, Y; Yagoro, A, 1998) |
| "Toxic thyroid nodules have been shown to be of clonal origin." | 1.30 | T3-release from autonomously functioning thyroid nodules in vitro. ( Hoermann, R; Kirner, J; Mann, K; Poertl, S; Saller, B, 1998) |
| "Although spontaneous development of Graves' disease cannot be excluded, the time sequence and the negative familial and personal history for autoimmune diseases suggest a possible connection between the two phenomena." | 1.30 | Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma. ( Pezzino, V; Regalbuto, C; Salamone, S; Scollo, C; Vigneri, R, 1999) |
| "Hyperthyroidism of Graves' disease (Morbus Basedow) is known to involve the thyroid gland in toto, unlike Graves' ophthalmopathy which clinically may either be unilateral or bilateral." | 1.30 | Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient. ( Dimai, HP; Lax, S; Leb, G; Lipp, RW; Ramschak-Schwarzer, S, 1999) |
| "These data indicated that she also had autoimmune hepatitis (AIH) and mixed connective tissue disease (MCTD)." | 1.30 | A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease. ( Ando, B; Inoue, K; Masuda, A; Okajima, T; Sakai, K; Takeshita, M; Tanaka, E; Yamamoto, M, 1999) |
| "Severe hypothyroidism was discovered in a young woman in her 29th week of pregnancy." | 1.30 | Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. ( Bellastella, A; Caccavale, C; Carella, C; Del Buono, A; Di Serio, C; Glinoer, D; Rotondi, M; Sorvillo, F, 1999) |
| "Iopanoic acid is a compound that induces a rapid decrease in serum T3 levels, mainly by inhibition of peripheral conversion of T4 to T3." | 1.30 | Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients. ( Lengyel, AM; Ramos-Dias, JC, 1999) |
| "295 patients of Graves' disease were studied for early development of transient hypothyroidism (TH) and its prognostic value following I131 therapy." | 1.30 | Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis. ( Gera, A; Khanna, CM; Magdum, M; Sankar, R, 1998) |
| "Five of them were affected by Graves' disease and one by De Quervain's thyroiditis." | 1.29 | Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases. ( Di Prima, MA; Faralli, AR; Leri, O; Paggi, A; Paparo, BS; Pellegrino, C; Sinopoli, MT, 1995) |
| "A maternal history of Graves' disease places the fetus at risk for thyrotoxicosis in utero via the placental transfer of thyroid-stimulating immunoglobulins." | 1.29 | Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. ( Couch, R; Ginsberg, J; Wallace, C, 1995) |
| "We examined 13 patients with euthyroid Graves' disease suspected ophthalmologically, by comparing them with 20 patients with untreated Graves' disease and by following them up for 5 to 10 years." | 1.29 | Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease. ( Amino, N; Asahi, K; Hidaka, Y; Iwatani, Y; Kashiwai, T; Tada, H; Tamaki, H, 1995) |
| "Fifteen patients affected by new-onset Graves' disease with ophthalmopathy have been examined for lymphocyte subset phenotypes by two-colour cytometric analysis." | 1.29 | CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease. ( Afeltra, A; Amoroso, A; Bonomo, L; Di Prima, MA; Faralli, AR; Ferri, GM; Paggi, A; Startari, S, 1993) |
| "Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI." | 1.29 | Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994) |
| "HLA alleles of 106 patients with Graves' disease were determined, and the frequency of HLA-B46 was found to be significantly increased." | 1.29 | Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. ( Inoko, H; Onuma, H; Ota, M; Sugenoya, A, 1994) |
| "The sCD4 level in the Graves' disease group was not different from control values and did not change significantly with treatment." | 1.29 | Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. ( Balázs, C; Bokk, A; Farid, NR, 1994) |
| "We present two cases of Graves' disease whose initial thyroidal scintiscan with 99mTcO4- (Case 1) and 123I (Case 2) showed unilateral diffuse uptake of radioisotopes." | 1.29 | Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes. ( Fukui, M; Fuwa, Y; Goto, S; Matsui, I; Ogawa, T; Sakata, S; Sarui, H; Sasano, N; Takuno, H; Yuasa, H, 1993) |
| "Aged patients with hyperthyroid Graves' disease show a more favorable response to antithyroid drugs than young counterparts." | 1.29 | Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease. ( Aizawa, T; Hashizume, K; Ichikawa, K; Koizumi, Y; Komiya, I; Yamada, T, 1994) |
| "Fourteen patients were affected by Graves' disease, eight by silent thyroiditis, five by Hashimoto's thyroiditis." | 1.29 | Anti-cardiolipin antibodies in autoimmune thyroid diseases. ( Afeltra, A; Amoroso, A; Bonomo, L; Caccavo, D; Di Prima, MA; Ferri, GM; Paggi, A; Vaccaro, F, 1994) |
| "The serum sIL2R in 17 patients with Graves' disease was determined after treatment with antithyroid drugs (propylthiouracil) for a short period (1." | 1.29 | [The association of Graves' disease with serum soluble interleukin 2 receptor]. ( Ren, YZ; Song, ZG, 1993) |
| "No ipodate was discontinued in the eight patients who did not respond, and they were then treated with MMI." | 1.29 | Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| "A 56-year-old female with Graves' disease who presented with decreased secretion of gonadotropins is described." | 1.29 | Decreased secretion of gonadotropins in a patient with Graves' disease. ( Hakamata, M; Itoh, M; Katada, E; Miyata, N; Sudo, Y, 1996) |
| "Graves disease is an autoimmune thyroid disease characterized by the presence of antibodies against the thyrotropin receptor (TSHR), which stimulate the thyroid to cause hyperthyroidism and/or goiter." | 1.29 | Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. ( Hirai, A; Hoshioka, A; Kikuoka, S; Kohn, LD; Kohno, Y; Niimi, H; Saito, Y; Shimojo, N; Tahara, K; Tamura, Y; Yamaguchi, K, 1996) |
| "The development of Graves' disease as evidenced by diagnostic imaging and appearance of TSH receptor antibodies is described in a 49-year-old woman 6 months after onset of subacute thyroiditis." | 1.29 | The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging. ( Bennedbaek, FN; Gram, J; Hegedüs, L, 1996) |
| "The serum P1CP levels of the untreated Graves' disease were significantly higher than in the controls (176." | 1.29 | Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease. ( Demura, H; Miyakawa, M; Tsushima, T, 1996) |
| "We report herein a case of hyperthyroid Graves' disease developed from asymptomatic autoimmune thyroiditis (AAT)." | 1.29 | Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report. ( Amano, J; Fujimori, M; Hama, Y; Kasuga, Y; Kobayashi, S; Maruyama, M; Shingu, K, 1996) |
| "The diagnosis of toxic Graves' disease with thyroid hemiagenesis was, therefore, made." | 1.28 | Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements. ( Dickstein, G; Kraiem, Z; Shechner, C; Zuckerman, E, 1992) |
| "Patients with T3-predominant Graves' disease have an increased serum T3 level despite a normal or even lower level of serum T4 caused by antithyroid drug treatment." | 1.28 | Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease. ( Katayama, S; Kuma, K; Morita, S; Ohsawa, N; Sakane, S; Takamatsu, J; Takeda, K, 1992) |
| "Thus, hyperthyroidism is one of the diseases in which serum concentrations of 7 S collagen are increased." | 1.28 | Increased concentrations of type IV (7 S) collagen in sera of hyperthyroid patients with Graves disease. ( Goto, H; Misaki, M; Shima, T; Yano, Y, 1992) |
| "The patients had Graves' disease, but no other immune-mediated diseases, had not yet received specific treatment for their ophthalmopathy and were euthyroid during the entire study period." | 1.28 | Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. ( Koornneef, L; Mourits, MP; Prummel, MF; Van der Gaag, R; Wiersinga, WM, 1992) |
| " The dose-response curves of inhibition of binding of [125I]T3S to anti-T3S antibody by serial dilutions of serum extracts were essentially parallel to the standard curve." | 1.28 | A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. ( Chopra, IJ; Santini, F; Teco, GN; Wu, SY, 1992) |
| " Group A patients (n = 31) received either methimazole (40-100 mg daily) or propylthiouracil (400-900 mg daily) combined with T3 daily throughout treatment." | 1.28 | The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine. ( Bromberg, N; Romaldini, JH; Sgarbi, JA; Werner, MC; Werner, RS, 1992) |
| "Neonatal hyperthyroidism is only seen in children whose mothers had an autoimmune thyroid disease." | 1.28 | [Neonatal hyperthyroidism secondary to Basedow's disease in the mother]. ( Bovero, G; Martin Laval, A; Mouroux, D; Nicolino, J, 1991) |
| "Nineteen patients with Graves' disease were regarded as euthyroid at the end of therapy." | 1.28 | Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug. ( Akiyama, H; Inukai, T; Kobayashi, I; Kobayashi, S; Kondo, Y; Shoda, Y; Yamaguchi, T, 1991) |
| "In 26 patients with untreated Graves' disease and 7 hyperthyroid patients with Hashimoto's thyroiditis, the mean levels of soluble IL-2 receptor were both significantly higher than in normal controls (1497 +/- 649 (mean +/- SD), 641 +/- 137 vs 221 +/- 63 10(3) U/l, p less than 0." | 1.28 | Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. ( Nakanishi, K; Ohta, Y; Taniguchi, Y, 1991) |
| "This retrospective study serves as an inquiry into the common practice of long-term administration of small maintenance doses of either methyl-mercaptoimidazole (MMI) or propylthiouracil (PTU) to Graves' hyperthyroid patients who became euthyroid with primary large doses of the same drugs." | 1.28 | Antithyroid drug therapy for Graves' hyperthyroidism: is long-term administration of a small maintenance dose necessary? ( Morita, M; Murakami, N; Noguchi, S; Tajiri, J; Tamaru, M, 1991) |
| "Thus, it is possible that Graves' disease, subacute aggravation of chronic thyroiditis and hypothyroidism coexist in the same individual." | 1.28 | Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism. ( Kouchi, T; Mashiba, H; Mitani, Y; Shigemasa, C; Shirota, K; Ueta, Y; Urabe, K; Yoshida, A, 1991) |
| "Sera of 63 patients with Graves' disease, and 49 control subjects were assayed for T3 autoantibodies by a sensitive radioimmunoassay after being stripped of the endogenous thyroid hormone." | 1.28 | Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies. ( Chen, CD; Huang, MJ; Liu, RT; Wang, PW, 1990) |
| "The other 22 patients with Graves' disease were followed while in remission during the observation period of up to 48 months." | 1.28 | Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. ( Furuya, H; Kato, Y; Masaki, Y; Notsu, K; Oka, N, 1991) |
| "One hundred and twelve new cases of Graves' disease were treated by tapazole for 6 months and followed up for another 12 months." | 1.28 | [Evaluation of a logistic regression model in predicting the prognosis of Graves' disease treated by antithyroid drugs]. ( Cheng, Y; Li, J; Liang, Z; Pan, X; Wei, S; Xu, S, 1991) |
| "Eighty-five patients with Graves' disease in clinical remission after treatment for over 1 year by methimazole therapy (36 patients, group A) or subtotal thyroidectomy (49 patients, group B) who became undetectable for serum thyrotropin levels (TSH less than 0." | 1.28 | A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays. ( Kuma, K; Matsubayashi, S; Morita, T; Mukuta, T; Nagai, K; Nakagawa, T; Tamai, H, 1991) |
| "The mean RBC CAI in Graves' disease was decreased (180 +/- 53 nmol/g Hb), and 22 patients (88%) had subnormal values." | 1.28 | Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. ( Abe, K; Fukazawa, H; Kaise, K; Kaise, N; Kiso, Y; Mori, K; Yoshida, K; Yoshinaga, K, 1991) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 1.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "We have experienced two cases of Graves' disease with antithyroid hormone autoantibodies (Case 1: anti-T4; Case 2: anti-T3) who finally underwent subtotal thyroidectomy after antithyroid drug treatment." | 1.28 | Two cases of Graves' disease with antithyroid hormone antibodies: implication on the role of thyroglobulin as an antigen. ( Kohno, Y; Komaki, T; Matsuda, M; Nagai, K; Ogawa, T; Saito, K; Sakata, S; Takuno, H; Tarutani, O; Tokimitsu, N, 1990) |
| "The performed studies covered 48 subjects, inhabiting the Western Pomerania, therein 40 patients with hyperthyroidism in the course of Graves-Basedow's disease (32 females and 8 males, aged 21-64 years) as well as 8 healthy individuals (5 females and 3 males, aged 23-36 years, with negative anamnesis towards thyroid diseases), who made up the control group at determining the pharmacokinetic parameters after a single oral dose containing 60 mg of thiamazole." | 1.28 | [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics]. ( Syrenicz, A, 1990) |
| "Seven days after surgery when Graves' disease patients became euthyroid their ANP markedly decreased to 4." | 1.28 | Plasma atrial natriuretic peptide in patients with Graves' disease. ( Kato, R; Morita, M; Murakami, N; Murakami, T; Naomi, S; Noguchi, S; Sato, T; Tajiri, J; Umeda, T, 1990) |
| "Eighty-three patients with Graves' disease had been treated with methylmercaptoimidazole (MMI)." | 1.28 | Studies on the T3 suppression test with reference to the thyroidal 123I uptake in Graves' disease: comparison of 24-hour and 3-hour uptake. ( Inukai, T; Iwashita, A; Kobayashi, I; Kobayashi, S; Ohshima, K; Shimomura, Y; Yamaguchi, T; Yamaguchi, Y, 1990) |
| "One hundred and twelve new cases with Graves' disease were treated by tapazole for 6 months and followed-up for another 12 months in a prospective study." | 1.28 | [Observation of the outcome of 112 cases with Graves' disease treated by short-term antithyroid drug therapy for one year]. ( Cheng, Y; Li, J; Liang, Z; Wang, Q; Wei, S; Xian, L, 1990) |
| "In patients with Graves' disease, thyrostatic drug treatment may induce definitive remission without the need of more aggressive measures such as surgery or radioiodine." | 1.28 | Factors influencing the outcome of thyrostatic drug therapy in Graves' disease. ( Agren, H; Dahlberg, A; Jansson, R; Karlsson, FA; Winsa, B, 1990) |
| "Secretion of thyroid hormones in Graves' disease may be regulated not only by circulating thyroid-stimulating antibodies but also by intrathyroidal stimulatory factors or by inhibitory or destructive factors." | 1.28 | Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease. ( Amino, N; Ichihara, K; Iwatani, Y; Kimura, M; Mitsuda, N; Miyai, K; Tachi, J; Tamaki, H; Tanizawa, O, 1989) |
| "Treatment with carbimazole produced a significant rise in LSH and SOD." | 1.28 | Free radicals and Graves' disease: the effects of therapy. ( Bradley, H; Chopra, M; McKillop, JH; Smith, WE; Thomson, JA; Wilson, R, 1989) |
| " For several years following treatment, the patient displayed clinical hypothyroidism and persistently low serum thyroxine (T4) and triiodothyronine (T3) levels despite large T4 replacement dosage (0." | 1.28 | Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy. ( Bregant, R; Burman, KD; Burns, TW; Premachandra, BN; Williams, IK, 1989) |
| "A patient with Graves' disease associated with severe muscle weakness who was finally diagnosed as polymyositis by pathological examination of the muscle is reported." | 1.28 | A case of Graves' disease associated with polymyositis. ( Fuwa, Y; Goshima, E; Maeda, M; Miura, K; Nakamura, S; Sakata, S; Yamakita, N, 1989) |
| "Treatment-induced improvement of Graves' disease was associated with an increase in LFA-1-positive cell number." | 1.28 | Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease. ( Amiel, C; Bene, MC; Faure, G; Guerin, V; Hartemann, P; Leclere, J, 1989) |
| "Subjects with Graves' disease had significant elevated serum levels of thyroxine (24." | 1.28 | Insulin secretion and sensitivity in hyperthyroidism. ( Ho, LT; Jap, TS; Won, JG, 1989) |
| "We suggest that hyperthyroidism due to Graves' disease is mild in aged patients because responsiveness of the thyrocyte to the abnormal stimulator, thyrotropin-receptor antibody, may be reduced." | 1.28 | Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease. ( Aizawa, T; Hashizume, K; Ishihara, M; Takasu, N; Yamada, T, 1989) |
| "Patients with Graves' disease were divided into the following two groups: (1) untreated, and (2) euthyroid during antithyroid drug (methylmercaptoimidazole) therapy." | 1.27 | [Studies on the suppressor T cell function in patients with autoimmune thyroid diseases]. ( Matsui, J, 1984) |
| "In this study of untreated toxic Graves' disease we have taken two assays (LATS protector and thyrotrophin binding inhibiting immunoglobulin, TBII) which depend upon the measurement of binding to thyroid cell membranes, and correlated them with a bioassay which measures as the index of activity the biologically relevant end point of T3 secretion from thyroid tissue." | 1.27 | The assay of Graves' immunoglobulins: a comparison of different methods. ( Atkinson, S; Hardisty, CA; Humphries, H; Kendall-Taylor, P; Munro, DS, 1983) |
| "The variable clinical course of Graves' disease has been followed in 27 patients each studied for 2 years from the time of diagnosis." | 1.27 | Thyroid function and immunological activity during and after medical treatment of Graves' disease. ( Copping, S; Crawley, JC; Gossage, AA; Himsworth, RL; Hinge, D, 1983) |
| "The hyperthyroidism in Graves' disease results from the action of thyroid-stimulating antibodies (TSAb)." | 1.27 | Evidence that thyroid-stimulating antibody is produced in the thyroid gland. ( Atkinson, S; Kendall-Taylor, P; Knox, AJ; Steel, NR, 1984) |
| "In 50 consecutive patients with Graves' disease treated with PTU, 7 (group 1) developed increasing goitre in spite of unmeasurable TSH." | 1.27 | Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment. ( Andersen, E; Bech, K; Bliddal, H; Hansen, JM; Hansen, P; Hegedüs, L; Jensen, K; Kampmann, JP; Karstrup, S, 1984) |
| "In 29 patients with thyrotoxic Graves' disease treated with conventional long term antithyroid drug therapy, serum thyroglobulin (Tg) was serially determined by RIA and compared with clinical course, goiter shrinkage, and 131I uptake suppression." | 1.27 | Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy. ( Kawamura, S; Kishino, B; Mashita, K; Tajima, K; Tarui, S, 1983) |
| "A man with previous Graves' disease spontaneously developed hypothyroidism." | 1.27 | Thyroid disease with monoclonal (immunoglobulin G lambda) antibody to triiodothyronine and thyroxine. ( Bastomsky, CH; Meltzer, SJ; Moroz, LA, 1983) |
| "Propranolol was also given for the first 3 weeks." | 1.27 | Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. ( Beardwell, CG; Davies, D; Longson, D; MacFarlane, IA; Shalet, SM, 1983) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 1.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "Glycerol clearance was increased in hyperthyroidism and followed a double exponential decay with a shortened second component half-time." | 1.27 | Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. ( Alberti, KG; Baylis, PH; Clark, F; Johnston, DG; Kendall-Taylor, P; McCulloch, AJ; Young, ET, 1983) |
| "Twenty-seven patients with untreated Graves' disease were studied in order to determine alterations of concentration/attention and their possible association with levels of T4, T3RU, free thyroxin index (FTI), and anxiety." | 1.27 | Attention disturbance in Graves' disease. ( Alavez, E; Alvarez, MA; Gómez, A; Navarro, D, 1983) |
| "These results suggest that Graves' disease may evolve into chronic thyroiditis in some patients who are in permanent remission, and some patients in apparent permanent remission have hyperthyroidism and concomitant chronic thyroiditis." | 1.27 | Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment. ( Hayashi, Y; Hirota, Y; Kuma, K; Kumagai, LF; Matsubayashi, S; Matsuzuka, F; Nagataki, S; Tamai, H, 1986) |
| "In 8 patients with euthyroid Graves' disease, TBII activity was detectable only in one patient and TSAb activity detected in 3 patients, these detectabilities being much lower than those in hyperthyroid Graves' disease." | 1.27 | [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug trea ( Nishikawa, M; Uno, C, 1988) |
| "Thyroid follicles obtained from Graves' disease glands gave modified results with an earlier and intensified T3 response and no increase in Tg." | 1.27 | Functional properties of human thyroid follicles cultured within collagen gel. ( Condé, D; Edan, G; Hody, B; Leclech, G; Massart, C; Nicol, M, 1988) |
| "Patients with hyperthyroid Graves' disease had high serum ACE activity (23." | 1.27 | Angiotensin-converting enzyme and anorexia nervosa. ( Fukata, S; Hirota, Y; Kobayashi, N; Kuma, K; Kumagai, LF; Matsubayashi, S; Nakagawa, T; Takaichi, Y; Tamai, H, 1988) |
| "In 49 patients with Graves' disease, the 20-min thyroidal uptake of 99mTc and serum levels of thyroid stimulating hormone (TSH) receptor antibody were estimated at presentation and at intervals during a 1-yr course of carbimazole and triiodothyronine." | 1.27 | Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. ( Cuthbert, GF; McKillop, JH; Pearson, DW; Thomson, JA; Wilson, R, 1985) |
| " In 6 of 25 patients, however, a discordant behaviour was clearly documented including dose-response curves." | 1.27 | Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease. ( Hörmann, R; Mann, K; Müller, R; Saller, B, 1985) |
| "Thyroidal Graves' disease--past or present--was clinically evident in 99 patients (79%): hyperthyroidism in 3 cases." | 1.27 | Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. ( Koornneef, L; Smit, T; van der Gaag, R; Wiersinga, WM, 1988) |
| "Twenty-three (12." | 1.27 | Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. ( Aizawa, T; Kamoi, K; Koizumi, Y; Murakami, M; Takahashi, Y; Watanabe, T; Yamada, T, 1988) |
| "Between 1973 and 1980, 93 patients with Graves' disease underwent subtotal thyroidectomy by the same surgeon (the size of thyroid remnant was 4 g per side)." | 1.27 | Long term thyroid function after subtotal thyroidectomy for Graves' disease. ( Betterle, C; Busnardo, B; Eccher, C; Girelli, ME; Rubello, D, 1988) |
| "Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs." | 1.27 | Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. ( Hosoya, T; Kohno, Y; Kuma, K; Mozai, T; Naito, N; Sakane, S; Takamatsu, J; Takeda, K; Tarutani, O; Yoshimura, H, 1988) |
| "In methimazole-treated patients with T3-suppressible thyroid uptake, anti-DNA antibody was found in 9% (3 of 35)." | 1.27 | Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. ( Aizawa, T; Hiramatsu, K; Ishihara, M; Kameko, M; Kanai, M; Katakura, M; Maruyama, K; Takasu, N; Yamada, T; Yukimura, Y, 1987) |
| "The thyroid volume in patients with Graves' disease who had been in remission (33." | 1.27 | [Determination of thyroid volume using computerized ultrasonography and its clinical application]. ( Miki, K, 1986) |
| "The iodine content of Tg was 28 +/- 3." | 1.27 | Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. ( Laurberg, P, 1987) |
| "In 4 patients with Graves' disease, the placental T4 concentration was elevated." | 1.27 | Measurement of thyroid hormone concentrations in human placenta. ( Furuhashi, N; Saito, S; Sakurada, T; Suzuki, M; Takahashi, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1987) |
| " In other cases, dosing of the free hormones T3 and T4 remains a vital supplementary test." | 1.27 | [Thyroid biological evaluation: critical study]. ( Heshmati, HM; Izembart, M; Nasser, H; Vallée, G, 1987) |
| "Hence patients with Graves' disease having a small thyroid gland should be treated medically while surgery or radioiodine may be a more reasonable choice in Graves' patients with medium size or large goitres." | 1.27 | Goitre size and outcome of medical treatment of Graves' disease. ( Buchholtz Hansen, PE; Eskjaer Jensen, S; Iversen, E; Laurberg, P; Weeke, J, 1986) |
| "Of 47 patients with hyperthyroid Graves' disease, 37 patients had a serum T3 to T4 ratio greater than 20 ng/micrograms before therapy (normal range, 12-20; mean, 16." | 1.27 | Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. ( Kuma, K; Mozai, T; Takamatsu, J, 1986) |
| "A rare complication of Graves' disease is thyrotoxic crisis." | 1.27 | Fatal thyrotoxic crisis. ( Herman, GE; Husain, M; Kanluen, S; Monforte, J; Spitz, WU, 1986) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 1.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| " Furthermore, they support the hypothesis that the dosage of thionamide compounds and the duration of therapy with the initial doses necessary to induce euthyroidism may vary in various parts of the world." | 1.27 | Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter. ( Azizi, F, 1985) |
| "Medical treatments for Graves' disease and for hypothyroidism are simulated with a view to enhancing clinical significance." | 1.27 | Computer simulation for hormones related to primary thyropathy. ( Hatakeyama, T; Yagi, H, 1985) |
| "A case of Graves' disease with high serum thyroxine (T4) and low triiodothyronine (T3) levels which was therefore initially diagnosed as a T4-thyrotoxicosis is reported." | 1.27 | A case of Graves' disease with anti-triiodothyronine antibodies. ( Kametani, M; Kamikubo, K; Komaki, T; Miura, K; Nakamura, S; Sakata, S; Takakuwa, K; Tokimitsu, N, 1985) |
| " We conclude that 1) ipodate (500 mg daily) reduces serum T4 and T3 levels as fast and as much as does the 1-g daily dose studied previously; 2) long term use (for 23-31 weeks) of ipodate for the treatment of Graves' hyperthyroidism is clinically feasible; no adverse effects occurred during or after ipodate treatment; and 3) RAI uptake returns to pretreatment levels as early as 7 days after the discontinuation of ipodate." | 1.27 | Long term treatment of Graves' hyperthyroidism with sodium ipodate. ( Bian, TY; Chopra, IJ; Huang, HW; Jeng, CY; Shen, DC; Shian, LR; Solomon, DH; Wu, SY, 1985) |
| "Five women with Graves' disease, 26-52 years of age, with serum concentrations of triiodothyronine (T3) 4." | 1.26 | Lack of effect of somatostatin on thyroid gland function in Graves' disease. ( Frey, HM; Skare, S, 1980) |
| "In 272 patients with Graves' disease, 209 of 240 (87%) untreated patients without complications had high T3 to T4 ratios (nanograms per micrograms) of more than 20." | 1.26 | Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. ( Amino, N; Iwatani, Y; Kumahara, Y; Miki, T; Miyai, K; Mori, H; Morimoto, S; Nakatani, K; Nishi, K; Yabu, Y, 1981) |
| "In untreated patients with Graves' disease, the percentage of T gamma lymphocytes (mean +/- SD, 8." | 1.26 | Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. ( Amino, N; Asari, S; Iwatani, Y; Izumiguchi, Y; Kumahara, Y; Miyai, K; Mori, H, 1982) |
| "Thus the Graves' disease specific immunoglobulins were found to be significantly associated with the relapse of the disease (p less than 0." | 1.26 | [The prognosis of Graves' disease after antithyroid drug treatment: clinical significance of the T3 suppression test and abnormal thyroid stimulators]. ( Endo, K; Iida, Y; Imura, H; Inada, M; Ishii, H; Kasagi, K; Konishi, J; Kuma, K; Misaki, T; Naito, K; Nesumi, N; Nishikawa, M; Tanaka, K; Torizuka, K, 1982) |
| "This suggests that thrombocytopenia in Graves' disease is caused by an increased sequestration potency of the reticuloendothelial phagocyte system stimulated by thyroid hormone." | 1.26 | Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. ( Kitani, T; Kurata, Y; Nishioeda, Y; Tsubakio, T, 1980) |
| "Furthermore in Graves' disease progression of exophthalmos has sometimes been seen following thyroidectomy." | 1.26 | Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease. ( Blichert-Toft, M; Christiansen, C; Date, J; Feldt-Rasmussen, U, 1982) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 1.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "In order to study the prognosis of Graves' disease, 236 patients, who had been diagnosed as having had Graves' disease more than 10 years before, were examined." | 1.26 | [Primary hypothyroidism as a possible cause of hypertension from long-term follow-up studies of patients with Graves' disease (author's transl)]. ( Inoue, K; Nakashima, T; Nishitani, H; Okamura, K; Omae, T; Shiroozu, A; Yoshinari, M; Yoshizumi, T, 1980) |
| "The findings might indicate that Graves' disease is closely related to Hashimoto's thyroiditis, especially in sibling patients with Graves' disease." | 1.26 | Clinical and pathological significance of sibling Graves' disease. ( Hidaka, H; Katayama, S; Kuma, K; Matsuzuka, F; Tamai, H; Tanaka, T, 1980) |
| " High pretreatment T3 values were comparatively common among patients in whom a fixed CMI dosage had a insufficient effect." | 1.26 | Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen. ( Dahlberg, PA; Karlsson, FA; Lindström, B; Wide, L, 1981) |
| "Twenty-eight patients with Graves' disease were treated with short-term antithyroid drug therapy." | 1.26 | Early remission in thyrotoxicosis produced by short courses of treatment. ( Bing, RF; Rosenthal, FD, 1982) |
| "Ninety five patients with Graves' disease were studied before and at three months intervals after antithyroid drugs (ATD) (31 cases) or radioiodine (64 cases) therapy until recovery." | 1.26 | Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. ( Baldet, L; Jaffiol, C; Lapinski, H; Mirouze, J; Papachristou, C; Robin, M, 1977) |
| " It is suggested therefore that the long term administration of antithryoid drugs can be a useful treatment for intractable cases." | 1.26 | Long term antithyroid drug therapy for intractable cases of Graves' disease. ( Shizume, K, 1978) |
| "The euthyroid patients with treated Graves' disease with a weak response to i." | 1.26 | [Value of the oral TRH test for the evaluation of thyroid function in impaired TSH reserve. Preliminary report]. ( Baur, U; Brikhäuser, MH; Gemsenjäger, E; Girard, J; Gräni, R; Staub, JJ, 1979) |
| "The relationship of Graves' disease and heredity was studied in 97 clinically and biochemically euthyroid relatives (resin T3 uptake and serum T3, T4, and TSH within normal ranges) who had more than two thyrotoxic relatives within the second degree relationship." | 1.26 | Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease. ( Ikemi, Y; Kuma, K; Kumagai, LF; Matsuzuka, F; Nagataki, S; Shizume, K; Suematsu, H; Tamai, H, 1978) |
| "In 6 TRH non-responsive patients with Graves' disease, serum TSH levels were suppressed from 2." | 1.26 | The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease. ( Frey, HM; Haug, E; Sand, T, 1977) |
| "32 patients with Graves' Disease were investigated before treatment, during ATD therapy and after recovery with a normal T3 suppression test." | 1.26 | [Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease]. ( Aberlenc, M; Baldet, L; Castelnau, P; Jaffiol, C; Mirouze, J, 1978) |
| "Four patients with Graves' disease whose hyperthyroidism was in remission following antithyroid therapy were studied without any treatment during and after pregnancy." | 1.26 | Transient recurrence of hyperthyroidism after delivery in Graves' disease. ( Amino, N; Kuro, R; Miyai, K; Tanaka, F; Yamamoto, T, 1977) |
| "Seventy-seven patients with Graves' disease, with an average of 56 years of age were treated with carbimazole in the period 1968-1975." | 1.26 | Outcome of long-term antithyroid treatment of graves' disease in relation to iodine intake. ( Friis, T; Hansen, JM; Kirkegaard, C; Lumholtz, IB; Poulsen, DL; Rogowski, P; Siersbaek-Nielsen, K, 1977) |
| "In Tg from patients with treated Graves' disease, iodine, T(3), and T(4) were reduced, but the reduction in the latter was more substantial, resulting in a T(4)/T(3) molar ratio of 3." | 1.26 | Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. ( Izumi, M; Larsen, PR, 1977) |
| "Triiodothyronine (T3) toxicity has been well documented in adults, but only isolated cases have been reported in children." | 1.26 | T3 toxicosis in children. ( Fawcett, DM; Harland, PC; McArthur, RG, 1977) |
| " The physiopathogenetic bases for this are examined in relation to dosage and early diagnosis." | 1.26 | [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism]. ( Biagioli, R; Dradi, C; Riceputi, G; Riva, P, 1979) |
| "Propranolol alone was used to prepare 20 thyrotoxic patients, 19 women and 1 man, for subtotal thyroidectomy." | 1.26 | Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy. ( Boyd, D; Tevaarwerk, GJ, 1979) |
| "In patients with Graves' disease there was no correlation between the level of TSAb and hormonal status except serum triiodothyronine (rs = 0." | 1.26 | Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases. ( Bech, K; Nistrup Madsen, S, 1979) |
| " Lithium carbonate was administered for 4-7 weeks in a dosage (900 mg/day) which maintained serum lithium levels between 0." | 1.26 | Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. ( Burman, KD; Dimond, RC; Earll, JM; Wartofsky, L; Wright, FD, 1976) |
| "Hyperthyroidism is a clinically dramatic but usually benign syndrome that is most commonly associated with the clinical triad known as Graves' disease." | 1.26 | Hyperthyroidism. ( Larsen, PR, 1976) |
| "Hyperthyroidism was diagnosed clinically after elevated serum T3 concentrations in 11 patients and at the same time in 2 patients." | 1.25 | Hormonal pattern of relapse in hyperthyroidism. ( Acosta, M; Chalkley, S; Howorth, PJ; Leatherdale, B; Marsden, P; McKerron, CG, 1975) |
| "Hypothyroidism was treated by thyroxine or tri-iodothyronine replacement therapy." | 1.25 | Intentional radioiodine ablation in Graves' disease. ( Ahmad, A; Burnet, RB; Harding, PE; Wise, PH, 1975) |
| "The 13 patients with Graves' disease were divided into three groups." | 1.25 | Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. ( Larsen, PR, 1975) |
| "2) In 30 cases with 131I treated Graves' disease, TSH concentration was 22." | 1.25 | [Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treate ( Takeda, Y, 1975) |
| "This ratio was increased in all Graves' disease patients with the highest value being 0." | 1.25 | Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. ( Dussault, JH; Fisher, DA; Low, JC; Nicoloff, JT, 1972) |
| "In four patients with hyperthyroid Graves' disease V(H) ranged from 3." | 1.25 | The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease. ( Cavalieri, RR; Searle, GL; Steinberg, M, 1970) |
| "In the patients with untreated hyperthyroidism, values for all these functions were greatly increased." | 1.25 | The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. ( Ingbar, SH; Sobel, RJ; Sterling, K; Woeber, KA, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 504 (53.90) | 18.7374 |
| 1990's | 185 (19.79) | 18.2507 |
| 2000's | 132 (14.12) | 29.6817 |
| 2010's | 86 (9.20) | 24.3611 |
| 2020's | 28 (2.99) | 2.80 |
| Authors | Studies |
|---|---|
| Akahori, H | 1 |
| Usuda, R | 1 |
| Ji, YK | 1 |
| Kim, SH | 1 |
| Fang, Y | 1 |
| Du, WH | 2 |
| Zhang, CX | 1 |
| Zhao, SX | 1 |
| Song, HD | 1 |
| Gao, GQ | 2 |
| Dong, M | 1 |
| Araruna, LVM | 1 |
| de Oliveira, DC | 1 |
| Pereira, MC | 1 |
| Moura Neto, A | 1 |
| Tambascia, MA | 1 |
| Zantut-Wittmann, DE | 1 |
| Weng, L | 2 |
| Huang, G | 2 |
| Gong, L | 2 |
| Xu, J | 3 |
| Mao, Y | 1 |
| Li, Y | 2 |
| Li, M | 4 |
| Cai, Y | 1 |
| Wang, Z | 1 |
| Liu, X | 2 |
| Wei, L | 1 |
| Li, S | 1 |
| Zheng, X | 1 |
| Yang, T | 1 |
| Xu, X | 1 |
| Nakano, M | 1 |
| Konishi, H | 1 |
| Koshiba, M | 1 |
| Cui, W | 1 |
| Lee, YW | 1 |
| Lin, YY | 1 |
| Weng, SF | 1 |
| Hsu, CH | 1 |
| Huang, CL | 1 |
| Lin, YP | 1 |
| Hsieh, YS | 1 |
| Liu, S | 1 |
| Miao, JJ | 1 |
| Zhou, X | 1 |
| Sun, Q | 1 |
| Mao, XM | 1 |
| Iwamoto, Y | 1 |
| Tatsumi, F | 1 |
| Katakura, Y | 1 |
| Dan, K | 1 |
| Wamata, R | 1 |
| Kimura, T | 4 |
| Shimoda, M | 1 |
| Nakanishi, S | 1 |
| Kaku, K | 1 |
| Mune, T | 1 |
| Kaneto, H | 1 |
| Shimmaru, K | 1 |
| Inami, M | 1 |
| Hamaoka, A | 1 |
| Fujiwara, N | 1 |
| Morioka, T | 1 |
| Emoto, M | 1 |
| Kamei, N | 1 |
| Suonsyrjä, N | 1 |
| Laihia, I | 1 |
| Huhtala, H | 1 |
| Jaatinen, P | 1 |
| Metso, S | 1 |
| Lane, LC | 1 |
| Cheetham, TD | 1 |
| Razvi, S | 2 |
| Allinson, K | 1 |
| Pearce, SHS | 1 |
| Ito, M | 7 |
| Kawasaki, M | 1 |
| Danno, H | 1 |
| Kohsaka, K | 1 |
| Nakamura, T | 1 |
| Hisakado, M | 1 |
| Yoshioka, W | 2 |
| Kasahara, T | 1 |
| Kudo, T | 2 |
| Nishihara, E | 3 |
| Fukata, S | 3 |
| Nishikawa, M | 12 |
| Nakamura, H | 6 |
| Miyauchi, A | 12 |
| Plazinska, MT | 1 |
| Sawicka-Gutaj, N | 2 |
| Czarnywojtek, A | 2 |
| Wolinski, K | 1 |
| Kobylecka, M | 1 |
| Karlińska, M | 1 |
| Prasek, K | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Borowska, M | 1 |
| Gut, P | 1 |
| Ruchala, M | 1 |
| Krolicki, L | 1 |
| Suzuki, N | 3 |
| Yoshimura Noh, J | 2 |
| Sugisawa, C | 1 |
| Hoshiyama, A | 1 |
| Hiruma, M | 1 |
| Kawaguchi, A | 1 |
| Morisaki, M | 1 |
| Ohye, H | 3 |
| Suzuki, M | 5 |
| Matsumoto, M | 5 |
| Kunii, Y | 4 |
| Yoshihara, A | 3 |
| Watanabe, N | 3 |
| Sugino, K | 5 |
| Ito, K | 22 |
| Hu, RT | 1 |
| Liu, DS | 1 |
| Li, B | 1 |
| Derkach, KV | 1 |
| Bakhtyukov, AA | 1 |
| Sorokoumov, VN | 1 |
| Shpakov, AO | 1 |
| Stachura, A | 1 |
| Gryn, T | 1 |
| Kałuża, B | 1 |
| Budlewski, T | 1 |
| Franek, E | 1 |
| Fujishima, A | 1 |
| Sato, A | 5 |
| Miura, H | 1 |
| Shimoda, Y | 1 |
| Kameyama, S | 1 |
| Ariake, C | 1 |
| Adachi, H | 1 |
| Fukuoka, Y | 1 |
| Terada, Y | 1 |
| Knezevic, J | 1 |
| Starchl, C | 1 |
| Tmava Berisha, A | 1 |
| Amrein, K | 1 |
| Ishikawa, T | 3 |
| Uchiyama, H | 1 |
| Iwashima, S | 1 |
| Baba, T | 1 |
| Ohishi, A | 1 |
| Iijima, S | 1 |
| Itoh, H | 1 |
| Cheng, Y | 3 |
| Sun, Z | 1 |
| Zhong, D | 1 |
| Ren, L | 1 |
| Yang, H | 1 |
| Litao, MKS | 1 |
| Alvarez, AG | 1 |
| Shah, B | 1 |
| Speer, G | 1 |
| Somogyi, P | 1 |
| Wu, Z | 1 |
| Zhu, Y | 1 |
| Zhang, M | 1 |
| Wang, C | 1 |
| Zhou, L | 1 |
| Liu, W | 1 |
| Yang, W | 1 |
| Zhang, S | 1 |
| Ren, Q | 1 |
| Han, X | 1 |
| Ji, L | 1 |
| Washio, K | 1 |
| Uenaka, M | 1 |
| Tanimura, K | 1 |
| Deguchi, M | 1 |
| Nishida, K | 1 |
| Fujioka, K | 1 |
| Yamada, H | 2 |
| Okazaki-Hada, M | 1 |
| Maruoka, A | 1 |
| Yamamoto, M | 12 |
| Hirokawa, M | 1 |
| Akamizu, T | 1 |
| Toyoda, N | 3 |
| Segal, KL | 1 |
| Nelson, CC | 1 |
| Wang, F | 2 |
| Zhang, SJ | 1 |
| Yao, X | 1 |
| Tian, DM | 1 |
| Zhang, KQ | 1 |
| She, DM | 1 |
| Guo, FF | 1 |
| Zhai, QW | 1 |
| Ying, H | 1 |
| Xue, Y | 1 |
| Citterio, CE | 1 |
| Veluswamy, B | 1 |
| Morgan, SJ | 1 |
| Galton, VA | 1 |
| Banga, JP | 1 |
| Atkins, S | 2 |
| Morishita, Y | 1 |
| Neumann, S | 1 |
| Latif, R | 1 |
| Gershengorn, MC | 1 |
| Smith, TJ | 3 |
| Arvan, P | 1 |
| Fischli, S | 2 |
| von Wyl, V | 1 |
| Trummler, M | 1 |
| Konrad, D | 1 |
| Wueest, S | 1 |
| Ruefer, A | 1 |
| Heering, K | 1 |
| Streuli, R | 1 |
| Steuer, C | 1 |
| Bernasconi, L | 1 |
| Recher, M | 1 |
| Henzen, C | 2 |
| Alonso, GT | 1 |
| Rabon, S | 1 |
| White, PC | 1 |
| Hashimoto, K | 1 |
| Matsumoto, S | 2 |
| Nakajima, Y | 2 |
| Tsujimoto, K | 1 |
| Yamakage, H | 1 |
| Satoh-Asahara, N | 1 |
| Noh, JY | 6 |
| Mori, M | 5 |
| Yamada, M | 2 |
| Ogawa, Y | 2 |
| Honda, A | 1 |
| Uchida, T | 1 |
| Komiya, K | 1 |
| Goto, H | 2 |
| Takeno, K | 3 |
| Sato, J | 1 |
| Suzuki, R | 1 |
| Himuro, M | 1 |
| Watada, H | 1 |
| Guo, Q | 1 |
| Wu, D | 1 |
| Yu, H | 1 |
| Bao, J | 1 |
| Peng, S | 1 |
| Shan, Z | 1 |
| Guan, H | 1 |
| Teng, W | 1 |
| Al Jassim, A | 1 |
| Wallace, T | 1 |
| Bouhabel, S | 1 |
| Majdan, A | 1 |
| Hier, M | 1 |
| Forest, VI | 1 |
| Payne, R | 1 |
| Davis, JR | 1 |
| Dackiw, AP | 1 |
| Holt, SA | 1 |
| Nwariaku, FE | 1 |
| Oltmann, SC | 1 |
| Gonzalez-Aguilera, B | 1 |
| Betea, D | 1 |
| Lutteri, L | 1 |
| Cavalier, E | 1 |
| Geenen, V | 1 |
| Beckers, A | 1 |
| Valdes-Socin, H | 1 |
| Cole, M | 1 |
| Hynes, AM | 1 |
| Howel, D | 1 |
| Hall, L | 1 |
| Abinun, M | 1 |
| Allahabadia, A | 1 |
| Barrett, T | 1 |
| Boelaert, K | 1 |
| Drake, AJ | 1 |
| Dimitri, P | 1 |
| Kirk, J | 1 |
| Zammitt, N | 1 |
| Pearce, S | 1 |
| Cheetham, T | 1 |
| Nojiri, T | 1 |
| Kurano, M | 1 |
| Araki, O | 1 |
| Nakawatari, K | 1 |
| Shimamoto, S | 1 |
| Igarashi, K | 1 |
| Kano, K | 1 |
| Aoki, J | 1 |
| Kihara, S | 1 |
| Murakami, M | 5 |
| Yatomi, Y | 1 |
| Wiersinga, WM | 8 |
| Siemińska, L | 1 |
| Foltyn, W | 1 |
| Głogowska-Szeląg, J | 1 |
| Kajdaniuk, D | 1 |
| Marek, B | 1 |
| Nowak, M | 1 |
| Walczak, K | 1 |
| Kos-Kudła, B | 1 |
| Baldini, M | 3 |
| Gambini, D | 1 |
| Airaghi, L | 1 |
| Tomirotti, M | 1 |
| Cappellini, MD | 1 |
| Kuznik, BI | 1 |
| Vitkovsky, YA | 1 |
| Gvozdeva, OV | 1 |
| Solpov, AV | 1 |
| Magen, E | 1 |
| Celik, HT | 1 |
| Abusoglu, S | 1 |
| Burnik, SF | 1 |
| Sezer, S | 1 |
| Serdar, MA | 1 |
| Ercan, M | 1 |
| Uguz, N | 1 |
| Avcikucuk, M | 1 |
| Ceylan, B | 1 |
| Yildirimkaya, M | 1 |
| Peng, D | 1 |
| Xu, B | 1 |
| Wang, Y | 1 |
| Guo, H | 2 |
| Jiang, Y | 1 |
| Carlé, A | 2 |
| Knudsen, N | 2 |
| Pedersen, IB | 1 |
| Perrild, H | 2 |
| Ovesen, L | 2 |
| Rasmussen, LB | 2 |
| Laurberg, P | 8 |
| Li, N | 1 |
| Li, XH | 1 |
| Yao, YM | 1 |
| Zhang, J | 2 |
| Zeng, H | 1 |
| Ren, M | 1 |
| Yan, H | 1 |
| Xu, M | 1 |
| Feng, Z | 1 |
| Liang, W | 1 |
| Yang, C | 1 |
| Cheng, H | 1 |
| Ding, H | 1 |
| Yan, L | 1 |
| Mohlin, E | 1 |
| Filipsson Nyström, H | 1 |
| Eliasson, M | 1 |
| Ide, A | 1 |
| Amino, N | 18 |
| Kang, S | 1 |
| Gutaj, P | 1 |
| Sowiński, J | 3 |
| Wender-Ożegowska, E | 1 |
| Brązert, J | 1 |
| Ruchała, M | 1 |
| Kruljac, I | 1 |
| Solter, D | 1 |
| Vrkljan, AM | 1 |
| Solter, M | 1 |
| Li, C | 2 |
| Tan, J | 2 |
| Zhang, G | 2 |
| Meng, Z | 1 |
| Wang, R | 2 |
| Li, W | 1 |
| Zheng, W | 2 |
| Zeng, J | 1 |
| Yan, YR | 1 |
| Yan, Z | 1 |
| Huang, H | 1 |
| Guo, N | 1 |
| Yang, K | 1 |
| Lin, YS | 1 |
| Wang, T | 1 |
| Schneider, DF | 1 |
| Sonderman, PE | 1 |
| Jones, MF | 1 |
| Ojomo, KA | 1 |
| Chen, H | 1 |
| Jaume, JC | 1 |
| Elson, DF | 1 |
| Perlman, SB | 1 |
| Sippel, RS | 1 |
| Sato, S | 4 |
| Yasuda, S | 1 |
| Mukasa, K | 3 |
| Nagataki, S | 22 |
| Taniyama, M | 2 |
| Zhang, H | 1 |
| Liang, L | 1 |
| Xie, Z | 1 |
| Yang, J | 1 |
| Li, LF | 1 |
| Xu, Q | 1 |
| Weng, WW | 1 |
| Zhu, YJ | 1 |
| Dong, MJ | 1 |
| Gesing, J | 1 |
| Pfaeffle, R | 1 |
| Christiansen, H | 1 |
| Keller, A | 1 |
| Lincke, T | 1 |
| Lamesch, P | 1 |
| Sabri, O | 2 |
| Kiess, W | 1 |
| Decroli, E | 1 |
| Manaf, A | 1 |
| Syahbuddin, S | 1 |
| Harvengt, J | 1 |
| Boizeau, P | 1 |
| Chevenne, D | 1 |
| Zenaty, D | 1 |
| Paulsen, A | 1 |
| Simon, D | 1 |
| Guilmin Crepon, S | 1 |
| Alberti, C | 1 |
| Carel, JC | 1 |
| Léger, J | 1 |
| Kameda, T | 2 |
| Chen, L | 2 |
| Shen, Q | 1 |
| Liu, T | 1 |
| Jiang, L | 1 |
| Gu, X | 1 |
| Sun, J | 1 |
| Liu, C | 1 |
| Tohma, Y | 2 |
| Akturk, M | 2 |
| Altinova, A | 1 |
| Yassibas, E | 1 |
| Cerit, ET | 2 |
| Gulbahar, O | 1 |
| Arslan, M | 1 |
| Sanlier, N | 1 |
| Toruner, F | 1 |
| Goichot, B | 1 |
| Caron, P | 1 |
| Landron, F | 1 |
| Bouée, S | 1 |
| Motylewska, E | 1 |
| Nieć, M | 1 |
| Siejka, A | 1 |
| Komorowski, J | 1 |
| Ławnicka, H | 1 |
| Świętosławski, J | 1 |
| Stępień, H | 1 |
| Iwaku, K | 1 |
| Kobayashi, S | 6 |
| Shi, B | 1 |
| Li, H | 1 |
| Li, QM | 1 |
| Wei, JP | 1 |
| Meng, SH | 1 |
| Lucchini, B | 1 |
| Müller, W | 1 |
| Slahor, L | 1 |
| Vita, R | 1 |
| Lapa, D | 1 |
| Trimarchi, F | 4 |
| Vita, G | 1 |
| Fallahi, P | 3 |
| Antonelli, A | 3 |
| Benvenga, S | 4 |
| Barbesino, G | 3 |
| Tun, NN | 1 |
| Beckett, G | 2 |
| Zammitt, NN | 1 |
| Strachan, MW | 1 |
| Seckl, JR | 1 |
| Gibb, FW | 1 |
| Aggarwal, N | 1 |
| Tee, SA | 1 |
| Saqib, W | 1 |
| Fretwell, T | 1 |
| Summerfield, GP | 1 |
| Cox, SC | 1 |
| Tamatea, JA | 1 |
| Conaglen, JV | 1 |
| Elston, MS | 1 |
| Xu, F | 1 |
| Gu, A | 1 |
| Pan, Y | 1 |
| Yang, L | 1 |
| Ma, Y | 1 |
| Peng, Y | 1 |
| Qi, Y | 1 |
| Huang, F | 1 |
| Chen, X | 1 |
| Zhou, Y | 1 |
| Ye, L | 1 |
| Wang, W | 1 |
| Ning, G | 5 |
| Wang, S | 4 |
| Leo, M | 1 |
| Bartalena, L | 6 |
| Rotondo Dottore, G | 1 |
| Piantanida, E | 2 |
| Premoli, P | 1 |
| Ionni, I | 1 |
| Di Cera, M | 1 |
| Masiello, E | 1 |
| Sassi, L | 2 |
| Tanda, ML | 3 |
| Latrofa, F | 1 |
| Vitti, P | 2 |
| Marcocci, C | 3 |
| Marinò, M | 1 |
| Fernando, R | 1 |
| Placzek, E | 1 |
| Reese, EA | 1 |
| Placzek, AT | 1 |
| Schwartz, S | 1 |
| Trierweiler, A | 1 |
| Niziol, LM | 1 |
| Raychaudhuri, N | 1 |
| Scanlan, TS | 1 |
| Martin, CS | 1 |
| Sirbu, AE | 1 |
| Betivoiu, MA | 1 |
| Florea, S | 1 |
| Barbu, CG | 1 |
| Fica, SV | 1 |
| Yalcin, MM | 1 |
| Altinova, AE | 1 |
| Arslan, E | 1 |
| Yetkin, I | 1 |
| Toruner, FB | 1 |
| Kim, YA | 1 |
| Cho, SW | 1 |
| Choi, HS | 1 |
| Moon, S | 1 |
| Moon, JH | 1 |
| Kim, KW | 2 |
| Park, DJ | 1 |
| Yi, KH | 1 |
| Park, YJ | 1 |
| Cho, BY | 3 |
| Brent, GA | 1 |
| Bossowski, A | 4 |
| Czarnocka, B | 1 |
| Bardadin, K | 1 |
| Urban, M | 3 |
| Niedziela, M | 1 |
| Dadan, J | 1 |
| Morishita, E | 1 |
| Sekiya, A | 1 |
| Hayashi, T | 1 |
| Kadohira, Y | 1 |
| Maekawa, M | 1 |
| Yamazaki, M | 1 |
| Asakura, H | 1 |
| Nakao, S | 2 |
| Ohtake, S | 1 |
| Miao, J | 1 |
| Zhao, YJ | 2 |
| Jiang, XH | 1 |
| Zhao, ZF | 1 |
| Gu, LQ | 2 |
| Gu, XJ | 1 |
| Chu, CH | 2 |
| Lee, JK | 2 |
| Wang, MC | 2 |
| Lu, CC | 2 |
| Sun, CC | 2 |
| Chuang, MJ | 2 |
| Lam, HC | 2 |
| Vos, XG | 1 |
| Smit, N | 1 |
| Endert, E | 1 |
| Brosschot, JF | 1 |
| Tijssen, JG | 1 |
| Koga, M | 1 |
| Murai, J | 1 |
| Saito, H | 2 |
| Kasayama, S | 1 |
| Regalbuto, C | 2 |
| Marturano, I | 1 |
| Condorelli, A | 1 |
| Latina, A | 1 |
| Pezzino, V | 2 |
| Endo, T | 1 |
| Kobayashi, T | 1 |
| Gen, R | 1 |
| Akbay, E | 1 |
| Camsari, A | 1 |
| Ozcan, T | 1 |
| Erem, C | 2 |
| Ucuncu, O | 1 |
| Yilmaz, M | 1 |
| Kocak, M | 2 |
| Nuhoglu, İ | 1 |
| Ersoz, HO | 2 |
| Shaheen, D | 1 |
| Kim, CS | 1 |
| García, JL | 1 |
| Etayo, BZ | 1 |
| Calvo, JI | 1 |
| Lai, A | 1 |
| Compri, E | 1 |
| Marino, F | 1 |
| Sivelli, P | 1 |
| Cetinkalp, S | 1 |
| Karadeniz, M | 1 |
| Erdoğan, M | 1 |
| Eroğlu, Z | 1 |
| Zengi, A | 1 |
| Kosova, B | 1 |
| Yilmaz, C | 1 |
| Tezcanli, B | 1 |
| Kabalak, T | 1 |
| Ozgen, AG | 1 |
| Potlukova, E | 1 |
| Jiskra, J | 1 |
| Freiberger, T | 1 |
| Limanova, Z | 1 |
| Zivorova, D | 1 |
| Malickova, K | 1 |
| Springer, D | 1 |
| Grodecka, L | 1 |
| Antosova, M | 1 |
| Telicka, Z | 1 |
| Pesickova, SS | 1 |
| Trendelenburg, M | 1 |
| Wasniewska, M | 1 |
| Corrias, A | 1 |
| Arrigo, T | 1 |
| Lombardo, F | 1 |
| Salerno, M | 1 |
| Mussa, A | 1 |
| Vigone, MC | 1 |
| De Luca, F | 2 |
| Sato, H | 1 |
| Sawicka, B | 1 |
| Szalecki, M | 1 |
| Wysoka, J | 1 |
| Koput, A | 1 |
| Zelazowska-Rutkowska, B | 1 |
| Tobolczyk, J | 1 |
| Rogowski, F | 2 |
| Łuba, M | 1 |
| Popoveniuc, G | 1 |
| Sharma, M | 1 |
| Devdhar, M | 1 |
| Wexler, JA | 1 |
| Carroll, NM | 1 |
| Wartofsky, L | 4 |
| Burman, KD | 3 |
| Kinoshita, H | 1 |
| Yasuda, M | 1 |
| Kaneko, S | 1 |
| Usui, R | 1 |
| Inoshita, S | 1 |
| Furumoto, Y | 1 |
| Maruyama, Y | 1 |
| Susa, K | 1 |
| Suenaga, M | 1 |
| Fujita, H | 1 |
| Tomiyama, J | 1 |
| Yakushiji, F | 1 |
| Nomura, E | 1 |
| Takamura, Y | 1 |
| Iwasaka, T | 1 |
| Takamatsu, J | 11 |
| Zhao, L | 1 |
| Zhu, W | 2 |
| Li, FY | 1 |
| Zhang, MJ | 1 |
| Liu, Y | 1 |
| Liu, JM | 1 |
| Mao, C | 1 |
| Xiao, Y | 1 |
| Jiang, Q | 1 |
| Jin, M | 1 |
| Jiang, X | 2 |
| Zhang, Y | 1 |
| Aslan, M | 1 |
| Cosar, N | 1 |
| Celik, H | 1 |
| Aksoy, N | 1 |
| Dulger, AC | 1 |
| Begenik, H | 1 |
| Soyoral, YU | 1 |
| Kucukoglu, ME | 1 |
| Selek, S | 1 |
| Amato-Stratmann, M | 1 |
| Kahaly, GJ | 1 |
| Grebe, SK | 1 |
| Lupo, MA | 1 |
| McDonald, N | 1 |
| Sipos, JA | 1 |
| Abdelrazek, S | 1 |
| Szumowski, P | 1 |
| Zonenberg, A | 1 |
| Parfienczyk, A | 1 |
| Sawicka, A | 1 |
| Dong, QY | 1 |
| Li, SJ | 1 |
| Liu, XM | 1 |
| Li, WX | 1 |
| Liang, CG | 1 |
| Wsng, YL | 1 |
| Osaki, Y | 1 |
| Sakurai, K | 1 |
| Arihara, Z | 1 |
| Hata, M | 1 |
| Fukazawa, H | 6 |
| González Cabrera, N | 1 |
| Kalic, AK | 1 |
| Antón Miguel, MÁ | 1 |
| Sierra Polo, P | 1 |
| Vicente Vicente, MÁ | 1 |
| Liu, R | 1 |
| Ma, X | 1 |
| Xu, L | 1 |
| Wang, D | 1 |
| Cui, B | 1 |
| Lin, D | 1 |
| Balázs, C | 5 |
| Türke, B | 1 |
| Vámos, A | 1 |
| Oi, N | 1 |
| Ohi, K | 1 |
| Matsumoto, C | 1 |
| Yamakawa, N | 1 |
| Yoshida, H | 1 |
| Date, A | 1 |
| Watanabe, M | 3 |
| Hidaka, Y | 8 |
| Iwatani, Y | 11 |
| Takano, T | 3 |
| van Veenendaal, NR | 1 |
| Ulmer, B | 1 |
| Boskovski, MT | 1 |
| Fang, X | 1 |
| Khokha, MK | 1 |
| Wendler, CC | 1 |
| Blum, M | 3 |
| Rivkees, SA | 1 |
| Bülow Pedersen, I | 1 |
| Jørgensen, T | 1 |
| Groom, K | 1 |
| Snowise, S | 1 |
| Wheeler, B | 1 |
| Mekhail, A | 1 |
| Farrand, S | 1 |
| Parry, E | 1 |
| Goswami, R | 2 |
| Guleria, R | 1 |
| Gupta, AK | 1 |
| Gupta, N | 1 |
| Marwaha, RK | 1 |
| Pande, JN | 1 |
| Kochupillai, N | 2 |
| Yaturu, S | 1 |
| McDonald, J | 1 |
| Nakagawa, Y | 1 |
| Mori, K | 5 |
| Hoshikawa, S | 1 |
| Ito, S | 1 |
| Yoshida, K | 9 |
| Bogazzi, F | 2 |
| Campomori, A | 1 |
| Brogioni, S | 1 |
| Traino, C | 2 |
| De Martino, F | 1 |
| Rossi, G | 1 |
| Lippi, F | 1 |
| Pinchera, A | 3 |
| Martino, E | 3 |
| Bunevicius, R | 1 |
| Jakuboniene, N | 1 |
| Jakubonien, N | 1 |
| Jurkevicius, R | 1 |
| Cernicat, J | 1 |
| Lasas, L | 1 |
| Prange, AJ | 1 |
| Gorman, CA | 5 |
| Garrity, JA | 1 |
| Fatourechi, V | 1 |
| Bahn, RS | 2 |
| Petersen, IA | 1 |
| Stafford, SL | 1 |
| Earle, JD | 1 |
| Forbes, GS | 1 |
| Kline, RW | 1 |
| Buettner, H | 1 |
| Robertson, DM | 1 |
| Bergstralh, EJ | 1 |
| Offord, KP | 1 |
| Rademacher, DM | 1 |
| Stanley, NM | 1 |
| Bartley, GB | 1 |
| Pichler, R | 3 |
| Wölfl, S | 1 |
| Bogner, S | 1 |
| Sulzbacher, H | 1 |
| Shamiyeh, A | 1 |
| Maschek, W | 3 |
| Schneider, P | 2 |
| Körber, C | 2 |
| Körber-Hafner, N | 2 |
| Hänscheid, H | 2 |
| Reiners, C | 3 |
| Stasiak-Barmuta, A | 2 |
| Morpurgo, PS | 1 |
| Beck-Peccoz, P | 2 |
| Reschini, E | 2 |
| Mannavola, D | 1 |
| Borgato, S | 1 |
| Vicentini, L | 1 |
| Spada, A | 1 |
| Zöphel, K | 1 |
| Wunderlich, G | 1 |
| Kopprasch, C | 1 |
| Koch, R | 1 |
| Franke, WG | 1 |
| Kotzerke, J | 1 |
| Hatzl-Griesenhofer, M | 2 |
| Huber, H | 1 |
| Crespillo-Gómez, C | 1 |
| Berg, J | 2 |
| Brokken, LJ | 1 |
| Prummel, MF | 2 |
| FREEDBERG, AS | 2 |
| HAMOLSKY, MW | 2 |
| MCCONAHEY, WM | 2 |
| OWEN, CA | 2 |
| BENUA, RS | 1 |
| KUMAOKA, S | 1 |
| LEEPER, RD | 1 |
| RAWSON, RW | 1 |
| HADDAD, H | 1 |
| LEVIN, ME | 1 |
| DE GENNES, JL | 1 |
| TRUFFERT, J | 1 |
| WATTS, WE | 1 |
| GILBERT-DREYFUS, M | 1 |
| LELONG, M | 1 |
| CANLORBE, P | 1 |
| JOB, JC | 1 |
| SCHAISON, G | 1 |
| LUPULESCU, A | 1 |
| KOSAKOWSKY, W | 1 |
| WERNER, SC | 4 |
| SPOONER, M | 1 |
| HAMILTON, H | 1 |
| HALES, IB | 1 |
| DOBYNS, BM | 2 |
| Tatsumi, KI | 2 |
| Izumi, Y | 2 |
| Nakata, Y | 1 |
| Weetman, AP | 3 |
| Shepherdley, CA | 1 |
| Mansell, P | 1 |
| Ubhi, CS | 1 |
| Visser, TJ | 4 |
| Kruś, J | 1 |
| Szymański, W | 1 |
| Korbal, P | 1 |
| Pandey, CK | 1 |
| Raza, M | 1 |
| Dhiraaj, S | 1 |
| Agarwal, A | 1 |
| Singh, PK | 1 |
| Gruñeiro-Papendieck, L | 1 |
| Chiesa, A | 1 |
| Finkielstain, G | 1 |
| Heinrich, JJ | 1 |
| Mastorakos, G | 1 |
| Doufas, AG | 1 |
| Mantzos, E | 1 |
| Mantzos, J | 1 |
| Koutras, DA | 3 |
| Vrca, VB | 1 |
| Skreb, F | 1 |
| Cepelak, I | 1 |
| Romic, Z | 1 |
| Mayer, L | 1 |
| Chao, TC | 1 |
| Lin, JD | 1 |
| Chen, MF | 1 |
| Grimes, CM | 1 |
| Muniz, H | 1 |
| Montgomery, WH | 1 |
| Goh, YS | 1 |
| Panzer, C | 1 |
| Beazley, R | 1 |
| Braverman, L | 1 |
| Bednarek, J | 2 |
| Wysocki, H | 2 |
| He, CT | 1 |
| Hsieh, AT | 1 |
| Pei, D | 2 |
| Hung, YJ | 1 |
| Wu, LY | 1 |
| Yang, TC | 1 |
| Lian, WC | 1 |
| Huang, WS | 1 |
| Kuo, SW | 2 |
| Pirnat, E | 1 |
| Zaletel, K | 1 |
| Gaberscek, S | 1 |
| Fidler, V | 1 |
| Hojker, S | 1 |
| Liel, Y | 1 |
| Kandemir, N | 1 |
| Hacihasanoglu, A | 1 |
| Ukinc, K | 1 |
| Cooper, DS | 5 |
| Yanagisawa, T | 1 |
| Sato, K | 1 |
| Kato, Y | 2 |
| Shimizu, S | 1 |
| Takano, K | 1 |
| Lee, DS | 1 |
| Chung, JK | 1 |
| Koh, CS | 2 |
| Lee, M | 1 |
| Kihara, M | 1 |
| Kontani, K | 1 |
| Yamauchi, A | 1 |
| Yodoi, J | 1 |
| Yokomise, H | 1 |
| Tsai, WC | 1 |
| Wang, TF | 1 |
| Wu, DA | 1 |
| Li, JC | 1 |
| Wei, CL | 1 |
| Lee, CH | 1 |
| Chen, SP | 1 |
| Czarkowski, M | 1 |
| Hilgertner, L | 1 |
| Powałowski, T | 1 |
| Radomski, D | 1 |
| Mikulska, M | 1 |
| Minelli, R | 3 |
| Coiro, V | 1 |
| Valli, MA | 1 |
| Finardi, L | 1 |
| Di Seclì, C | 1 |
| Bertoni, R | 1 |
| La Gioia, D | 1 |
| Barilli, AL | 1 |
| Ferrari, C | 3 |
| Jotti, GS | 1 |
| Delsignore, R | 1 |
| Slyper, AH | 1 |
| Wyatt, D | 1 |
| Boudreau, C | 1 |
| Woeber, KA | 3 |
| Vigersky, RA | 1 |
| Filmore-Nassar, A | 1 |
| Glass, AR | 1 |
| Tang, XL | 1 |
| Liu, XJ | 1 |
| Sun, WM | 1 |
| Zhao, J | 1 |
| Zheng, RL | 1 |
| Luton, D | 1 |
| Le Gac, I | 1 |
| Noel, M | 1 |
| Guibourdenche, J | 1 |
| Polak, M | 1 |
| Orsatti, A | 1 |
| Bonfanti, MT | 1 |
| Castagnone, D | 2 |
| Cantalamessa, L | 3 |
| Riis, AL | 1 |
| Hansen, TK | 1 |
| Thiel, S | 1 |
| Gravholt, CH | 1 |
| Gjedde, S | 1 |
| Gormsen, LC | 1 |
| Jørgensen, JO | 1 |
| Weeke, J | 4 |
| Møller, N | 1 |
| Momotani, N | 9 |
| Fukada, S | 1 |
| Ueda, M | 3 |
| Inaba, M | 3 |
| Kumeda, Y | 3 |
| Nagasaki, T | 2 |
| Hiura, Y | 2 |
| Tahara, H | 2 |
| Onoda, N | 2 |
| Nishizawa, Y | 3 |
| Anolik, JR | 1 |
| Rotondi, M | 5 |
| Romagnani, P | 2 |
| Ferrari, SM | 2 |
| Barani, L | 1 |
| Ferrannini, E | 2 |
| Serio, M | 2 |
| O'Sullivan, AJ | 1 |
| Lewis, M | 2 |
| Diamond, T | 1 |
| Xia, N | 1 |
| Zhou, S | 1 |
| Liang, Y | 1 |
| Xiao, C | 1 |
| Shen, H | 1 |
| Pan, H | 1 |
| Deng, H | 1 |
| Wang, N | 1 |
| Li, QQ | 1 |
| Azizi, F | 2 |
| Hiraiwa, T | 1 |
| Imagawa, A | 1 |
| Kuma, K | 34 |
| Hanafusa, T | 1 |
| Chen, JL | 1 |
| Chiu, HW | 1 |
| Tseng, YJ | 1 |
| Chu, WC | 1 |
| Keng, HM | 1 |
| Wei, MC | 1 |
| Duntas, LH | 1 |
| Nonchev, BI | 1 |
| Terzieva, DD | 1 |
| Dimov, RS | 1 |
| Mateva, NG | 1 |
| Tsvetkova, TZ | 1 |
| Dimitrakov, DY | 1 |
| Ito, C | 1 |
| Okuda, N | 1 |
| Watanabe, C | 1 |
| Bilen, H | 1 |
| Atasoy, M | 1 |
| Akcay, G | 1 |
| Akcay, M | 1 |
| Capoglu, I | 1 |
| Gursan, N | 1 |
| Akbas, M | 1 |
| Bidingija, M | 1 |
| Galgani, A | 1 |
| Buzzetti, R | 1 |
| Ditu, M | 1 |
| Chung, YJ | 1 |
| Lee, BW | 1 |
| Kim, JY | 1 |
| Jung, JH | 1 |
| Min, YK | 1 |
| Lee, MS | 1 |
| Lee, MK | 1 |
| Chung, JH | 1 |
| Grosso, M | 1 |
| Boni, G | 1 |
| Mariani, G | 2 |
| Abraham-Nordling, M | 2 |
| Wallin, G | 2 |
| Lundell, G | 2 |
| Törring, O | 1 |
| Vestergaard, H | 1 |
| Nielsen, S | 1 |
| Christensen, SE | 1 |
| Seefeldt, T | 1 |
| Helleberg, K | 1 |
| Pedersen, KM | 1 |
| Itoh, K | 1 |
| Hamada, N | 5 |
| Fujiwara-Ueda, M | 1 |
| Dietlein, M | 1 |
| Moka, D | 1 |
| Reinholz, U | 1 |
| Schmidt, M | 1 |
| Schomäcker, K | 1 |
| Schicha, H | 1 |
| Wellner, U | 1 |
| Loy, M | 1 |
| Perra, E | 1 |
| Melis, A | 1 |
| Cianchetti, ME | 1 |
| Piga, M | 2 |
| Serra, A | 1 |
| Pinna, G | 1 |
| Mariotti, S | 2 |
| Tagami, T | 1 |
| Hagiwara, H | 1 |
| Usui, T | 1 |
| Shimatsu, A | 1 |
| Naruse, M | 1 |
| Dardano, A | 1 |
| Ballardin, M | 1 |
| Ferdeghini, M | 1 |
| Lazzeri, E | 1 |
| Caraccio, N | 2 |
| Barale, R | 1 |
| Monzani, F | 2 |
| Bodlaj, G | 1 |
| Brandstätter, W | 1 |
| Biesenbach, G | 1 |
| Kabadi, UM | 2 |
| Premachandra, BN | 2 |
| Santoh, T | 1 |
| Kuroda, S | 1 |
| Ueda, D | 1 |
| Tallstedt, L | 1 |
| Tørring, O | 1 |
| Azezli, AD | 1 |
| Bayraktaroglu, T | 1 |
| Orhan, Y | 1 |
| Namo Cury, A | 1 |
| Longui, CA | 1 |
| Kochi, C | 1 |
| Calliari, LE | 1 |
| Scalissi, N | 1 |
| Salles, JE | 1 |
| Neves Rocha, M | 1 |
| Barbosa de Melo, M | 1 |
| Rezende Melo, M | 1 |
| Monte, O | 1 |
| Feind, CR | 1 |
| Aida, M | 1 |
| Tamaki, H | 5 |
| Kawashima, M | 1 |
| Nishimura, H | 1 |
| Kitaura, T | 1 |
| Matsuzuka, F | 17 |
| Kumahara, Y | 5 |
| Miyai, K | 10 |
| Nakai, T | 1 |
| Matsui, J | 1 |
| Farid, NR | 4 |
| Docter, R | 4 |
| Bos, G | 2 |
| Hennemann, G | 7 |
| Kourides, IA | 2 |
| Pekonen, F | 1 |
| Weintraub, BD | 2 |
| Skare, S | 1 |
| Frey, HM | 2 |
| Solomon, DH | 15 |
| Ravel, R | 1 |
| Atkinson, S | 3 |
| Kendall-Taylor, P | 5 |
| Smyth, PP | 1 |
| Neylan, D | 1 |
| O'Donovan, DK | 1 |
| Gheri, RG | 1 |
| Borghi, A | 1 |
| Pratesi, E | 1 |
| Maiello, M | 1 |
| Hardisty, CA | 1 |
| Humphries, H | 1 |
| Munro, DS | 1 |
| Gossage, AA | 1 |
| Crawley, JC | 1 |
| Copping, S | 1 |
| Hinge, D | 1 |
| Himsworth, RL | 2 |
| Wenzel, KW | 3 |
| Lente, JR | 2 |
| Knox, AJ | 1 |
| Steel, NR | 2 |
| Leng, S | 1 |
| Hegedüs, L | 4 |
| Hansen, JM | 3 |
| Bech, K | 7 |
| Kampmann, JP | 1 |
| Jensen, K | 1 |
| Andersen, E | 1 |
| Hansen, P | 1 |
| Karstrup, S | 1 |
| Bliddal, H | 3 |
| Smeulers, J | 1 |
| Waldstein, SS | 1 |
| Dahlberg, PA | 5 |
| Karlsson, FA | 5 |
| Wide, L | 2 |
| Wuttke, H | 2 |
| Schlieter, D | 2 |
| Rajatanavin, R | 2 |
| Mahatumarat, P | 1 |
| Poochanugool, L | 1 |
| Kumpolpunth, S | 1 |
| Himathongkam, T | 2 |
| Yabu, Y | 5 |
| Miki, T | 1 |
| Morimoto, S | 1 |
| Mori, H | 3 |
| Nishi, K | 1 |
| Nakatani, K | 2 |
| Degrossi, OJ | 1 |
| Pinkas, M | 1 |
| El Tamer, S | 1 |
| Watanabe, T | 2 |
| Claus, H | 1 |
| García del Rio, H | 1 |
| Sakurada, T | 7 |
| Kaise, N | 6 |
| Kaise, K | 6 |
| Kitaoka, H | 3 |
| Saito, S | 7 |
| Yoshinaga, K | 6 |
| Asari, S | 2 |
| Izumiguchi, Y | 2 |
| Iida, Y | 6 |
| Konishi, J | 8 |
| Kasagi, K | 8 |
| Misaki, T | 5 |
| Endo, K | 5 |
| Nesumi, N | 1 |
| Torizuka, K | 3 |
| Tanaka, K | 5 |
| Ishii, H | 7 |
| Naito, K | 5 |
| Inada, M | 7 |
| Imura, H | 6 |
| Kawamura, S | 1 |
| Kishino, B | 1 |
| Tajima, K | 1 |
| Mashita, K | 1 |
| Tarui, S | 2 |
| Bagnasco, M | 1 |
| Canonica, GW | 1 |
| Ferrini, S | 1 |
| Biassoni, P | 1 |
| Melioli, G | 1 |
| Ferrini, O | 1 |
| Giordano, G | 1 |
| Romaldini, JH | 4 |
| Bromberg, N | 3 |
| Werner, RS | 3 |
| Tanaka, LM | 1 |
| Rodrigues, HF | 1 |
| Werner, MC | 4 |
| Farah, CS | 2 |
| Reis, LC | 1 |
| Kobayashi, I | 5 |
| Maruta, S | 1 |
| Ishihara, H | 1 |
| Iriuchijima, T | 1 |
| Takahashi, M | 1 |
| Shimomura, Y | 2 |
| Fukuda, H | 1 |
| Sugawara, M | 4 |
| Lau, R | 1 |
| Wasser, HL | 1 |
| Nelson, AM | 1 |
| Hershman, JM | 4 |
| Hallengren, B | 1 |
| Forsgren, A | 1 |
| Takata, I | 2 |
| Suzuki, Y | 2 |
| Saida, K | 2 |
| Sato, T | 4 |
| Saxe, VC | 1 |
| Meskell, M | 1 |
| Maloof, F | 6 |
| Ridgway, EC | 5 |
| Moroz, LA | 1 |
| Meltzer, SJ | 1 |
| Bastomsky, CH | 1 |
| Kajiwara, S | 1 |
| Miyamori, C | 1 |
| Kato, T | 1 |
| Cognini, G | 1 |
| Piantanelli, L | 1 |
| Paolinelli, E | 1 |
| Orlandoni, P | 1 |
| Pellegrini, A | 1 |
| Masera, N | 1 |
| Mashio, Y | 3 |
| Funauchi, M | 1 |
| Wehmann, RE | 1 |
| Nisula, BC | 1 |
| Górowski, T | 2 |
| Fukino, O | 8 |
| Tamai, H | 22 |
| Fujii, S | 2 |
| Ohsako, N | 7 |
| Matsubayashi, S | 6 |
| MacFarlane, IA | 1 |
| Davies, D | 1 |
| Longson, D | 1 |
| Shalet, SM | 2 |
| Beardwell, CG | 2 |
| McKenzie, JM | 4 |
| De Marchena, E | 1 |
| Yamada, T | 14 |
| Koizumi, Y | 6 |
| Hashizume, K | 3 |
| Aizawa, T | 10 |
| Takasu, N | 10 |
| Nagata, H | 2 |
| Takahashi, H | 5 |
| Kobayashi, A | 4 |
| Mozai, T | 5 |
| Földes, J | 6 |
| Bános, C | 4 |
| Krasznai, I | 1 |
| Petrányi, G | 1 |
| Steczek, K | 1 |
| McConnon, JK | 1 |
| Semenov, VD | 2 |
| Mal'ginova, OV | 1 |
| Erezeeva, LA | 1 |
| Tsanev, A | 1 |
| Khlebarova, M | 1 |
| Dishlianova, B | 1 |
| Zlateva, S | 1 |
| Schlumberger, M | 1 |
| Fragu, P | 1 |
| Hill, C | 1 |
| Parmentier, C | 1 |
| Tubiana, M | 1 |
| Haraguchi, K | 1 |
| Akasu, F | 2 |
| Aida, K | 1 |
| Mochizuki, H | 1 |
| Kanemaru, Y | 1 |
| Onaya, T | 2 |
| Pearce, CJ | 1 |
| Channick, BJ | 1 |
| Burgos, FL | 1 |
| Micames, C | 1 |
| Rivera, JV | 1 |
| Nakagawa, T | 7 |
| Inaba, S | 1 |
| Kubota, K | 1 |
| Kuzuya, N | 3 |
| Uchimura, H | 5 |
| Shigemasa, C | 3 |
| Onoyama, S | 1 |
| Okamura, Y | 1 |
| Yoshida, A | 2 |
| Mashiba, H | 2 |
| Abe, K | 2 |
| Romussi, M | 1 |
| Rampini, P | 1 |
| Benco, R | 1 |
| Boghen, M | 1 |
| Paracchi, A | 1 |
| Frezzati, S | 1 |
| Ross, DS | 1 |
| Daniels, GH | 4 |
| De Stefano, P | 1 |
| McCulloch, AJ | 1 |
| Johnston, DG | 1 |
| Baylis, PH | 1 |
| Clark, F | 4 |
| Young, ET | 2 |
| Alberti, KG | 1 |
| Costante, G | 1 |
| Barbera, C | 1 |
| Melluso, R | 2 |
| Chiovato, L | 2 |
| Consolo, F | 1 |
| Totsuka, Y | 1 |
| Kojima, I | 1 |
| Yamashita, N | 1 |
| Togawa, K | 3 |
| Sawaki, N | 1 |
| Ogata, E | 3 |
| Arteaga, E | 1 |
| López, JM | 1 |
| Rodríguez, JA | 1 |
| Michaud, P | 1 |
| López, G | 1 |
| Nakamura, S | 8 |
| Murayama, M | 1 |
| Kojima, N | 4 |
| Kamikubo, K | 4 |
| Sakata, S | 9 |
| Yasuda, K | 3 |
| Miura, K | 6 |
| Alvarez, MA | 1 |
| Gómez, A | 1 |
| Alavez, E | 1 |
| Navarro, D | 1 |
| Mizukami, Y | 1 |
| Matsubara, F | 3 |
| Kurata, Y | 1 |
| Nishioeda, Y | 1 |
| Tsubakio, T | 1 |
| Kitani, T | 1 |
| Ichihara, K | 3 |
| Azukizawa, M | 2 |
| Kumagai, LF | 7 |
| Ahmad, N | 1 |
| Cohen, MP | 1 |
| Banovac, K | 1 |
| Zakarija, M | 2 |
| Witte, A | 1 |
| Sekso, M | 1 |
| Jaffiol, C | 8 |
| Baldet, L | 8 |
| Missonne, CL | 1 |
| Papachristou, C | 3 |
| Esaki, M | 4 |
| Hurwitz, JJ | 1 |
| Feldt-Rasmussen, U | 5 |
| Blichert-Toft, M | 3 |
| Christiansen, C | 2 |
| Date, J | 3 |
| Otter, R | 1 |
| Peeters, HF | 1 |
| Bleeker, GM | 1 |
| Touber, JL | 2 |
| Charpentier, G | 1 |
| Coutris, G | 1 |
| Aubry, P | 1 |
| Duron, F | 1 |
| Rieu, M | 1 |
| Thomas, M | 1 |
| Teng, CS | 2 |
| Yeung, RT | 1 |
| Feek, CM | 2 |
| Sawers, JS | 1 |
| Irvine, WJ | 1 |
| Beckett, GJ | 1 |
| Ratcliffe, WA | 1 |
| Toft, AD | 1 |
| Shinzato, R | 2 |
| Suematsu, H | 7 |
| Carey, C | 1 |
| Skosey, C | 1 |
| Pinnamaneni, KM | 1 |
| Barsano, CP | 1 |
| DeGroot, LJ | 2 |
| Bradley, EL | 1 |
| DiGirolamo, M | 1 |
| Tarcan, Y | 1 |
| Oishi, M | 1 |
| Kurata, S | 1 |
| Puchalski, Z | 1 |
| Piotrowski, Z | 1 |
| Chyczewski, L | 1 |
| Orłowski, K | 1 |
| Rodriguez-Espinosa, J | 1 |
| Gomez-Gerique, JA | 1 |
| Ordoñez-Llanos, J | 1 |
| Soldevila-Bosch, J | 1 |
| Concustella-Bas, E | 1 |
| Okamura, K | 3 |
| Inoue, K | 5 |
| Shiroozu, A | 2 |
| Nakashima, T | 2 |
| Yoshinari, M | 1 |
| Omae, T | 2 |
| Yoshizumi, T | 1 |
| Nishitani, H | 2 |
| Venge, P | 1 |
| Roxin, LE | 1 |
| Jakubowska-Pakułowa, D | 2 |
| Tanaka, T | 3 |
| Katayama, S | 4 |
| Hidaka, H | 4 |
| Soud, GG | 1 |
| Derovanesian, J | 1 |
| Horster, FA | 2 |
| Zellmann, HE | 3 |
| Yamaguchi, T | 3 |
| Kemp, A | 1 |
| Madsen, SN | 1 |
| Sterling, K | 3 |
| Aranow, H | 1 |
| Wilkin, TJ | 4 |
| Isles, TE | 4 |
| Crooks, J | 6 |
| Gunn, A | 4 |
| Beck, JS | 4 |
| Hurley, JR | 1 |
| Becker, DV | 3 |
| Lundqvist, G | 1 |
| Sharp, B | 1 |
| Reed, AW | 1 |
| Tamagra, EI | 1 |
| Geffner, DL | 1 |
| Scott, DL | 1 |
| Tymms, DJ | 1 |
| Taylor, MA | 1 |
| Chapman, C | 1 |
| Al Moussa, M | 1 |
| Swanson Beck, J | 1 |
| Lindström, B | 1 |
| Wu, SY | 7 |
| Shyh, TP | 1 |
| Chopra, IJ | 18 |
| Huang, HW | 2 |
| Chu, PC | 1 |
| Hagen, GA | 1 |
| Izumi, M | 5 |
| Kohut, WD | 1 |
| Gharib, H | 3 |
| Anderson, MW | 1 |
| Bergman, TA | 1 |
| Mariash, CN | 1 |
| Oppenheimer, JH | 2 |
| Vasta, M | 1 |
| Donati, L | 1 |
| Aagaard, J | 1 |
| Bing, RF | 1 |
| Rosenthal, FD | 1 |
| Higashi, JT | 1 |
| Ishikawa, S | 1 |
| Mukuno, K | 1 |
| Watanabe, A | 1 |
| Savoie, JC | 1 |
| Thomas, G | 1 |
| Gayno, JP | 1 |
| Laurent, MF | 1 |
| Savoie, F | 1 |
| Leger, AF | 1 |
| Hirota, Y | 4 |
| Hayashi, Y | 2 |
| Ban, Y | 9 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 2 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Kusunoki, T | 1 |
| Nishida, S | 1 |
| Koezuka, M | 1 |
| Murata, K | 1 |
| Tomura, T | 1 |
| Bürgi, U | 1 |
| Maurer, P | 1 |
| Wenisch, C | 1 |
| Myskiw, D | 1 |
| Gessl, A | 2 |
| Graninger, W | 1 |
| Soliman, M | 1 |
| Kaplan, E | 1 |
| Straus, F | 1 |
| Fisfalen, ME | 1 |
| Guimaraes, V | 1 |
| Akamine, H | 2 |
| Komiya, I | 5 |
| Benker, G | 3 |
| Kahaly, G | 4 |
| Raue, F | 1 |
| Tegler, L | 3 |
| Hirche, H | 1 |
| Reinwein, D | 5 |
| Paggi, A | 3 |
| Di Prima, MA | 3 |
| Paparo, BS | 1 |
| Pellegrino, C | 1 |
| Faralli, AR | 2 |
| Sinopoli, MT | 1 |
| Leri, O | 1 |
| Ichikawa, K | 2 |
| Takemura, Y | 2 |
| Als, C | 2 |
| Listewnik, M | 1 |
| Rösler, H | 3 |
| Bartkowiak, E | 1 |
| Wallace, C | 1 |
| Couch, R | 1 |
| Ginsberg, J | 1 |
| Gómez, N | 1 |
| Gómez, JM | 2 |
| Orti, A | 1 |
| Gavaldà, L | 1 |
| Villabona, C | 1 |
| Leyes, P | 1 |
| Soler, J | 2 |
| Kashiwai, T | 4 |
| Tada, H | 5 |
| Asahi, K | 1 |
| Afeltra, A | 2 |
| Ferri, GM | 2 |
| Amoroso, A | 2 |
| Startari, S | 1 |
| Bonomo, L | 2 |
| Ito, E | 1 |
| Hayaki, I | 1 |
| Kawai, K | 2 |
| Komaki, G | 2 |
| Peters, H | 1 |
| Fischer, C | 1 |
| Bogner, U | 1 |
| Schleusener, H | 1 |
| Celik, I | 1 |
| Akalin, S | 2 |
| Erbaş, T | 1 |
| Yoshikawa, N | 3 |
| Morita, T | 3 |
| Arreaza, G | 1 |
| Resetkova, E | 1 |
| Mukuta, T | 2 |
| Volpé, R | 2 |
| Nishi, I | 1 |
| Takeoka, K | 1 |
| Mitsuda, N | 2 |
| Sugimoto, T | 1 |
| Iino, S | 2 |
| Denereaz, N | 1 |
| Lemarchand-Beraud, T | 2 |
| Chou, FF | 1 |
| Wang, PW | 2 |
| Sheen-Chen, SM | 1 |
| Nagamine, T | 1 |
| Takehara, K | 1 |
| Fukui, T | 1 |
| Hattori, J | 1 |
| Ogawa, T | 4 |
| Takuno, H | 4 |
| Matsui, I | 2 |
| Sarui, H | 2 |
| Onuma, H | 1 |
| Ota, M | 1 |
| Sugenoya, A | 2 |
| Inoko, H | 1 |
| Bokk, A | 1 |
| Hidaka, A | 2 |
| Takeuchi, R | 2 |
| Roti, E | 5 |
| Gardini, E | 5 |
| Bianconi, L | 2 |
| Salvi, M | 4 |
| Gavaruzzi, G | 1 |
| Ugolotti, G | 1 |
| Braverman, LE | 6 |
| Fuwa, Y | 2 |
| Goto, S | 1 |
| Fukui, M | 1 |
| Yuasa, H | 1 |
| Sasano, N | 1 |
| Caccavo, D | 1 |
| Vaccaro, F | 1 |
| Eisenstein, Z | 1 |
| Engelsman, E | 1 |
| Weiss, M | 3 |
| Kalechman, Y | 1 |
| Sredni, B | 1 |
| Ren, YZ | 1 |
| Song, ZG | 1 |
| Mallet, B | 1 |
| Lejeune, PJ | 1 |
| Baudry, N | 1 |
| Niccoli, P | 1 |
| Carayon, P | 1 |
| Franc, JL | 1 |
| McIver, B | 1 |
| Rae, P | 1 |
| Wilkinson, E | 1 |
| Gold, A | 1 |
| Toft, A | 1 |
| Van Loon, AJ | 1 |
| Derksen, JT | 1 |
| Bos, AF | 1 |
| Rouwé, CW | 1 |
| Klee, GG | 1 |
| Listevnik, M | 1 |
| Ritter, EP | 1 |
| Kim, WB | 1 |
| Park, HY | 1 |
| Lee, HK | 1 |
| Kohn, LD | 3 |
| Tahara, K | 2 |
| Skuza, KA | 1 |
| Sills, IN | 2 |
| Stene, M | 1 |
| Rapaport, R | 2 |
| Costa Rosa, LF | 1 |
| Curi, R | 1 |
| Hakamata, M | 1 |
| Itoh, M | 3 |
| Sudo, Y | 1 |
| Katada, E | 1 |
| Miyata, N | 1 |
| Shimojo, N | 1 |
| Kohno, Y | 3 |
| Yamaguchi, K | 2 |
| Kikuoka, S | 1 |
| Hoshioka, A | 1 |
| Niimi, H | 1 |
| Hirai, A | 1 |
| Tamura, Y | 1 |
| Saito, Y | 1 |
| Ozata, M | 1 |
| Bolu, E | 1 |
| Sengul, A | 1 |
| Tasar, M | 1 |
| Beyhan, Z | 1 |
| Corakci, A | 1 |
| Gundogan, MA | 1 |
| Charkes, ND | 1 |
| Bennedbaek, FN | 1 |
| Gram, J | 1 |
| Yoshida, S | 1 |
| Murakami, Y | 1 |
| Sakane, S | 4 |
| Ohsawa, N | 3 |
| Pfeilschifter, J | 2 |
| Ziegler, R | 4 |
| Hara, H | 3 |
| Sugita, E | 1 |
| Sato, R | 3 |
| Miyakawa, M | 2 |
| Tsushima, T | 2 |
| Demura, H | 2 |
| Kasuga, Y | 2 |
| Fujimori, M | 2 |
| Shingu, K | 1 |
| Hama, Y | 1 |
| Maruyama, M | 1 |
| Amano, J | 1 |
| Massart, C | 5 |
| Gibassier, J | 2 |
| Raoul, ML | 1 |
| Le Gall, F | 1 |
| Lancien, G | 1 |
| Genetet, N | 1 |
| Denais, A | 1 |
| Darcel, F | 1 |
| Lucas, C | 1 |
| Elser, H | 1 |
| Haufe, S | 1 |
| Georgi, P | 1 |
| Sauter, G | 1 |
| Hoermann, R | 5 |
| Roth, C | 1 |
| Siggelkow, H | 1 |
| Grüters, A | 1 |
| Hüfner, M | 1 |
| Lakomek, M | 1 |
| Kousaka, T | 1 |
| Miyamoto, S | 1 |
| Razack, MS | 1 |
| Lore, JM | 1 |
| Lippes, HA | 1 |
| Schaefer, DP | 1 |
| Rassael, H | 1 |
| Lucas, A | 1 |
| Salinas, I | 1 |
| Rius, F | 1 |
| Pizarro, E | 1 |
| Granada, ML | 1 |
| Foz, M | 1 |
| Sanmartí, A | 1 |
| Del Guerra, P | 1 |
| Casolaro, A | 1 |
| Lippolis, PV | 1 |
| Goletti, O | 1 |
| Tomaski, SM | 1 |
| Mahoney, EM | 1 |
| Burgess, LP | 1 |
| Raines, KB | 1 |
| Bornemann, M | 1 |
| Ozaki, O | 2 |
| Mimura, T | 5 |
| Goto, Y | 2 |
| Ohta, Y | 2 |
| Ogawa, N | 1 |
| Ohashi, H | 1 |
| Tendler, BE | 1 |
| Shoukri, K | 1 |
| Malchoff, C | 1 |
| MacGillivray, D | 1 |
| Duckrow, R | 1 |
| Talmadge, T | 1 |
| Ramsby, GR | 1 |
| Persani, L | 1 |
| Preziati, D | 1 |
| Matthews, CH | 1 |
| Sartorio, A | 1 |
| Chatterjee, VK | 1 |
| Masunaga, R | 1 |
| Nagasaka, A | 2 |
| Nakai, A | 1 |
| Kotake, M | 1 |
| Sawai, Y | 1 |
| Oda, N | 1 |
| Mokuno, T | 1 |
| Shimazaki, K | 1 |
| Hayakawa, N | 2 |
| Kato, R | 3 |
| Hirano, E | 1 |
| Hagiwara, M | 1 |
| Kawakami-Tani, T | 1 |
| Fukawa, E | 1 |
| Tanaka, H | 1 |
| Abe, Y | 2 |
| Makino, I | 1 |
| Oshiro, C | 1 |
| Nagata, A | 1 |
| Sato, Y | 1 |
| Yoshimura, H | 3 |
| Ueshiba, H | 1 |
| Takeda, S | 1 |
| Matoba, H | 1 |
| Tanaka, Y | 2 |
| Yuasa, R | 1 |
| Tsuboi, K | 1 |
| Miyachi, Y | 1 |
| Mori, T | 4 |
| Sugawa, H | 1 |
| Kosugi, S | 1 |
| Hai, N | 1 |
| Matsuda, A | 1 |
| Rivolta, R | 1 |
| Meroni, L | 1 |
| Pappalettera, M | 1 |
| Scheen, AJ | 1 |
| Kazuo, K | 1 |
| Fujikado, T | 2 |
| Ohmi, G | 1 |
| Hosohata, J | 1 |
| Tano, Y | 1 |
| Akuzawa, M | 1 |
| Satoh, T | 1 |
| Shimizu, H | 1 |
| Fukao, A | 1 |
| Shimamoto, C | 1 |
| Schulz, G | 1 |
| Zimny, M | 1 |
| Schreckenberger, M | 1 |
| Zimny, D | 1 |
| Wagenknecht, G | 1 |
| Kaiser, HJ | 1 |
| Dohmen, BM | 1 |
| Bares, R | 1 |
| Büll, U | 1 |
| Rink, T | 1 |
| Holle, LH | 1 |
| Schroth, HJ | 1 |
| Garth, H | 1 |
| Potter, MA | 1 |
| Gauthier, D | 1 |
| Hill, RE | 1 |
| Pujol, P | 1 |
| Osman, A | 1 |
| Grabar, S | 1 |
| Daurès, JP | 1 |
| Galtier-Dereure, F | 1 |
| Boegner, C | 1 |
| Raye, R | 1 |
| Bringer, J | 1 |
| Tandon, RK | 1 |
| Dudha, A | 1 |
| Uchimura, K | 1 |
| Makino, M | 1 |
| Hayashi, R | 1 |
| Nagata, M | 1 |
| Kakizawa, H | 1 |
| Sakamoto, H | 1 |
| Kuzuya, H | 1 |
| Sasián, S | 1 |
| Rojano, J | 1 |
| Gavilán, I | 1 |
| Aguilar, M | 1 |
| Escobar, L | 1 |
| Girón, JA | 1 |
| Inukai, T | 3 |
| Takanashi, K | 1 |
| Kobayashi, H | 1 |
| Fujiwara, Y | 1 |
| Tayama, K | 1 |
| Aso, Y | 1 |
| Yonemoto, T | 1 |
| Tabata, S | 1 |
| Sakaguchi, N | 1 |
| Tokoro, T | 1 |
| Gondou, A | 1 |
| Yoshimura, M | 1 |
| Escobar Jiménez, F | 1 |
| Luna López, V | 1 |
| Fernández Soto, ML | 1 |
| Quezada Charneco, M | 1 |
| Glinoer, D | 3 |
| Watanabe, Y | 1 |
| Shimaoka, Y | 1 |
| Yagoro, A | 1 |
| Zha, LL | 1 |
| Vierhapper, H | 4 |
| Bieglmayer, C | 1 |
| Nowotny, P | 3 |
| Waldhäusl, W | 2 |
| Hagag, P | 1 |
| Nissenbaum, H | 1 |
| Siddiqi, A | 1 |
| Monson, JP | 2 |
| Wood, DF | 1 |
| Besser, GM | 2 |
| Burrin, JM | 1 |
| Poertl, S | 1 |
| Kirner, J | 1 |
| Saller, B | 5 |
| Mann, K | 5 |
| Bando, Y | 1 |
| Nagai, Y | 1 |
| Ushiogi, Y | 1 |
| Toya, D | 1 |
| Tanaka, N | 1 |
| Fujisawa, M | 1 |
| Salamone, S | 1 |
| Scollo, C | 1 |
| Vigneri, R | 2 |
| Dimai, HP | 1 |
| Ramschak-Schwarzer, S | 1 |
| Lax, S | 1 |
| Lipp, RW | 1 |
| Leb, G | 1 |
| Maugendre, D | 3 |
| Gatel, A | 1 |
| Campion, L | 1 |
| Guilhem, I | 1 |
| Lorcy, Y | 1 |
| Lescouarch, J | 1 |
| Herry, JY | 1 |
| Allannic, H | 2 |
| Okajima, T | 1 |
| Tanaka, E | 1 |
| Ando, B | 1 |
| Takeshita, M | 1 |
| Masuda, A | 1 |
| Sakai, K | 1 |
| Sonnet, E | 1 |
| Nygaard, B | 3 |
| Metcalfe, RA | 1 |
| Phipps, J | 1 |
| Caccavale, C | 1 |
| Di Serio, C | 1 |
| Del Buono, A | 1 |
| Sorvillo, F | 1 |
| Bellastella, A | 2 |
| Carella, C | 3 |
| Andrade, VA | 2 |
| Gross, JL | 2 |
| Maia, AL | 2 |
| Ramos-Dias, JC | 1 |
| Lengyel, AM | 1 |
| Raber, W | 2 |
| Kmen, E | 1 |
| Kajita, Y | 2 |
| Ochi, Y | 2 |
| Konrády, A | 1 |
| Amato, G | 2 |
| Salzano, I | 1 |
| De Bellis, A | 2 |
| De Felice, G | 1 |
| Costagliola, C | 1 |
| Yamashita, H | 2 |
| Noguchi, S | 5 |
| Murakami, T | 2 |
| Watanabe, S | 2 |
| Uchino, S | 1 |
| Ohshima, A | 1 |
| Kawamoto, H | 1 |
| Toda, M | 1 |
| Zimmermann-Belsing, T | 2 |
| Christensen, L | 1 |
| Hansen, HS | 1 |
| Kirkegaard, J | 1 |
| Mazziotti, G | 1 |
| Biondi, B | 1 |
| Manganella, G | 1 |
| Del Buono, AD | 1 |
| Montella, P | 1 |
| di Cristofaro, M | 1 |
| Di Iorio, G | 1 |
| Sewerynek, J | 1 |
| Wiktorska, J | 1 |
| Nowak, D | 1 |
| Lewinski, A | 1 |
| Kubo, T | 1 |
| Toki, J | 1 |
| Kado, Y | 1 |
| Kurihara, M | 1 |
| Moriwake, T | 1 |
| Kanzaki, S | 1 |
| Seino, Y | 1 |
| Nishimori, T | 1 |
| Ito, Y | 2 |
| Terao, A | 1 |
| Eto, S | 1 |
| Jarløv, AE | 1 |
| Kristensen, LO | 1 |
| Faber, J | 2 |
| Khanna, CM | 2 |
| Shankar, LR | 1 |
| Jaggi, CB | 1 |
| Bansal, JK | 1 |
| Chugh, P | 1 |
| Inoue, Y | 1 |
| Miyauchi, S | 1 |
| Matsuura, B | 1 |
| Onji, M | 1 |
| Kurioka, Y | 1 |
| Morii, H | 3 |
| Gessi, A | 1 |
| Saïd, R | 1 |
| Khoo, DH | 2 |
| Eng, PH | 2 |
| Ho, SC | 2 |
| Tai, ES | 2 |
| Morgenthaler, NG | 1 |
| Seah, LL | 1 |
| Fong, KS | 1 |
| Chee, SP | 1 |
| Choo, CT | 1 |
| Aw, SE | 1 |
| Sankar, R | 1 |
| Magdum, M | 1 |
| Gera, A | 1 |
| Seven, R | 1 |
| Gelişgen, R | 1 |
| Seven, A | 1 |
| Erbil, Y | 1 |
| Bozbora, A | 1 |
| Burçak, G | 1 |
| Homsanit, M | 1 |
| Sriussadaporn, S | 1 |
| Vannasaeng, S | 1 |
| Peerapatdit, T | 1 |
| Nitiyanant, W | 1 |
| Vichayanrat, A | 1 |
| Davies, JS | 1 |
| Morrish, PK | 1 |
| Scanlon, MF | 1 |
| Yong, AM | 1 |
| Wong, ZW | 1 |
| Crivellaro, C | 1 |
| Oberhofer, R | 1 |
| Leimgruber, K | 1 |
| Amor, H | 1 |
| Burch, HB | 1 |
| Solomon, BL | 1 |
| Ferguson, P | 1 |
| Walpert, N | 1 |
| Howard, R | 1 |
| Colzani, RM | 1 |
| Emdin, M | 1 |
| Conforti, F | 1 |
| Passino, C | 1 |
| Scarlattini, M | 1 |
| Iervasi, G | 1 |
| Suzuki, K | 1 |
| Nakagawa, O | 1 |
| Aizawa, Y | 1 |
| Nishino, M | 1 |
| Yabe, S | 1 |
| Kanda, T | 1 |
| Nishiyama, K | 1 |
| Kitahara, A | 1 |
| Natsume, H | 1 |
| Matsushita, A | 1 |
| Nakano, K | 1 |
| Sasaki, S | 1 |
| Genma, R | 1 |
| Yamamoto, Y | 1 |
| Manetti, L | 1 |
| Dell'Unto, E | 1 |
| Rocchi, R | 1 |
| Mazzi, B | 1 |
| Bartolomei, MP | 1 |
| Lepri, P | 1 |
| Cartei, F | 1 |
| Nardi, M | 1 |
| Kung, AW | 1 |
| Lau, KS | 1 |
| Feldkamp, J | 1 |
| Pascher, E | 1 |
| Schott, M | 1 |
| Goretzki, P | 1 |
| Seissler, J | 1 |
| Scherbaum, WA | 1 |
| Wiinberg, N | 1 |
| Schifter, S | 1 |
| Mehlsen, J | 1 |
| Miller, KK | 1 |
| Wu, G | 1 |
| Jie, Y | 1 |
| Situ, Y | 1 |
| Shimizu, K | 1 |
| Kumita, S | 1 |
| Kitamura, Y | 1 |
| Nagahama, M | 1 |
| Kitagawa, W | 1 |
| Akasu, H | 1 |
| Oshina, T | 1 |
| Kumasaki, T | 1 |
| Tanaka, S | 1 |
| Rasmussen, AK | 1 |
| Wahrenberg, H | 1 |
| Wennlund, A | 1 |
| Hoffstedt, J | 1 |
| Bieglmayer, Ch | 1 |
| Ikekubo, K | 4 |
| Okuno, T | 1 |
| Takeda, Y | 4 |
| Lauridsen, UB | 1 |
| Kirkegaard, C | 2 |
| Friis, T | 2 |
| Siersbaek-Nielsen, K | 2 |
| Marsden, P | 2 |
| Chalkley, S | 1 |
| Leatherdale, B | 1 |
| Howorth, PJ | 1 |
| Acosta, M | 1 |
| McKerron, CG | 2 |
| Herrmann, J | 1 |
| Schaps, D | 1 |
| Rusche, HJ | 1 |
| Berger, M | 1 |
| Krüskemper, HL | 2 |
| von zur Hühlen, A | 1 |
| Hackenberg, K | 2 |
| Clifton-Bligh, P | 2 |
| Burke, G | 3 |
| Lamb, AM | 1 |
| Gowland, E | 1 |
| Wise, PH | 1 |
| Burnet, RB | 1 |
| Ahmad, A | 1 |
| Harding, PE | 1 |
| Larsen, PR | 4 |
| Buerklin, EM | 1 |
| Schimmel, M | 1 |
| Utiger, RD | 2 |
| Robin, M | 3 |
| Lapinski, H | 1 |
| Mirouze, J | 5 |
| Birkhäuser, M | 2 |
| Burer, T | 1 |
| Busset, R | 1 |
| Burger, A | 4 |
| Greer, MA | 1 |
| Kammer, H | 1 |
| Bouma, DJ | 1 |
| Kurakawa, N | 1 |
| Aoki, H | 3 |
| Nishikawa, Y | 4 |
| Miura, T | 1 |
| Ohno, M | 1 |
| Kitabatake, S | 1 |
| Fujie, T | 1 |
| Onishi, T | 1 |
| Shizume, K | 4 |
| Walfish, PG | 2 |
| Krück, F | 1 |
| Kuro, R | 2 |
| Weiske, R | 1 |
| Gelinsky, P | 1 |
| Müller, E | 1 |
| Meyer, R | 1 |
| Wood, LC | 1 |
| Ingbar, SH | 3 |
| Gardner, DF | 1 |
| Rothman, J | 1 |
| Mazanek-Szymańska, E | 1 |
| Bigos, ST | 1 |
| Singer, L | 1 |
| Schlienger, JL | 1 |
| Kammerer, F | 1 |
| Stephan, F | 1 |
| Brikhäuser, MH | 1 |
| Staub, JJ | 1 |
| Gräni, R | 1 |
| Girard, J | 1 |
| Baur, U | 1 |
| Gemsenjäger, E | 1 |
| Lawton, NF | 2 |
| Ikemi, Y | 1 |
| D'Amour, P | 1 |
| Joasoo, A | 1 |
| Bürgi, H | 1 |
| Eguchi, N | 1 |
| Shimizu, T | 4 |
| Shishiba, Y | 4 |
| Johnson, DE | 2 |
| Kaplan, HJ | 1 |
| Mortimer, CH | 1 |
| Anderson, DC | 1 |
| Liendo-Ch, P | 1 |
| Fisher, R | 1 |
| Chan, V | 1 |
| Self, M | 1 |
| Horwitz, DL | 1 |
| Refetoff, S | 1 |
| Haug, E | 1 |
| Sand, T | 1 |
| Chopra, U | 3 |
| Yoshihara, E | 1 |
| Terasaki, PI | 1 |
| Smith, F | 1 |
| Kalinin, AP | 2 |
| Izmaĭlov, GI | 2 |
| Kurokawa, N | 2 |
| Fournier, M | 2 |
| Orgiazzi, J | 6 |
| Magnon-Pujo, B | 2 |
| Quintana, J | 2 |
| Mornex, R | 2 |
| Castelnau, P | 1 |
| Aberlenc, M | 1 |
| Yamamoto, T | 1 |
| Tanaka, F | 1 |
| Yeo, PP | 2 |
| Lumholtz, IB | 1 |
| Poulsen, DL | 1 |
| Rogowski, P | 1 |
| Croxson, MS | 3 |
| Hall, TD | 2 |
| Jaramillo, JE | 1 |
| Nicoloff, JT | 4 |
| Ikeda, H | 4 |
| Masuyama, Y | 1 |
| Verhoeven, RP | 1 |
| Doctor, R | 2 |
| Schalekamp, MA | 1 |
| Golden, MP | 1 |
| Kaplan, SA | 1 |
| Lippe, BM | 1 |
| Lee, WN | 1 |
| Sobrinho, LG | 1 |
| Limbert, ES | 1 |
| Santos, MA | 1 |
| Lotti, G | 1 |
| Delitala, G | 1 |
| Devilla, L | 1 |
| Alagna, S | 1 |
| Masala, A | 1 |
| Harland, PC | 1 |
| McArthur, RG | 1 |
| Fawcett, DM | 1 |
| Gatzke, HD | 1 |
| Wildmeister, W | 1 |
| Schwartz, KD | 1 |
| Scazziga, BR | 1 |
| Dorfman, SG | 1 |
| Young, RL | 1 |
| Schellekens, AP | 1 |
| Stuart, DD | 1 |
| Schultz, AL | 1 |
| Brun, R | 1 |
| Jenny, M | 1 |
| Junod, JP | 1 |
| Diez Jiménez, L | 1 |
| Estenoz Alfaro, J | 1 |
| Hawkins Carranza, F | 1 |
| Arnaiz Bueno, F | 1 |
| Igarashi, T | 2 |
| Kimura, S | 1 |
| Tsukamoto, S | 1 |
| Takayama, H | 1 |
| Chiu, SC | 1 |
| Dradi, C | 1 |
| Riceputi, G | 1 |
| Biagioli, R | 1 |
| Riva, P | 1 |
| Tevaarwerk, GJ | 1 |
| Boyd, D | 1 |
| Kaplan, MM | 2 |
| Miyaji, K | 1 |
| Maciel, RM | 1 |
| Ozawa, Y | 2 |
| Geola, F | 1 |
| Bennett, LR | 1 |
| Davies, TF | 2 |
| Weightman, DR | 1 |
| Marshall, J | 1 |
| Ratcliffe, JG | 1 |
| Evered, DC | 2 |
| Nistrup Madsen, S | 1 |
| Schrub, JC | 1 |
| Nouel, JP | 1 |
| Brunelle, P | 1 |
| Segond, G | 1 |
| Courtois, H | 1 |
| Poirier, A | 1 |
| Sandler, R | 1 |
| Sanguineti, M | 1 |
| Betti, E | 1 |
| Clague, R | 1 |
| Mukhtar, ED | 1 |
| Pyle, GA | 1 |
| Nutt, J | 1 |
| Scott, M | 1 |
| Evered, D | 1 |
| Smith, BR | 1 |
| Hall, R | 5 |
| Emrich, D | 2 |
| Bähre, M | 1 |
| zur Mühlen, A | 1 |
| Hesch, RD | 1 |
| Köbberling, J | 1 |
| Dimond, RC | 1 |
| Earll, JM | 1 |
| Wright, FD | 1 |
| Umise, N | 1 |
| Umise, K | 1 |
| Rainer, O | 1 |
| Hartwig, W | 1 |
| Dolman, A | 1 |
| De Reus, A | 1 |
| Van Zijl, J | 2 |
| Jånos, F | 1 |
| Erzsebet, G | 1 |
| Jozsefne, J | 1 |
| Williams, DE | 2 |
| Eliopoulos, G | 1 |
| Sawhney, RC | 1 |
| Kannan, V | 1 |
| Rastogi, GK | 1 |
| Longhini, C | 1 |
| Malavasi, F | 1 |
| Bonetti, P | 1 |
| Shirotani, T | 1 |
| Kishikawa, H | 1 |
| Wake, N | 1 |
| Miyamura, N | 1 |
| Hashimoto, Y | 1 |
| Motoyoshi, S | 1 |
| Shichiri, M | 1 |
| Shechner, C | 1 |
| Kraiem, Z | 1 |
| Zuckerman, E | 1 |
| Dickstein, G | 1 |
| Reglinski, J | 1 |
| Smith, WE | 2 |
| Wilson, R | 7 |
| Buchanan, LM | 1 |
| McKillop, JH | 7 |
| Thomson, JA | 7 |
| Takeda, K | 2 |
| Morita, S | 2 |
| Itagaki, Y | 1 |
| Ohzeki, T | 1 |
| Hanaki, K | 1 |
| Motozumi, H | 1 |
| Matsuda-Ohtahara, H | 1 |
| Ishitani, N | 1 |
| Shiraki, K | 1 |
| Etoh, M | 1 |
| Isozaki, O | 1 |
| Arai, M | 1 |
| Harsch, I | 1 |
| Paschke, R | 1 |
| Usadel, KH | 1 |
| Mohari, K | 1 |
| Janoki, G | 1 |
| Tarjan, G | 2 |
| Varga, F | 1 |
| Shima, T | 1 |
| Yano, Y | 1 |
| Misaki, M | 1 |
| Leövey, A | 1 |
| Nagy, E | 1 |
| Balazs, G | 1 |
| Bako, G | 1 |
| Shirota, T | 1 |
| Shinoda, T | 1 |
| Ford, HC | 1 |
| Cooke, RR | 1 |
| Keightley, EA | 1 |
| Inui, T | 1 |
| Chen, W | 1 |
| Van der Gaag, R | 3 |
| Mourits, MP | 1 |
| Koornneef, L | 2 |
| Teco, GN | 1 |
| Santini, F | 1 |
| Sgarbi, JA | 1 |
| De Filippis, V | 1 |
| Giraudi, G | 1 |
| Di Cerbo, A | 1 |
| Mascher, M | 1 |
| Gallone, G | 1 |
| Cerruti, R | 1 |
| Horlick, MN | 1 |
| Mouroux, D | 1 |
| Martin Laval, A | 1 |
| Bovero, G | 1 |
| Nicolino, J | 1 |
| Shoda, Y | 1 |
| Akiyama, H | 1 |
| Kondo, Y | 1 |
| Nakanishi, K | 1 |
| Taniguchi, Y | 1 |
| Tajiri, J | 3 |
| Morita, M | 3 |
| Tamaru, M | 2 |
| Murakami, N | 3 |
| Shirota, K | 1 |
| Urabe, K | 1 |
| Kouchi, T | 1 |
| Mitani, Y | 1 |
| Ueta, Y | 1 |
| Balzano, S | 1 |
| Loviselli, A | 1 |
| Sica, V | 1 |
| Petrini, L | 1 |
| Grasso, L | 1 |
| Solomon, B | 1 |
| Lagasse, R | 1 |
| Nagayama, Y | 1 |
| Iitaka, M | 1 |
| Ishii, J | 1 |
| Ishikawa, N | 2 |
| Saitou, H | 1 |
| Wolf, MW | 1 |
| Tvede, M | 1 |
| Silva, JE | 1 |
| Huang, MJ | 1 |
| Liu, RT | 1 |
| Chen, CD | 1 |
| Schifferdecker, E | 1 |
| Gedik, O | 1 |
| Ozdemir, T | 1 |
| Notsu, K | 1 |
| Oka, N | 1 |
| Masaki, Y | 1 |
| Furuya, H | 1 |
| Navarro, MA | 1 |
| Wei, S | 2 |
| Pan, X | 1 |
| Liang, Z | 2 |
| Xu, S | 1 |
| Li, J | 2 |
| Caturegli, P | 1 |
| Del Prete, GF | 1 |
| Piraino, P | 1 |
| Zura, ML | 1 |
| Loureiro, O | 1 |
| Andrade, A | 1 |
| Hashimoto, T | 2 |
| Nishibu, M | 1 |
| Nagai, K | 3 |
| Abs, R | 1 |
| Martin, M | 1 |
| Blockx, P | 1 |
| Molnár, I | 1 |
| Shen, DC | 2 |
| Shian, LR | 2 |
| Florsheim, W | 2 |
| Devoto, E | 1 |
| Aravena, L | 1 |
| Hidalgo, MS | 1 |
| Gajardo, H | 1 |
| Lioi, X | 1 |
| Soto, N | 1 |
| Barrera, R | 1 |
| Munizaga, F | 1 |
| Heshmati, HM | 2 |
| Izembart, M | 2 |
| Turpin, G | 1 |
| Vallée, G | 2 |
| Federman, DD | 1 |
| Kiso, Y | 1 |
| Koukkou, E | 1 |
| Panayiotidis, P | 1 |
| Alevizou-Terzaki, V | 1 |
| Thalassinos, N | 1 |
| Nolte, C | 1 |
| Olbricht, T | 2 |
| Galvan, G | 1 |
| Gräf, KJ | 1 |
| Schneider, HG | 1 |
| Philippou, G | 1 |
| Piperingos, G | 1 |
| Souvatzoglou, A | 1 |
| Moulopoulos, SD | 1 |
| Weryha, G | 1 |
| Gobert, B | 1 |
| Leclère, J | 2 |
| Béné, MC | 2 |
| Faure, G | 2 |
| Hartemann, P | 2 |
| Kaneko, G | 1 |
| Masuda, H | 1 |
| Takahashi, S | 1 |
| Iida, F | 1 |
| Imai, Y | 3 |
| Odajima, R | 1 |
| Fagerberg, B | 1 |
| Nyström, E | 1 |
| Sjöström, L | 1 |
| Lundberg, PA | 1 |
| Darpö, B | 1 |
| Lindstedt, G | 1 |
| Gamstedt, A | 4 |
| Karlsson, A | 2 |
| Kimura, H | 1 |
| Fong, P | 1 |
| Kendler, D | 1 |
| Shultz, LD | 1 |
| Thung, S | 1 |
| Martin, A | 1 |
| Tarutani, O | 2 |
| Saito, K | 1 |
| Komaki, T | 4 |
| Matsuda, M | 2 |
| Tokimitsu, N | 2 |
| Syrenicz, A | 1 |
| Uehata, S | 1 |
| Kiyohara, K | 1 |
| Naomi, S | 1 |
| Umeda, T | 1 |
| Chailurkit, LO | 1 |
| Kongsuksai, A | 1 |
| Teeravaninthorn, U | 1 |
| Messer, PM | 1 |
| Hauffa, BP | 1 |
| Kotulla, P | 1 |
| Chow, CC | 1 |
| Lai, KN | 1 |
| Leung, JC | 1 |
| Chan, JC | 1 |
| Cockram, CS | 1 |
| Yamaguchi, Y | 1 |
| Iwashita, A | 1 |
| Ohshima, K | 1 |
| Morotomi, Y | 1 |
| Fujishima, M | 1 |
| Vana, S | 1 |
| Lakatos, P | 1 |
| Kushima, K | 1 |
| Nagakura, H | 1 |
| Kaihara, M | 1 |
| Giustina, A | 1 |
| Bodini, C | 1 |
| Buffoli, MG | 1 |
| Legati, F | 1 |
| Schettino, M | 1 |
| Zuccato, F | 1 |
| Wehrenberg, WB | 1 |
| Rom-Bugoslavskaia, ES | 1 |
| Sakhatov, BIa | 1 |
| Pesotskaia, PM | 1 |
| Chang, DC | 1 |
| Woodcock, JP | 1 |
| Shedden, EJ | 1 |
| Lazarus, JH | 3 |
| Wheeler, MH | 1 |
| McGregor, AM | 2 |
| Xian, L | 1 |
| Wang, Q | 1 |
| Winsa, B | 1 |
| Dahlberg, A | 1 |
| Jansson, R | 1 |
| Agren, H | 1 |
| Okamoto, T | 1 |
| Fujimoto, Y | 1 |
| Obara, T | 1 |
| Kodama, T | 1 |
| Kusakabe, K | 1 |
| Stefăneanu, L | 1 |
| Taşcă, C | 1 |
| Randin, JP | 2 |
| Schutz, Y | 1 |
| Scazziga, B | 2 |
| Felber, JP | 2 |
| Jéquier, E | 2 |
| Chen, JJ | 1 |
| Ladenson, PW | 1 |
| Noh, J | 1 |
| Oyanagi, H | 1 |
| Fang, WY | 1 |
| Ye, WX | 1 |
| Hatabu, H | 3 |
| Tokuda, Y | 2 |
| Arai, K | 1 |
| Uno, C | 2 |
| Lin, LX | 1 |
| Horimoto, M | 1 |
| Taniguchi, N | 1 |
| Chen, G | 1 |
| Zhang, KZ | 1 |
| Liao, ZH | 1 |
| Wang, SH | 1 |
| Ma, SJ | 1 |
| Long, ZZ | 1 |
| Tian, WT | 1 |
| Zhu, JY | 1 |
| Ishihara, T | 1 |
| Yuan, JP | 1 |
| Krause, U | 2 |
| Hülbusch, K | 1 |
| Beyer, J | 3 |
| Fraser, WD | 1 |
| Grübl, M | 1 |
| Moncayo, R | 1 |
| Schilling, S | 1 |
| Weber, P | 1 |
| Tachi, J | 1 |
| Kimura, M | 1 |
| Tanizawa, O | 1 |
| Takazawa, K | 1 |
| Akasu, R | 1 |
| Chopra, M | 1 |
| Bradley, H | 1 |
| Berghout, A | 1 |
| Brummelkamp, WH | 1 |
| Gauna, A | 1 |
| Segura, G | 1 |
| Sartorio, G | 1 |
| Soto, R | 1 |
| Segal-Eiras, A | 1 |
| Burns, TW | 1 |
| Bregant, R | 1 |
| Williams, IK | 1 |
| Goshima, E | 1 |
| Yamakita, N | 2 |
| Maeda, M | 1 |
| Guerin, V | 1 |
| Amiel, C | 1 |
| Kohno, T | 1 |
| Mitsukawa, T | 1 |
| Matsukura, S | 1 |
| Tsunetoshi, Y | 1 |
| Ishikawa, E | 1 |
| Jap, TS | 1 |
| Ho, LT | 1 |
| Won, JG | 1 |
| Harada, T | 1 |
| Katagiri, M | 1 |
| Shimaoka, K | 1 |
| Ishihara, M | 3 |
| Trzepacz, PT | 1 |
| Klein, I | 1 |
| Roberts, M | 1 |
| Greenhouse, J | 1 |
| Levey, GS | 1 |
| Hody, B | 1 |
| Condé, D | 1 |
| Leclech, G | 1 |
| Edan, G | 1 |
| Nicol, M | 1 |
| Kobayashi, N | 1 |
| Takaichi, Y | 1 |
| Desai, RK | 1 |
| Norman, RJ | 1 |
| Jialal, I | 1 |
| Joubert, SM | 1 |
| Eshøj, O | 1 |
| Kvetny, J | 1 |
| Mogensen, EF | 1 |
| Pearson, DW | 1 |
| Cuthbert, GF | 1 |
| Vermiglio, F | 1 |
| Hörmann, R | 1 |
| Müller, R | 1 |
| Wadman, B | 1 |
| Mueller, R | 2 |
| Katakura, M | 2 |
| Yukimura, Y | 2 |
| Ratanachaiyavong, S | 1 |
| Middleton, GW | 1 |
| Love, W | 1 |
| John, R | 1 |
| Owen, GM | 2 |
| Darke, C | 1 |
| Foley, TP | 1 |
| White, C | 1 |
| New, A | 1 |
| van Ouwerkerk, BM | 1 |
| Krenning, EP | 1 |
| van Oudenaren, A | 1 |
| Benner, R | 1 |
| Drexhage, HA | 1 |
| Madec, AM | 1 |
| Stefanutti, A | 1 |
| Taylor, JJ | 1 |
| Stephenson, AM | 1 |
| Stratton, A | 1 |
| Holcombe, M | 1 |
| Smit, T | 1 |
| Bizzarro, A | 1 |
| Fontana, A | 1 |
| Daponte, A | 1 |
| Iacono, G | 1 |
| Peluso, G | 1 |
| Grönhagen-Riska, C | 1 |
| Fyhrquist, F | 1 |
| Välimäki, M | 1 |
| Lamberg, BA | 2 |
| Czernobilsky, H | 1 |
| Fiehn, W | 1 |
| Brandi, ML | 1 |
| Zonefrati, R | 1 |
| Rotella, CM | 1 |
| Toccafondi, R | 1 |
| Yamashita, S | 2 |
| Petrov, IM | 1 |
| Luo, GC | 1 |
| Takahashi, Y | 1 |
| Kamoi, K | 2 |
| Tao, Y | 1 |
| Song, GX | 1 |
| Robuschi, G | 3 |
| Montermini, M | 3 |
| Manfredi, A | 3 |
| Gnudi, A | 3 |
| Busnardo, B | 1 |
| Girelli, ME | 1 |
| Rubello, D | 1 |
| Eccher, C | 1 |
| Betterle, C | 1 |
| Wu, RH | 1 |
| Kumar, M | 1 |
| Parente, JT | 1 |
| Pearson, C | 1 |
| Burnett, AK | 1 |
| Hosoya, T | 1 |
| Naito, N | 1 |
| Hoffman, WH | 1 |
| Miceli, JN | 1 |
| Kågedal, B | 2 |
| Manabe, Y | 1 |
| Hasegawa, Y | 1 |
| Ogata, H | 1 |
| Kaneko, K | 1 |
| Barge, A | 1 |
| Chowns, J | 1 |
| Broadbent, M | 1 |
| Noonan, K | 1 |
| Temple, RC | 1 |
| Houghton, BJ | 1 |
| Hiramatsu, K | 1 |
| Maruyama, K | 1 |
| Kameko, M | 1 |
| Kanai, M | 1 |
| Miki, K | 3 |
| Wada, M | 1 |
| d'Amato, L | 2 |
| Borciani, E | 1 |
| Negrotti, L | 1 |
| Muramoto, S | 1 |
| Heyma, P | 1 |
| Harrison, LC | 1 |
| Takahashi, T | 1 |
| Furuhashi, N | 1 |
| Petrick, PA | 1 |
| Nissim, M | 1 |
| Menezes-Ferreira, MM | 1 |
| Blank, MS | 1 |
| Tucci, JR | 1 |
| Shima, H | 1 |
| Doi, K | 1 |
| Majima, M | 1 |
| Kitazawa, A | 1 |
| Matsuzawa, Y | 1 |
| Harada, M | 1 |
| Matsuda, T | 1 |
| Nasser, H | 1 |
| Buchholtz Hansen, PE | 1 |
| Iversen, E | 1 |
| Eskjaer Jensen, S | 1 |
| Shirakami, A | 1 |
| Hirai, Y | 1 |
| Takeichi, T | 1 |
| Nishino, H | 1 |
| Inomoto, T | 1 |
| Shigekiyo, T | 1 |
| Kawauchi, S | 1 |
| Herman, GE | 1 |
| Kanluen, S | 1 |
| Monforte, J | 1 |
| Husain, M | 1 |
| Spitz, WU | 1 |
| Järnerot, G | 1 |
| Karpman, BA | 1 |
| Rapoport, B | 1 |
| Filetti, S | 1 |
| Fisher, DA | 5 |
| Reggio, R | 1 |
| Tørring, J | 1 |
| Barlli, AL | 1 |
| Gärtner, R | 1 |
| Bechtner, G | 1 |
| Greil, W | 1 |
| Horn, K | 2 |
| Pickardt, CR | 2 |
| Hatakeyama, T | 1 |
| Yagi, H | 1 |
| Bayer, MF | 1 |
| Kriss, JP | 1 |
| McDougall, IR | 1 |
| Takakuwa, K | 1 |
| Kametani, M | 1 |
| Palmer, BN | 1 |
| Holdaway, IM | 1 |
| Frengley, PA | 1 |
| Evans, MC | 1 |
| Bian, TY | 1 |
| Jeng, CY | 1 |
| Silverstein, GE | 2 |
| Van Herle, AJ | 2 |
| Gesztesi, E | 3 |
| Takács, I | 1 |
| Miller, LD | 1 |
| Sugarman, HJ | 1 |
| Miller, WW | 1 |
| Delivoria-Papadopoulos, M | 1 |
| Diaco, JF | 1 |
| Gottlieb, AJ | 1 |
| Oski, FA | 1 |
| Ekins, RP | 2 |
| Nabarro, JD | 1 |
| Cavalieri, RR | 2 |
| Steinberg, M | 2 |
| Searle, GL | 2 |
| Beall, GN | 2 |
| Hollingsworth, DR | 1 |
| Austin, E | 1 |
| Hollander, CS | 6 |
| Mitsuma, T | 4 |
| Nihei, N | 1 |
| Shenkman, L | 6 |
| Burday, SZ | 1 |
| Low, JC | 1 |
| Dussault, JH | 3 |
| Wong, ET | 1 |
| Doe, RP | 1 |
| Scriba, PC | 1 |
| Nilsson, G | 1 |
| Lynch, PJ | 1 |
| Maize, JC | 1 |
| Sisson, JC | 1 |
| Pittman, JG | 1 |
| Guinet, P | 1 |
| Monnier, L | 1 |
| Ghachem, M | 1 |
| Jacobs, HS | 1 |
| Mackie, DB | 1 |
| Eastman, CJ | 1 |
| Ellis, SM | 1 |
| McHardy-Young, S | 1 |
| AvRuskin, TW | 1 |
| Tang, S | 1 |
| Zurcher, H | 2 |
| Sakoloff, C | 2 |
| Vallotton, MB | 2 |
| Schulz, U | 1 |
| Breuel, HP | 1 |
| Nowrousian, MR | 1 |
| Kattermann, R | 1 |
| Luig, H | 1 |
| Ormston, BJ | 1 |
| Alexander, L | 1 |
| Bird, T | 1 |
| Appleton, D | 1 |
| Aliakparova, ASh | 1 |
| Mills, LC | 1 |
| Irie, M | 1 |
| Enomoto, K | 1 |
| Enomoto, H | 1 |
| Nukii, T | 1 |
| Weidinger, P | 1 |
| Johnson, PM | 1 |
| Schneider, PB | 1 |
| Liewendahl, K | 2 |
| Gordin, A | 1 |
| Richards, AR | 1 |
| Addison, GM | 1 |
| Yamaji, T | 1 |
| Matsuzaki, S | 1 |
| Matsuzaki, F | 1 |
| Furth, ED | 1 |
| Rives, K | 1 |
| Horst, W | 1 |
| Schneider, C | 1 |
| Labhart, A | 1 |
| Alexander, WD | 3 |
| Harden, RM | 2 |
| Shimmins, J | 2 |
| McLarty, D | 1 |
| McGill, P | 1 |
| Dymling, JF | 1 |
| Mahaux, JE | 4 |
| Levin, S | 2 |
| Nagel, M | 3 |
| Ispas, I | 1 |
| Milcu, S | 1 |
| McCullagh, EP | 1 |
| Bussemaker, JK | 1 |
| Chamla-Soumenkoff, J | 1 |
| Delcourt, R | 1 |
| Nagel, N | 1 |
| Valentini, F | 2 |
| Lodeserto, A | 2 |
| Vivarelli, S | 1 |
| Miedico, D | 1 |
| Schneck, O | 1 |
| Eber, O | 2 |
| Wascher, H | 1 |
| Wils, JA | 4 |
| Kloppenborg, PW | 4 |
| Kirkham, K | 1 |
| Doniach, D | 1 |
| el-Kabir, D | 1 |
| Nordyke, RA | 1 |
| Freeman, GC | 1 |
| Mayberry, WE | 1 |
| Wallack, MS | 1 |
| Adelberg, HM | 1 |
| Anderson, J | 1 |
| Farmer, FT | 1 |
| Heinonen, OP | 1 |
| Viherkoski, M | 1 |
| Aro, A | 1 |
| Kvist, G | 1 |
| Laitinen, O | 1 |
| Knekt, P | 1 |
| Hedley, AJ | 2 |
| Ross, IP | 2 |
| Franco, PS | 1 |
| Haigler, ED | 1 |
| Pittman, JA | 1 |
| Coulombe, P | 2 |
| Zoppetti, G | 1 |
| Cottino, F | 1 |
| Costa, A | 1 |
| Loos, U | 1 |
| Rothenbuchner, G | 1 |
| Birk, J | 1 |
| Ishihara, A | 1 |
| Pfeiffer, EF | 1 |
| Brenner, MA | 1 |
| Newman, ES | 1 |
| Odell, WD | 1 |
| Bellabarba, D | 1 |
| Tsukui, T | 1 |
| Furihata, R | 1 |
| Ivy, HK | 2 |
| Beckers, C | 1 |
| Cornette, C | 1 |
| Thalasso, M | 1 |
| Adams, DD | 1 |
| Kennedy, TH | 1 |
| Stewart, RD | 1 |
| Danilova, IN | 1 |
| Minenkov, AA | 1 |
| Munro, R | 1 |
| Row, VV | 1 |
| Lange, E | 1 |
| Zieliński, W | 1 |
| Skvortsova, RI | 1 |
| Shuvalova, IE | 1 |
| Ametov, AS | 1 |
| Mashimo, K | 1 |
| Kishino, F | 1 |
| Nishiooeda, Y | 1 |
| Morita, R | 1 |
| Hamada, T | 1 |
| Grabs, V | 1 |
| Schumann, J | 1 |
| Retiene, K | 1 |
| Gasiorowski, W | 1 |
| Hoffenberg, R | 1 |
| Van Welsum, M | 1 |
| Feltkamp, TE | 1 |
| De Vries, MJ | 1 |
| Ho, RS | 1 |
| Patel, YC | 1 |
| Burger, HG | 1 |
| Lande, G | 1 |
| Kjolseth, I | 1 |
| Peillon, F | 1 |
| Doucet, D | 1 |
| Gyertyánfy, G | 1 |
| Tako, J | 2 |
| Cavlieri, RR | 1 |
| Sung, LC | 1 |
| Becker, CE | 1 |
| Djabri, M | 1 |
| Uller, RP | 1 |
| Szybiński, Z | 1 |
| Sieradzki, J | 1 |
| McLarty, DG | 1 |
| Horton, P | 1 |
| Pharmakiotis, AD | 1 |
| DeSanto, LW | 1 |
| MacCarty, CS | 1 |
| Riley, FC | 1 |
| Anderson, DR | 1 |
| Thijs, LG | 1 |
| Wahner, HW | 3 |
| Menzel, K | 1 |
| Hoffmann, W | 1 |
| Menking, M | 1 |
| Wiebel, J | 1 |
| Schmid, WU | 1 |
| Schmidt, WT | 1 |
| Ebel, KD | 1 |
| Ritter, R | 1 |
| Rolland, M | 1 |
| Montfort, MF | 1 |
| Valenta, L | 1 |
| Lissitzky, S | 1 |
| Ayromlooi, J | 1 |
| Asper, SP | 1 |
| Juhász, J | 1 |
| Hamburger, JI | 1 |
| Donald, D | 1 |
| Albert-Recht, F | 1 |
| Michie, W | 1 |
| Scarlato, G | 1 |
| Pellegrini, G | 1 |
| Sobel, RJ | 1 |
| Rosenfeld, PS | 1 |
| Burgos-Vasquez, F | 1 |
| Leistner, GH | 1 |
| Wessel, C | 1 |
| Gronau, U | 1 |
| Heinze, HG | 1 |
| Pabst, HW | 1 |
| Hör, G | 1 |
| Frey, KW | 1 |
| Sonntag, A | 1 |
| Klemm, J | 1 |
| Berman, M | 1 |
| Hoff, E | 1 |
| Barandes, M | 1 |
| Becker, DB | 1 |
| Sonenberg, M | 1 |
| Benua, R | 1 |
| Samuelsson, SM | 1 |
| Werner, I | 1 |
| Moll, W | 1 |
| Gillich, KH | 1 |
| Papalia, D | 1 |
| Casale, P | 1 |
| Macca, G | 1 |
| Motta, L | 1 |
| Bowden, AN | 1 |
| Ross, FC | 1 |
| Giustina, G | 1 |
| Vallino, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease[NCT05643365] | 300 participants (Anticipated) | Observational [Patient Registry] | 2013-01-01 | Recruiting | |||
| he Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial[NCT06068179] | Phase 2/Phase 3 | 205 participants (Anticipated) | Interventional | 2023-10-08 | Not yet recruiting | ||
| B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease[NCT02316691] | 2 participants (Actual) | Observational | 2016-01-31 | Terminated | |||
| Comparison of Exercise Capacity and Physical Activity Levels in Patients With Hyperthyroid and Healthy Controls[NCT04825964] | 30 participants (Actual) | Observational | 2021-03-19 | Completed | |||
| A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease[NCT02685514] | 22 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients[NCT02993302] | Phase 2 | 25 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
| Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism: A Clinical Trial With Historical Control[NCT01039818] | Phase 3 | 30 participants (Actual) | Interventional | 1997-02-28 | Completed | ||
| Comparison of Efficacy and Safety of Intravenous Pulsed Methylprednisolone and Oral Methotrexate Versus Intravenous Pulsed Methylprednisolone and Oral Placebo in the Treatment of Active Moderate and Severe Thyroid Eye Disease - a Prospective, Randomized, [NCT00348413] | 80 participants (Anticipated) | Interventional | 2003-06-30 | Completed | |||
| Implantation of Thyroid Gland After Total Thyroidectomy in Quadriceps Femoris Muscle[NCT04684953] | 40 participants (Anticipated) | Interventional | 2022-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Dendritic cells maturation levels were measured by the CD206 (NCT02993302)
Timeframe: 1 year
| Intervention | nM (Mean) |
|---|---|
| PTU + Oral 1α-D3 | 54.08 |
| PTU + Placebos | 53.42 |
Dendritic cells maturation levels were measured by the CD80 (cluster of differentiation 80) (NCT02993302)
Timeframe: 1 year
| Intervention | nM (Median) |
|---|---|
| PTU + Oral 1α-D3 | 45.60 |
| PTU + Placebos | 54.51 |
fT4 (free thyroxine) (NCT02993302)
Timeframe: 1 year
| Intervention | ng/dL (Mean) |
|---|---|
| PTU + Oral 1α-D3 | 2.65 |
| PTU + Placebos | 2.09 |
Dendritic cells maturation levels were measured by the IL-12 (interleukin-12)/IL-10 ratio (NCT02993302)
Timeframe: 1 year
| Intervention | ratio (Median) |
|---|---|
| PTU + Oral 1α-D3 | 0.49 |
| PTU + Placebos | 0.21 |
30 reviews available for triiodothyronine and Graves Disease
| Article | Year |
|---|---|
Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function?
Topics: Bariatric Surgery; Celiac Disease; Dysbiosis; Female; Gastrointestinal Microbiome; Graves Disease; H | 2020 |
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Graves Disease; Humans; Hypothyroidism; Mortality; Progno | 2021 |
Graves' Disease: Can It Be Cured?
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypot | 2019 |
[Neonatal hyperthyroidism: a case report and literature review].
Topics: Antithyroid Agents; Apnea; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, | 2013 |
Influence of cigarette smoking on thyroid gland--an update.
Topics: Female; Graves Disease; Hashimoto Disease; Humans; Hyperthyroidism; Hypothyroidism; Pregnancy; Pregn | 2014 |
Clinical practice. Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Arrhythmias, Cardiac; Female; Graves Disease | 2008 |
Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
Topics: Antithyroid Agents; Combined Modality Therapy; Graves Disease; Humans; Iodine Radioisotopes; Lithium | 2003 |
Antithyroid drugs.
Topics: Agranulocytosis; Algorithms; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Me | 2005 |
[T3 toxicosis].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Diagnosis, Differential; Goiter, Nodular; Graves Di | 2006 |
Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Arteries; Elasticity; Female; Graves Disease; Humans; Hyperthyroidism; Male | 2007 |
[Etiology and diagnosis of Basedow's disease].
Topics: Animals; Graves Disease; Guinea Pigs; Humans; Iodine Radioisotopes; Receptors, Cell Surface; Recepto | 1984 |
[Hormone receptor disease (author's transl)].
Topics: Adolescent; Adult; Aged; Androgen-Insensitivity Syndrome; Antibody Formation; Child, Preschool; Cycl | 1980 |
Radioimmunoassay of human thyrotropin: analytical and clinical developments.
Topics: Adolescent; Adult; Aged; Aging; Child; Child, Preschool; Circadian Rhythm; Female; Goiter; Graves Di | 1984 |
[Progress in studies on the physiopathology, diagnosis and treatment of Graves-Basedow disease (selected problems)].
Topics: Autoimmune Diseases; Graves Disease; Humans; Thyrotropin; Thyroxine; Triiodothyronine | 1984 |
Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements.
Topics: Graves Disease; Guidelines as Topic; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Hormones; Trea | 1996 |
The assessment of thyroid function and structure.
Topics: Biopsy, Needle; Carrier Proteins; Goiter; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; P | 1978 |
[Lithium and thyroid function. Significance of the TRH test in the diagnosis of lithium-induced thyroid dysfunction].
Topics: Adolescent; Adult; Aged; Female; Goiter; Graves Disease; Growth Hormone; Humans; Hyperthyroidism; Hy | 1979 |
[Current diagnosis and differential diagnosis of thyroid diseases].
Topics: Adenoma; Diagnosis, Differential; Edema; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotope | 1979 |
Endocrine exophthalmos: an immunologic aberration.
Topics: Autoantibodies; Exophthalmos; Graves Disease; Humans; Immunity; Immunity, Cellular; Immunoglobulin G | 1977 |
[Thyrotropic hormone and the thyroid gland (present status)].
Topics: Blood Proteins; Circadian Rhythm; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; P | 1977 |
[TSH receptor antibody in hyperthyroid patients due to Graves' disease treated with antithyroid drugs].
Topics: Adult; Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, | 1991 |
[Postoperative hypothyroidism].
Topics: Adult; Antigens; Autoantibodies; Autoimmune Diseases; Graves Disease; Hormones; Humans; Hypothyroidi | 1986 |
[Chemotherapy of hyperthyroidism and its remission in Japan].
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Japan; Prognosis; Remission, Spontaneou | 1974 |
[Toxic adenoma of the thyroid gland].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Ra | 1966 |
Interaction of drugs with thyroid hormone binding sites.
Topics: Binding Sites; Blood Proteins; Cell Nucleus; Drug Interactions; Endoplasmic Reticulum; Graves Diseas | 1973 |
Thyroid physiology in health and disease.
Topics: Adult; Animals; Cattle; Chemical Phenomena; Chemistry; Chorionic Gonadotropin; Female; Graves Diseas | 1974 |
[Advances in diagnosis and treatment of hypothyroidism].
Topics: Autoantibodies; Autoimmune Diseases; Cholesterol; Dextrothyroxine; Graves Disease; Humans; Hypothyro | 1973 |
Aetiology of hyperthyroidism. I.
Topics: Africa; Age Factors; Chromatography, Paper; Europe; Female; Goiter, Nodular; Graves Disease; Humans; | 1974 |
Mechanisms of Graves' disease and endocrine exophthalmos.
Topics: Animals; Binding Sites; Biological Assay; Exophthalmos; Fishes; Graves Disease; Humans; Hyperthyroid | 1969 |
Symposium on hyperthyroidism.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxine; Triiodothyronine | 1970 |
67 trials available for triiodothyronine and Graves Disease
| Article | Year |
|---|---|
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Potas | 2020 |
Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial.
Topics: Adolescent; Antithyroid Agents; Child; Drug Therapy, Combination; Graves Disease; Humans; Immunoglob | 2019 |
Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women.
Topics: Adiponectin; Female; Graves Disease; Humans; Insulin Resistance; Middle Aged; Sex Hormone-Binding Gl | 2013 |
Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Drug Administration Schedule; Drug Therapy, Comb | 2015 |
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Topics: Adult; Antioxidants; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Meth | 2017 |
The influence of non-radioactive iodine (127I) on the outcome of radioiodine (131I) therapy in patients with Graves' disease and toxic nodular goitre.
Topics: Female; Goiter, Nodular; Graves Disease; Half-Life; Humans; Iodine; Iodine Radioisotopes; Male; Midd | 2011 |
Short-term effect of radioactive iodine therapy on CXCL-10 production in Graves' disease.
Topics: Adult; Chemokine CXCL10; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Th | 2011 |
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Topics: Antithyroid Agents; Graves Disease; Humans; Iodine Radioisotopes; Lithium; Methimazole; Prospective | 2002 |
Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Hormone Replacement Therapy; Humans; Hypot | 2002 |
Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Th | 2003 |
T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantigens; Carbimazole; Female; Graves Disease; Horm | 2003 |
Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium.
Topics: Adult; Antioxidants; Antithyroid Agents; Drug Therapy, Combination; Female; Glutathione Peroxidase; | 2004 |
Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Catalase; Ceruloplasmin; Female; Glutathione Peroxid | 2004 |
Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
Topics: Adolescent; Adult; Analysis of Variance; Antibodies, Monoclonal; Antithyroid Agents; Drug Administra | 2004 |
Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Female; Graves Disease; Humans; Iodi | 2004 |
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Cholestyramine R | 2005 |
Thyroid hormone increases mannan-binding lectin levels.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Ma | 2005 |
Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake.
Topics: Adult; Antithyroid Agents; Diet; Female; Graves Disease; Humans; Iodine; Male; Methimazole; Middle A | 2006 |
Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease.
Topics: Aged; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Health Status; Humans; Iodide Perox | 2007 |
Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
Topics: Adolescent; Adult; Antithyroid Agents; Child; Drug Therapy, Combination; Female; Goiter, Nodular; Gr | 2007 |
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Methimazole; Propy | 2007 |
Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Topics: Administration, Oral; Adult; Aged; Antibodies; Combined Modality Therapy; Female; Graves Disease; Hu | 2007 |
Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy.
Topics: Adult; Aged; Antimutagenic Agents; Chromosome Breakage; Dietary Supplements; Dose-Response Relations | 2007 |
TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Topics: Adult; Antithyroid Agents; Autoantibodies; Autoimmunity; Graves Disease; Humans; Immunoglobulins, Th | 2008 |
The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Hyperthyroidis | 2007 |
Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Autoantibodies; Dose-Response Relationship, | 1983 |
Response to methimazole in Graves' disease. The European Multicenter Study Group.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Iodides; Male; | 1995 |
Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Topics: Adolescent; Adult; Antibodies; Child; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1995 |
Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study.
Topics: Adult; Age Factors; Autoantibodies; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Midd | 1995 |
Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
Topics: Adult; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Interleukin-6; Male; Middle | 1995 |
Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
Topics: Adult; Antibodies; Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Female; Graves Diseas | 1996 |
Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hormones; Humans; Injections, Subcutaneous; Intercell | 1996 |
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Carbimazole; Female; Graves Disease; Humans; Hypert | 1997 |
Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?
Topics: Adolescent; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Child; Female; Graves Disease; H | 1997 |
Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Antithyroid Agents; Autoantibodies; Female; Graves Di | 1997 |
Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Topics: Adolescent; Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobuli | 1997 |
Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Topics: Adult; Aged; Antibodies; Antithyroid Agents; Arteries; Female; Graves Disease; Hormones; Humans; Iod | 1997 |
TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates.
Topics: Adolescent; Adult; Antithyroid Agents; Carbimazole; Depression, Chemical; Drug Therapy, Combination; | 1998 |
[Therapeutic effect and its mechanism exploration on mainly using traditional Chinese medicine of replenishing qi and nourishing yin in treating Graves disease].
Topics: Adolescent; Adult; Antithyroid Agents; Biological Transport, Active; Child; Drug Therapy, Combinatio | 1997 |
Role of colestipol in the treatment of hyperthyroidism.
Topics: Adult; Antithyroid Agents; Colestipol; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroid | 1998 |
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatment.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Carbimazole; Drug Administration Schedule; | 1999 |
Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunochemistry; Immunoglobulins, Thyroid-S | 1999 |
Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 1999 |
Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Drug Combinations; Female; Goiter; Graves D | 2000 |
Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Evaluation Studies as Topic; Female; Graves Disease; Hu | 1996 |
Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Topics: Adult; Antithyroid Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Graves Dis | 2001 |
The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 2001 |
The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Topics: Adult; Antithyroid Agents; Combined Modality Therapy; Female; Follow-Up Studies; Graves Disease; Hum | 2001 |
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Topics: Administration, Oral; Bone Density; Combined Modality Therapy; Diplopia; Exophthalmos; Eyelids; Fema | 2001 |
Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.
Topics: Adult; Apoptosis; Disease Progression; fas Receptor; Female; Graves Disease; Humans; Hyperthyroidism | 2001 |
[Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Huma | 2001 |
The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidi | 1975 |
Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
Topics: Adult; Drug Evaluation; Female; Follow-Up Studies; Graves Disease; Hormones; Humans; Hypothyroidism; | 1979 |
[Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
Topics: Age Factors; Clinical Trials as Topic; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroi | 1976 |
Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Autoantibodies; Female; Graves Disease; Humans; Immun | 1991 |
Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Hyperthyroidism; Ipodate; M | 1991 |
Antithyroid drug treatment of von Basedow's disease: results from a multicenter study.
Topics: Adult; Aged; Graves Disease; Humans; Methimazole; Middle Aged; Thyroxine; Triiodothyronine | 1991 |
Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.
Topics: Aged; Aged, 80 and over; Autoantibodies; Betamethasone; Female; Graves Disease; Humans; Iodine Radio | 1991 |
The effect of amiodarone on the control of hyperthyroidism by propylthiouracil.
Topics: Adult; Amiodarone; Drug Therapy, Combination; Female; Graves Disease; Hemodynamics; Humans; Middle A | 1990 |
Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease.
Topics: Adult; Aged; Autoantibodies; Betamethasone; Female; Graves Disease; Humans; Immunoglobulin G; Immuno | 1986 |
The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; | 1987 |
Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
Topics: Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Graves Disease; Heart Rat | 1988 |
Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Female; Graves Disease; Humans; Male; Middle Aged; Ra | 1988 |
Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
Topics: Adult; Clinical Trials as Topic; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Potassi | 1986 |
Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid and hyperthyroid man.
Topics: Antithyroid Agents; Clinical Trials as Topic; Graves Disease; Humans; Hyperthyroidism; Hypothyroidis | 1966 |
Optic neuropathy of graves's disease. Treatment by transantral or transfrontal orbital decompression.
Topics: Craniotomy; Diplopia; Frontal Bone; Graves Disease; Humans; Iodine Radioisotopes; Length of Stay; Ma | 1974 |
Diagnostic ultrasound in clinical thyroid investigation.
Topics: Adenoma; Clinical Trials as Topic; Cysts; Diagnosis, Differential; Goiter; Graves Disease; Humans; I | 1971 |
838 other studies available for triiodothyronine and Graves Disease
| Article | Year |
|---|---|
Graves' disease coexisted with resistance to thyroid hormone: a case report.
Topics: Activities of Daily Living; Adult; Graves Disease; Humans; Male; Methimazole; Thyrotropin; Triiodoth | 2021 |
Myopathy Associated with Treatment of Graves' Disease.
Topics: Antithyroid Agents; Child; Female; Graves Disease; Humans; Methimazole; Myalgia; Thyroxine; Triiodot | 2021 |
The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.
Topics: Adult; Animals; Autoantibodies; China; CHO Cells; Cricetulus; Female; Graves Disease; Humans; Immuno | 2021 |
Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Echocardiography; Female; Forced Expiratory | 2021 |
Low levels of serum IL-39 are associated with autoimmune thyroid disease.
Topics: Case-Control Studies; Graves Disease; Hashimoto Disease; Humans; Interleukins; Triiodothyronine | 2022 |
The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves' Disease and Hashimoto's Thyroiditis.
Topics: Adult; Autoantibodies; Biomarkers; Disease Progression; Female; Graves Disease; Hashimoto Disease; H | 2022 |
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
Topics: Autoantibodies; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; | 2022 |
Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease.
Topics: Autoantibodies; C-Reactive Protein; Cytokines; Graves Disease; Humans; Interleukins; Iodide Peroxida | 2022 |
Clinical significance of hepatic function in Graves disease with type 2 diabetic mellitus: A single-center retrospective cross-sectional study in Taiwan.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Cross-Sectional Studies; Diabetes Mel | 2022 |
High levels of thyroid hormones promote recurrence of Graves' disease via overexpression of B-cell-activating factor.
Topics: Graves Disease; Humans; Hyperthyroidism; Immunoglobulin G; Interleukin-4; Thyroxine; Triiodothyronin | 2022 |
Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia.
Topics: Adult; C-Reactive Protein; Glycosaminoglycans; Graves Disease; Humans; Hypothyroidism; Male; Pericar | 2022 |
Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
Topics: Biotin; Graves Disease; Humans; Male; Middle Aged; Streptavidin; Thyroid Hormones; Thyroxine; Triiod | 2023 |
Thyroid function test variability and cardiovascular morbidity in hyperthyroidism.
Topics: Antithyroid Agents; Cardiovascular Diseases; Graves Disease; Humans; Hyperthyroidism; Male; Retrospe | 2023 |
Expansion of the immature B lymphocyte compartment in Graves' disease.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Precursor Cells, B-Lymphoid; Thyroid Ho | 2023 |
Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Topics: Adult; Aged; Atrophy; Case-Control Studies; Female; Graves Disease; Humans; Hypothyroidism; Iodine R | 2019 |
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; | 2020 |
New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone.
Topics: Animals; Cell Membrane; Chorionic Gonadotropin; Drug Design; Graves Disease; Humans; Iodide Peroxida | 2020 |
Predictors of euthyreosis in hyperthyroid patients treated with radioiodine
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Goiter, Nodular; Graves Disease; Humans; Hypert | 2020 |
Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Pregnancy; | 2020 |
Hemodynamic changes in neonates born to mothers with Graves' disease.
Topics: Female; Graves Disease; Hemodynamics; Humans; Infant, Newborn; Mothers; Thyroxine; Triiodothyronine | 2021 |
Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antithyroid Agents; Case-Control Studies; Child; Chin | 2020 |
Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism
Topics: Adolescent; Age Distribution; Antithyroid Agents; Autoantibodies; Biomarkers; Child; Female; Graves | 2021 |
Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis.
Topics: Adult; Biomarkers; Cohort Studies; Diagnosis, Differential; Female; Graves Disease; Humans; Male; Mi | 2020 |
Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Maternal-F | 2021 |
Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
Topics: Aged; Biomarkers, Tumor; Goiter, Nodular; Graves Disease; Humans; Iodide Peroxidase; Iodothyronine D | 2021 |
Neonatal Graves' Eye Disease.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Infant; Methimazole; Thyrotropin; Thyroxine; Tri | 2017 |
Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Circulating MicroRNA; Female; Graves Disease; Humans; | 2017 |
Topics: Animals; Calcium-Binding Proteins; Casein Kinase I; Cell Line; Cells, Cultured; Extracellular Matrix | 2017 |
Iron metabolism in patients with Graves' hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Cytokines; Female; Ferritins; Graves Disease; Hep G2 Cells; Hepcidin | 2017 |
Weight gain after treatment of Graves' disease in children.
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Graves Disease; Humans; Hyperthyroidism; Iodin | 2018 |
Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease: A Multicenter Study.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Graves Disease; Humans; Male; Middle Aged; Progn | 2018 |
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged | 2017 |
Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
Topics: Adult; B-Lymphocytes; Cross-Sectional Studies; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylatio | 2018 |
A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Retr | 2018 |
Rapid Relief: Thyroidectomy is a Quicker Cure than Radioactive Iodine Ablation (RAI) in Patients with Hyperthyroidism.
Topics: Adult; Communication; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Patie | 2019 |
Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hashimoto Disease; Humans; Hypothyroidism; Immunoglob | 2018 |
Serum autotaxin levels are associated with Graves' disease.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Antithyroid Agents; Graves Disease; Humans; Mice; Phosphoric Dies | 2019 |
Remission of autoimmune hyperthyroidism after chemotherapy for cancer.
Topics: Adult; Antithyroid Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Comorbidity; Female; Graves | 2014 |
Lymphocyte-platelet crosstalk in Graves' disease.
Topics: Adolescent; Adult; Blood Platelets; Female; Goiter, Nodular; Graves Disease; Humans; Lymphocyte Acti | 2014 |
Increased serum interleukin-33 levels in patients with Graves' disease.
Topics: Adult; Aged; Autoimmunity; Biomarkers; Female; Graves Disease; Hashimoto Disease; Humans; Interferon | 2013 |
A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Interferon-gamma; Int | 2013 |
Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aging; Autoantibodies; Female; Goiter, Nodular; Graves Dise | 2013 |
Interleukin-21 is associated with disease activity in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Female; Graves Disease; Humans; Immunoglobulins, Thyr | 2014 |
Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Kaplan-Meier Estimate; Male; Midd | 2014 |
Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Topics: Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Postpartum Period; Receptors, Thy | 2014 |
Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; H | 2015 |
Risk factors of hyperthyroidism with hepatic function injury: a 4-year retrospective study.
Topics: Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Iodine; Liver; Liver Diseases; Male; Mi | 2015 |
[Relationship between depression and thyroid hormone levels in patients with Graves disease].
Topics: Depression; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Radiopharmaceuticals; Risk | 2014 |
Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging | 2014 |
Failure of radioactive iodine in the treatment of hyperthyroidism.
Topics: Adult; Biomarkers; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Iodine Radioi | 2014 |
Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Male; Middle Aged; Receptors, Thyrotropin; Th | 2015 |
Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Topics: Adult; Aged; Antithyroid Agents; Chemical and Drug Induced Liver Injury; China; Female; Graves Disea | 2015 |
Papillary thyroid carcinoma in an adolescent girl with graves' disease.
Topics: Adolescent; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Female; Graves Disease; Huma | 2014 |
Immunologic and hormonal effects of prophylthiouracil treatment using maintenance dose in Graves' disease patients.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Interleukin-4; Male; Propylthiouracil; Th | 2014 |
Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
Topics: Adolescent; Age Factors; Antithyroid Agents; Child; Child, Preschool; Female; Follow-Up Studies; Gra | 2015 |
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Topics: Algorithms; Chorionic Gonadotropin; Diagnosis, Differential; Female; Graves Disease; Hashimoto Disea | 2015 |
Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Topics: Adult; Autoantibodies; Case-Control Studies; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lym | 2015 |
Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
Topics: Adult; Agouti-Related Protein; Appetite; Basal Metabolism; Calcium-Binding Proteins; Case-Control St | 2015 |
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.
Topics: Adenoma; Adult; Age Factors; Aged; Atrial Fibrillation; Chi-Square Distribution; Female; France; Goi | 2016 |
Decreased serum level of IL-7 in patients with active Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Enzyme-Linked Immunosorbent Assay; Femal | 2015 |
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Topics: Abnormalities, Drug-Induced; Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; H | 2015 |
Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2015 |
[Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study].
Topics: Actins; Animals; Capsules; Disease Models, Animal; Drugs, Chinese Herbal; Female; Graves Disease; Me | 2015 |
Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Cohort Studies; Dexamethasone; | 2016 |
Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.
Topics: Age of Onset; Alleles; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Genetic Assoc | 2017 |
Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.
Topics: Biotin; Diagnostic Errors; Dietary Supplements; Graves Disease; Humans; Hyperthyroidism; Male; Middl | 2016 |
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Topics: Adult; Age Factors; Antithyroid Agents; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; | 2016 |
Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease.
Topics: Adult; Antithyroid Agents; Cell Count; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle | 2016 |
The management of Graves' disease in New Zealand 2014.
Topics: Antithyroid Agents; Disease Management; Endocrinologists; Graves Disease; Humans; Internal Medicine; | 2016 |
Analysis of iodine-131-induced early thyroid hormone variations in Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulatin | 2016 |
Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease.
Topics: Antithyroid Agents; Biomarkers; Case-Control Studies; Cell Line; Down-Regulation; Enzyme-Linked Immu | 2016 |
Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Case-Control Studies; Cells, Cultured; Chromatograp | 2017 |
Serum immunoglobulin G4 levels and Graves' disease phenotype.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulin G; Male; Middle Aged; Phenotyp | 2017 |
Irisin and Myostatin Levels in Patients with Graves' Disease.
Topics: Adult; Case-Control Studies; Energy Metabolism; Female; Fibronectins; Graves Disease; Humans; Male; | 2016 |
The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Logistic Models; Male; | 2017 |
Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.
Topics: Adult; Age Factors; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Rad | 2017 |
Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Topics: Adolescent; Adult; Antithyroid Agents; Apoptosis; Blotting, Western; Child; Female; Goiter, Nodular; | 2008 |
Increased macrophage colony-stimulating factor levels in patients with Graves' disease.
Topics: Administration, Oral; Adult; Female; Graves Disease; Humans; Inflammation Mediators; Macrophage Colo | 2008 |
[Prognostic factors in the relapse of Graves disease].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Immu | 2008 |
Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Topics: Adult; Antithyroid Agents; Blood Glucose; C-Reactive Protein; Carbimazole; Cytokines; Female; Graves | 2008 |
Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
Topics: Adolescent; Adult; Aged; Aging; Cross-Sectional Studies; Female; Graves Disease; Humans; Male; Middl | 2009 |
Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects.
Topics: Aged; Blood Glucose; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Ad | 2009 |
Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; | 2009 |
Immunization with thyroglobulin induces Graves'-like disease in mice.
Topics: Animals; Autoantibodies; Cattle; Disease Models, Animal; Female; Graves Disease; Immunization; Immun | 2009 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.
Topics: Adult; Blood Pressure; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Down-Regu | 2009 |
Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome?
Topics: Creatine Kinase; Female; Graves Disease; Humans; Myositis; Syndrome; Thyroid Hormones; Thyroidectomy | 2009 |
[Blockade of the renin-angiotensin-aldosterone system in Graves' disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output; F | 2009 |
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
Topics: Adult; Aged; Chi-Square Distribution; Female; Glucocorticoids; Graves Disease; Graves Ophthalmopathy | 2010 |
Human multidrug resistance-1 gene expression levels in graves-basedow disease.
Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance; Female | 2010 |
The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Czech Republic; Female; Genotype; Graves Disease | 2010 |
Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease.
Topics: Adolescent; Autoantibodies; Child; Disease Progression; Female; Graves Disease; Hashimoto Disease; H | 2010 |
Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Hashimoto Disease; Humans; Immunoglobulins, Thyro | 2010 |
Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
Topics: Adolescent; Blood Glucose; Child; Female; Ghrelin; Goiter; Graves Disease; Hashimoto Disease; Humans | 2010 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Bl | 2010 |
Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
Topics: Adult; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Pleural Effusion; Thyroto | 2010 |
Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Female; Graves Disease; Humans; Iodide Peroxidase; Iodo | 2011 |
Graves' disease. When thyroid hormones run wild.
Topics: Graves Disease; Humans; Patient Education as Topic; Thyroxine; Triiodothyronine | 2011 |
Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Endot | 2011 |
Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Topics: Adult; Apoptosis; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Forkhe | 2011 |
Evaluation of oxidative status in patients with hyperthyroidism.
Topics: Adult; Algorithms; Antioxidants; Cross-Sectional Studies; Female; Goiter, Nodular; Graves Disease; H | 2011 |
Radioiodine therapy for hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyroxine; T | 2011 |
Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Topics: Autoantibodies; Education, Medical, Continuing; Education, Nursing, Continuing; Female; Graves Disea | 2011 |
Prediction of late (24-hour) radioactive iodine uptake using early (3-hour) uptake values in Japanese patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Graves Disease; Humans; Iod | 2012 |
Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
Topics: Adult; Diagnosis, Differential; Exons; Female; Genes, Dominant; Genes, erbA; Goiter, Nodular; Graves | 2012 |
Differential microRNA expression in peripheral blood mononuclear cells from Graves' disease patients.
Topics: Adult; Autoimmunity; Female; Gene Expression; Genetic Markers; Graves Disease; Humans; Leukocytes, M | 2012 |
[Determination of serum neopterin levels in patients with autoimmune thyroid diseases].
Topics: Adult; Aged; Autoantibodies; Biomarkers; Female; Graves Disease; Hashimoto Disease; Humans; Iodide P | 2012 |
Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years.
Topics: Adult; Arrhythmias, Cardiac; Autoantibodies; Diagnosis, Differential; Female; Flushing; Graves Disea | 2013 |
Genes that characterize T3-predominant Graves' thyroid tissues.
Topics: Adult; Bone Morphogenetic Proteins; Cadherins; Creatine Kinase; Creatine Kinase, Mitochondrial Form; | 2013 |
Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos.
Topics: Animals; Antithyroid Agents; Body Patterning; Cilia; Digestive System Abnormalities; Female; Gene Ex | 2013 |
Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
Topics: Adult; Alcohol Drinking; Anti-Infective Agents, Local; Case-Control Studies; Denmark; Disease Progre | 2013 |
Maternal thyrotoxicosis and fetal goitre requiring in utero therapy for hypothyroidism and subsequent neonatal therapy for hyperthyroidism.
Topics: Antithyroid Agents; Carbimazole; Female; Fetal Diseases; Fetal Therapies; Goiter; Graves Disease; Hu | 2013 |
Prevalence of diaphragmatic muscle weakness and dyspnoea in Graves' disease and their reversibility with carbimazole therapy.
Topics: Adult; Antithyroid Agents; Carbimazole; Diaphragm; Dyspnea; Exercise; Female; Forced Expiratory Volu | 2002 |
Levels of soluble human leukocyte antigen class 1 are increased in Graves' disease and toxic multinodular goiter and correlate with the levels of triiodothyronine.
Topics: Adult; Aged; Black People; Follow-Up Studies; Goiter, Nodular; Graves Disease; Histocompatibility An | 2002 |
Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Pregnancy; Prenatal Ca | 2002 |
The aftermath of orbital radiotherapy for graves' ophthalmopathy.
Topics: Adult; Aged; Decompression, Surgical; Dose Fractionation, Radiation; Female; Follow-Up Studies; Grav | 2002 |
[Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report].
Topics: Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; Radion | 2002 |
Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?
Topics: Adult; Follow-Up Studies; Graves Disease; Half-Life; Humans; Iodine Radioisotopes; Middle Aged; Radi | 2002 |
Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Topics: Adolescent; Antigens, CD19; B-Lymphocytes; Case-Control Studies; CD3 Complex; CD4-Positive T-Lymphoc | 2003 |
Serum activin A levels in different thyroid disorders.
Topics: Activins; Adenoma; Adult; Aged; Aged, 80 and over; Female; Goiter; Graves Disease; Humans; Hypothyro | 2002 |
[Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radioiodine treatment in Graves' disease].
Topics: Follow-Up Studies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioisotope | 2003 |
Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' disease.
Topics: Adult; C-Reactive Protein; Female; Graves Disease; Humans; Immunoenzyme Techniques; Interleukin-6; M | 2003 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
Studies of the inhibitory effect of l-triiodo-thyronine on thyroidal I131 uptake in euthyroid persons and patients with exophthalmic goiter.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine; Thyroid Gland; Thyronines; Triiodothyronine | 1956 |
Studies of the inhibitory effect of l-triiodo-thyronine on thyroidal I131 uptake in euthyroid persons and patients with exophthalmic goiter.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine; Thyroid Gland; Thyronines; Triiodothyronine | 1956 |
Studies of the inhibitory effect of l-triiodo-thyronine on thyroidal I131 uptake in euthyroid persons and patients with exophthalmic goiter.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine; Thyroid Gland; Thyronines; Triiodothyronine | 1956 |
Studies of the inhibitory effect of l-triiodo-thyronine on thyroidal I131 uptake in euthyroid persons and patients with exophthalmic goiter.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine; Thyroid Gland; Thyronines; Triiodothyronine | 1956 |
The effect of dl-3,3',5'-triiodothyronine in Graves' disease.
Topics: Graves Disease; Humans; Hyperthyroidism; Triiodothyronine; Triiodothyronine, Reverse | 1959 |
Failure of a new TSH inhibitor, the methyl ether of triiodothyrepropionic acid, in the treatment of endocrine exophthalmos.
Topics: Exophthalmos; Goiter; Graves Disease; Humans; Methyl Ethers; Thyrotropin; Thyrotropin-Releasing Horm | 1963 |
[ISOTOPE TESTS OF RADIO-THYROXIN HALF-LIFE AND IN VITRO ERYTHROCYTE FIXATION OF LABELLED TRIIODOTHYRONINE].
Topics: Anorexia Nervosa; Erythrocytes; Goiter; Graves Disease; Half-Life; Hypercholesterolemia; Hyperthyroi | 1963 |
LOCALIZED MYXEDEMA--GENERALIZED IN SCARS.
Topics: Cicatrix; Dexamethasone; Diuretics; Exophthalmos; Goiter; Graves Disease; Humans; Hydrochlorothiazid | 1964 |
[DIAGNOSTIC ABUSES IN BASEDOWIAN THYROTOXICOSIS. FREQUENCY OF BASEDOWIAN THYROSIS IN THE LIGHT OF THE TEST OF INHIBITION BY TRIIODOTHYRONINE].
Topics: Diagnosis; Goiter; Graves Disease; Humans; Thyroid Function Tests; Thyrotoxicosis; Triiodothyronine | 1964 |
[BASEDOW'S DISEASE AND JUVENILE AND INFANTILE HYPERTHYROIDISM. CRITICAL STUDY APROPOS OF 5 CASES].
Topics: Adolescent; Bone and Bones; Child; Child Behavior Disorders; Congenital Abnormalities; Diagnosis; Ex | 1964 |
[CHANGES IN THE THYROTROPIC CELLS IN DIFFERENT PATHOLOGICAL AND EXPERIMENTAL STATES].
Topics: Adenoma; Goiter; Graves Disease; Iodine; Methylthiouracil; Pathology; Pharmacology; Pituitary Gland; | 1964 |
Euthyroid patients with early eye signs of Graves' disease; their responses to L-triiodothyronine and thyrotropin.
Topics: Eye; Graves Disease; Hormones; Humans; Hyperthyroidism; Pituitary Gland; Pituitary Gland, Anterior; | 1955 |
Further evidence that hyperthyroidism (Graves' disease) is not hyperpituitarism: effects of triiodothyronine and sodium iodide.
Topics: Graves Disease; Humans; Hyperpituitarism; Hyperthyroidism; Sodium Iodide; Triiodothyronine | 1955 |
The metabolism of triiodothyronine in Graves' disease.
Topics: Graves Disease; Humans; Hyperthyroidism; Triiodothyronine | 1960 |
Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues.
Topics: Adult; Female; Gonadotropin-Releasing Hormone; Graves Disease; Humans; Immunoglobulins, Thyroid-Stim | 2003 |
Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment.
Topics: Adult; Antithyroid Agents; Enzyme Activation; Female; Graves Disease; Humans; Iodide Peroxidase; Iso | 2003 |
Thyroid hormone autoantibodies in Hashimoto's thyroiditis: often transient but also increasingly frequent.
Topics: Autoantibodies; Epstein-Barr Virus Infections; Graves Disease; Humans; Thyroid Hormones; Thyroiditis | 2003 |
[Thyroid dysfunction in pregnant women and correlation with clinical and metabolical status of their newborns].
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Infant, Newborn, Diseases; P | 2003 |
Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report.
Topics: Adolescent; Anesthesia; Anti-Inflammatory Agents; Dexamethasone; Graves Disease; Humans; Iopanoic Ac | 2004 |
Pediatric Graves' disease: outcome and treatment.
Topics: Adolescent; Antithyroid Agents; Body Height; Child; Child, Preschool; Decision Making; Exophthalmos; | 2003 |
Surgical treatment of thyroid cancers with concurrent Graves disease.
Topics: Adult; Aged; Female; Graves Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Retrospective | 2004 |
Intraoperative thyroid storm: a case report.
Topics: Adolescent; Antithyroid Agents; Diagnosis, Differential; Female; Graves Disease; Humans; Intraoperat | 2004 |
Rapid preoperative preparation for severe hyperthyroid Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Dexamethasone; Female; Glucocorticoids; Grav | 2004 |
Rapid preoperative preparation for severe hyperthyroid Graves' disease.
Topics: Graves Disease; Humans; Preoperative Care; Thyroidectomy; Triiodothyronine | 2004 |
Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Goiter, Nodular; Graves Disease; Hu | 2004 |
Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
Topics: Antithyroid Agents; Carboxylic Acids; Female; Graves Disease; Humans; Hydrogen Peroxide; Male; Methi | 2005 |
Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity.
Topics: Adult; Alkaline Phosphatase; Female; Graves Disease; Humans; Likelihood Functions; Male; Middle Aged | 2005 |
Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.
Topics: Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Peptidyl | 1986 |
Expression of thioredoxin in patients with Graves' disease.
Topics: Graves Disease; Humans; Immunohistochemistry; Iodides; Thioredoxins; Thyroid Gland; Triiodothyronine | 2005 |
Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease?
Topics: Adolescent; Adult; Carotid Artery, Common; Cholesterol; Female; Graves Disease; Humans; Male; Middle | 2005 |
Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoantibodies; Female; Graves Disease; Hepacivirus; Hepatitis C, Chronic; Humans; | 2005 |
Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; G | 2005 |
Observations concerning the natural history of subclinical hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Goiter, Nodular; Gra | 2005 |
Thyrotropin suppression by metformin.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Interactions; Female; Goiter; Graves D | 2006 |
Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Topics: Adolescent; Antigens, CD; Antigens, Differentiation; Autoantibodies; CD28 Antigens; Child; CTLA-4 An | 2005 |
Oxidative stress in Graves' disease patients and antioxidant protection against lymphocytes DNA damage in vitro.
Topics: Acetylcysteine; Adult; Antioxidants; Ascorbic Acid; Comet Assay; DNA Damage; Female; Graves Disease; | 2005 |
Thyroid function during pregnancy in women with past Graves' disease.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Pregnancy C | 2005 |
Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease.
Topics: Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Pro | 2005 |
Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Male; Sensitivity and Specificity; T | 2005 |
The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse.
Topics: Adolescent; Adult; Aged; Arteries; Autoantibodies; Case-Control Studies; Female; Graves Disease; Hum | 2005 |
Hypothyroid symptoms following radioiodine therapy for Graves' disease.
Topics: Antithyroid Agents; Drug Therapy, Combination; Fatigue; Graves Disease; Humans; Hypothyroidism; Iodi | 2005 |
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Topics: Adult; Antibodies; Antithyroid Agents; Chemokine CXCL10; Chemokines, CXC; Cross-Sectional Studies; F | 2006 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Female; | 2006 |
Treatment of post-partum thyrotoxicosis.
Topics: Antithyroid Agents; Breast Feeding; Female; Graves Disease; Humans; Infant, Newborn; Iodine Radioiso | 2006 |
Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
Topics: Adult; Antithyroid Agents; Autonomic Nervous System; Case-Control Studies; Electrocardiography, Ambu | 2006 |
Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Topics: Adult; Antithyroid Agents; Case-Control Studies; Endothelin-1; Female; Graves Disease; Humans; Insul | 2006 |
The role of selenium in thyroid autoimmunity and cancer.
Topics: Animals; Antioxidants; Autoimmune Diseases; Glutathione Peroxidase; Graves Disease; Humans; Models, | 2006 |
Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
Topics: Adult; Antithyroid Agents; Chi-Square Distribution; Female; Graves Disease; Humans; Hypothyroidism; | 2005 |
Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene.
Topics: Autoantibodies; DNA; Electrophoresis, Agar Gel; Genotype; Graves Disease; Hashimoto Disease; Humans; | 2006 |
Triiodothyronine production in Graves' hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Neoplasms | 2006 |
Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease.
Topics: Adult; Elephantiasis; Female; Graves Disease; Humans; Leg Dermatoses; Myxedema; Skin Diseases; Thyro | 2006 |
HLA class II distribution in Congolese with hyperthyroidism: preliminary results.
Topics: Child; Democratic Republic of the Congo; Exophthalmos; Graves Disease; HLA-D Antigens; Humans; Hyper | 2006 |
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2006 |
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
Topics: Chemokine CXCL10; Chemokines, CXC; Female; Goiter, Nodular; Graves Disease; Humans; Interferon-gamma | 2007 |
Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Blood Flow Velocity; Female; Graves Disease; Humans; Im | 2007 |
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Goiter, Nodular; Graves D | 2007 |
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; | 2007 |
Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
Topics: Adult; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged; Pred | 2007 |
Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hashimoto Disease; Humans; Immunoglobulin G; Immunogl | 2007 |
Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
Topics: Adult; Aged, 80 and over; Antigens, CD; Autoantibodies; Brazil; Case-Control Studies; Child; Child, | 2008 |
Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Topics: Adult; Aged; Eye; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Long-Acting Thyr | 1967 |
Relation of structural polarity to responses of cyclic 3', 5'-adenosine monophosphate accumulation and thyroid hormone release in cultured human thyroid follicles.
Topics: Bucladesine; Cells, Cultured; Cyclic AMP; Graves Disease; Humans; Microscopy, Electron; Thyroid Glan | 1984 |
[Studies on the suppressor T cell function in patients with autoimmune thyroid diseases].
Topics: Adult; Autoimmune Diseases; Concanavalin A; Cyclic AMP; Female; Graves Disease; Humans; Immunoglobul | 1984 |
Effect of triiodothyronine on the short-lived and concanavalin-A generated suppressor T-cell functions.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Cells, Cultured; Concanavalin A; Graves Disease; Humans; | 1984 |
Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid | 1980 |
Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1980 |
Lack of effect of somatostatin on thyroid gland function in Graves' disease.
Topics: Adult; Female; Graves Disease; Growth Hormone; Humans; Insulin; Middle Aged; Somatostatin; Thyroid G | 1980 |
Pregnancy and PTU.
Topics: Female; Fetus; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunoglobulin G; Immunoglob | 1981 |
Conditions which affect interpretation of thyroid function tests.
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Function Tests; T | 1981 |
The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies.
Topics: Animals; Antibodies; Biological Assay; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; | 1981 |
The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.
Topics: Adult; Aged; Animals; Antibodies; Biological Assay; Female; Goiter; Goiter, Nodular; Graves Disease; | 1982 |
[Euthyroid exophthalmos: evaluation of 6 patients].
Topics: Antibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Thyrotropin; Thyrotr | 1983 |
The assay of Graves' immunoglobulins: a comparison of different methods.
Topics: Adult; Aged; Antibodies; Biological Assay; Female; Graves Disease; Humans; Immunoglobulin G; Immunog | 1983 |
Thyroid function and immunological activity during and after medical treatment of Graves' disease.
Topics: Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglob | 1983 |
Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease.
Topics: Adult; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; Middle Aged; | 1983 |
Evidence that thyroid-stimulating antibody is produced in the thyroid gland.
Topics: Adult; Aged; Antibodies; Antibody Formation; B-Lymphocytes; Biological Assay; Carbimazole; Female; G | 1984 |
[Determination of serum thyroid-stimulating immunoglobulin and its clinical significance in patients with Graves' disease].
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
Topics: Adult; Aged; Antithyroid Agents; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; M | 1980 |
The assessment and management of hyperthyroidism.
Topics: Adenoma; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Sympatholytics; | 1980 |
The effects of long-term antithyroid drug treatment on serum reverse T3 in patients with Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Male; Middle Aged; Pro | 1980 |
[Stimulation of endogenous TSH secretion and endocrine orbitopathy].
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Male; Methimazole; Middle Ag | 1980 |
Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Gl | 1981 |
Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Topics: Adult; Alpha-Globulins; Calcitonin; Female; Graves Disease; Humans; Hyperthyroidism; Postpartum Peri | 1981 |
[Hyperthyroidism caused by triiodothyronine (T3-toxicosis)].
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Thyroid Function Te | 1981 |
Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
Topics: Alpha-Globulins; Graves Disease; Humans; Thyroiditis; Thyroxine; Thyroxine-Binding Proteins; Triiodo | 1982 |
Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin Fc Fragments; | 1982 |
Laboratory tests for evaluating thyroid therapy.
Topics: Antithyroid Agents; Drug Evaluation; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Methim | 1982 |
[The prognosis of Graves' disease after antithyroid drug treatment: clinical significance of the T3 suppression test and abnormal thyroid stimulators].
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroi | 1982 |
Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
Topics: Adult; Aged; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Long-Term Care; Male; Middl | 1983 |
T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.
Topics: Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglo | 1983 |
[Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; Male; Methimazole; Mid | 1983 |
Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
Studies on the T3 suppression test by the 24-hour thyroidal 131I uptake in patients with Graves' disease: comparison of the effects of propylthiouracil and methylmercaptoimidazole.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Propylt | 1983 |
Thyroid T4 5'-deiodinase activity in normal and abnormal human thyroid glands.
Topics: Adenoma; Antithyroid Agents; Graves Disease; Humans; In Vitro Techniques; Iodide Peroxidase; Peroxid | 1984 |
Suppressor T lymphocyte function in Graves' disease.
Topics: Adult; Aged; Cells, Cultured; DNA; Female; Graves Disease; Humans; Lymphocyte Activation; Male; Midd | 1982 |
Human thyroid stimulating activity and clinical state in antithyroid treatment of juvenile Graves' disease.
Topics: Adolescent; Biological Assay; Child; Child, Preschool; Cyclic AMP; Female; Graves Disease; Humans; I | 1980 |
Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay.
Topics: Adult; Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Kinetics; Male; Perchlorates; P | 1982 |
Thyroid disease with monoclonal (immunoglobulin G lambda) antibody to triiodothyronine and thyroxine.
Topics: Adult; Antibodies, Monoclonal; Antibody Affinity; Graves Disease; Humans; Hypothyroidism; Immunoglob | 1983 |
Na-K-dependent ATPase in red cells and thyroid status.
Topics: Adolescent; Child; Child, Preschool; Congenital Hypothyroidism; Dwarfism; Dwarfism, Pituitary; Eryth | 1982 |
Decreased beta-adrenergic receptor density in mononuclear leukocytes from thyroidectomized patients.
Topics: Adenoma; Adult; Cholecystectomy; Dihydroalprenolol; Goiter; Graves Disease; Humans; Middle Aged; Mon | 1983 |
Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin.
Topics: Bucladesine; Culture Techniques; Dactinomycin; Enzyme Induction; Graves Disease; Humans; Iodide Pero | 1983 |
[The role of circulating immune complexes in the pathogenesis of Graves' disease].
Topics: Antibodies; Antigen-Antibody Complex; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Lympho | 1983 |
A study of thyroid function after subtotal thyroidectomy for Graves' disease: particularly on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients.
Topics: Adolescent; Adult; Antibodies; Female; Graves Disease; Humans; Hypothalamo-Hypophyseal System; Male; | 1983 |
Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease.
Topics: Adult; Carbimazole; Drug Administration Schedule; Drug Therapy, Combination; Female; Graves Disease; | 1983 |
A pregnant women with 'large' eyes.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Pregnancy; Pregnancy Complications; | 1984 |
Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Autoantibodies; Child; Evaluation Studies as Topic; Female; Graves Disease; | 1984 |
[Thyroidal response to thyrotropin-releasing hormone (TRH) as a predictive test of remission in euthyroid patients with Graves' disease].
Topics: Adolescent; Aged; Graves Disease; Humans; Middle Aged; Prognosis; Thyroid Function Tests; Thyroid Gl | 1984 |
Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Methimazole; Prognosis; Propylthiouracil; R | 1984 |
[Effect of radioiodine therapy on the serum calcitonin level in patients with Basedow's disease].
Topics: Adult; Calcitonin; Female; Graves Disease; Humans; Iodine Radioisotopes; Middle Aged; Triiodothyroni | 1984 |
Thirty-five cases of transient hyperthyroidism.
Topics: Adult; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Iod | 1984 |
[Radioimmunologic T3-test and its clinical significance].
Topics: Adult; Female; Goiter, Nodular; Graves Disease; Humans; Middle Aged; Pregnancy; Radioimmunoassay; Tr | 1984 |
[Dynamics of the serum lipid indices in thyrotoxicosis].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Lipids; Male; Middle Aged; | 1984 |
Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland.
Topics: Graves Disease; Humans; Iodine; Iodine Radioisotopes; Thyroid Gland; Thyrotropin; Thyroxine; Time Fa | 1984 |
[Clinical evaluation of serum free T3 measurement--with special reference to patients in remission from Graves' disease].
Topics: Evaluation Studies as Topic; Female; Graves Disease; Humans; Male; Radioimmunoassay; Reagent Kits, D | 1984 |
Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement.
Topics: Administration, Oral; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1984 |
T4 suppression test involving 24-hour thyroidal 131I uptake in patients with Graves' disease compared to the T3 suppression test.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Middle Aged; Propylt | 1984 |
Overview of thyroidology--1984.
Topics: Goiter; Graves Disease; Humans; Hypothyroidism; Therapeutic Equivalency; Thyroid Diseases; Thyroid F | 1984 |
Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
Topics: Adult; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid Function Tests; Thyr | 1983 |
[The effects of plasma exchange upon patients with malignant exophthalmos due to Graves' disease].
Topics: Adult; Female; Graves Disease; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulator; Male; Middl | 1983 |
[Serum ratios of triiodothyronine to thyroxine and reverse-triiodothyronine in Graves' disease and destruction-induced thyrotoxicosis].
Topics: Adult; Aged; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle | 1983 |
Serum free thyroid hormones in T3-toxicosis: a study of 35 patients.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Function Tests; Thyroid Hormones; Thyrotropin; Thyr | 1983 |
Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotop | 1983 |
[In vitro diagnosis of T3 thyrotoxicosis].
Topics: Adult; Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Middle Age | 1983 |
Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man.
Topics: Blood Glucose; Female; Gluconeogenesis; Glycerol; Graves Disease; Humans; Hypothyroidism; Male; Meta | 1983 |
Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders.
Topics: Adult; Aged; Autoantibodies; Autoradiography; Chromatography, Gel; Female; Graves Disease; Humans; I | 1983 |
Outcome of patients with Graves' disease after long-term medical treatment guided by triiodothyronine (T3) suppression test.
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged | 1983 |
Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves' disease.
Topics: Adolescent; Adult; Dexamethasone; Drug Therapy, Combination; Female; Graves Disease; Humans; Ipodate | 1983 |
[Thyroid hormone autoantibodies in Hashimoto's disease and Graves' disease].
Topics: Adult; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Hormones; T | 1983 |
Attention disturbance in Graves' disease.
Topics: Adult; Attention; Female; Graves Disease; Humans; Male; Thyroxine; Triiodothyronine | 1983 |
Changes in thyroid functions in patients with euthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Antibodies; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypothy | 1980 |
[Clinicopathological study on the chronic thyroiditis and Graves' disease --relationship between histological classification and function (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Female; Graves Disease; Humans; M | 1980 |
Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics.
Topics: Animals; Autoimmune Diseases; Blood Platelets; Blood Transfusion; Graves Disease; Humans; Kinetics; | 1980 |
Graves' disease associated with elevated serum thyroxine-binding globulin concentrations.
Topics: Adult; Child; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Pedigree; Thyrotropin; | 1980 |
Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Thyr | 1980 |
Thyroid storm with normal serum triiodothyronine level during diabetic ketoacidosis.
Topics: Adolescent; Diabetic Ketoacidosis; Female; Graves Disease; Humans; Ketone Bodies; Thyroid Crisis; Th | 1981 |
Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Topics: Antibodies; Female; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyrotropin; Thyrotropin | 1981 |
T3 kinetics in euthyroid Graves' disease patients who exhibit hyper-responsiveness to TRH after radioiodine treatment.
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Kinetics; Male; Metabolic Clearan | 1981 |
Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
Topics: Feedback; Graves Disease; Humans; Methimazole; Pituitary Gland; Thyroid Gland; Thyrotropin; Thyrotro | 1982 |
[A study of thyroid function in patients with Graves' disease after 5 to 10 years of subtotal thyroidectomy: with special emphasis on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients (author's transl)].
Topics: Adolescent; Adult; Autoantibodies; Female; Graves Disease; Humans; Male; Middle Aged; Postoperative | 1981 |
Tests of thyroid function important to the ophthalmologist.
Topics: Antibody Formation; Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Thyroid Functi | 1982 |
Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease.
Topics: Adolescent; Adult; Autoantibodies; Female; Graves Disease; Hemagglutination Tests; Humans; Male; Mid | 1982 |
[Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy].
Topics: Adult; Aged; Diagnosis, Differential; Exophthalmos; Female; Graves Disease; Humans; Male; Middle Age | 1982 |
[Indications and pharmacokinetic study of lithium carbonate in the treatment of the acute phase of Basedow's disease].
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Kinetics; Lithium; Lithium Carbonate; Male | 1982 |
Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
Topics: Adult; Antibodies; Carbimazole; Female; Graves Disease; Humans; Male; Propylthiouracil; Thyrotropin; | 1980 |
Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Potassium Iodide; Preoperative Car | 1980 |
Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methimazole; Prop | 1980 |
Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Prognosis; Thyroid F | 1980 |
Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease.
Topics: Adolescent; Adult; Aging; Autoantibodies; Child; Female; Follow-Up Studies; Graves Disease; Humans; | 1980 |
Modified subtotal thyroidectomy in the management of Graves' disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Graves Disease; Humans; Hypothyroidism; Male; Po | 1980 |
Triiodothyronine-binding immunoglobulin in a patient with Grave's disease and its effect on metabolism and radioimmunoassay of triiodothyronine.
Topics: Autoantibodies; Chromatography, Gel; Female; Graves Disease; Humans; Immunoglobulin Fab Fragments; I | 1980 |
[Clinical evaluation of the thyroid gland function based on T3, T4 and TSH activity and histopathological changes in various types of goiter].
Topics: Adult; Goiter, Nodular; Graves Disease; Humans; Middle Aged; Thyroid Gland; Thyrotropin; Thyroxine; | 1980 |
Circulant anti-triiodothyronine antibodies in a patient with Graves' disease: effects on measurement of T3 with different RIA procedures.
Topics: Adult; Anilino Naphthalenesulfonates; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; | 1980 |
[Primary hypothyroidism as a possible cause of hypertension from long-term follow-up studies of patients with Graves' disease (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Graves Disease; Humans; Hypertension; Hyp | 1980 |
Serum myoglobin in thyroid disease.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle A | 1980 |
[Facility of aqueous humor outflow and the serum level of thyroid hormones (author's transl)].
Topics: Adolescent; Adult; Aged; Aqueous Humor; Female; Graves Disease; Humans; Male; Middle Aged; Thyroidec | 1980 |
Clinical and pathological significance of sibling Graves' disease.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Male; Thyroglobulin; Thyroid Gland; Thyroidectomy | 1980 |
Neonatal thyrotoxicosis: a rare pediatric emergency.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Iodine; Long-Acting Thyroid | 1980 |
[Nuclear medicine aspects of Basedow's disease and other forms of hyperthyroidism].
Topics: Adenoma; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Iodine Radioisotopes; Pituitary N | 1980 |
[Elastotonometric curves and blood triiodothyronine and thyroxine levels (author's transl)].
Topics: Adult; Aged; Female; Goiter, Nodular; Graves Disease; Humans; Intraocular Pressure; Male; Middle Age | 1980 |
Thyroid physiology and functional tests.
Topics: Calcitonin; Goiter, Nodular; Graves Disease; Humans; Iodine Radioisotopes; Long-Acting Thyroid Stimu | 1980 |
Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.
Topics: Adolescent; Adult; Dopamine beta-Hydroxylase; Female; Graves Disease; Humans; Male; Propranolol; Thy | 1980 |
Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos.
Topics: Adult; Aged; Antibodies; Autoantibodies; Exophthalmos; Female; Graves Disease; Humans; Male; Middle | 1981 |
Acquired refractoriness to thyroid hormone action in treated toxic nodular goiter.
Topics: Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyrotropin; Thyroxine; Triiodothyronine | 1981 |
Long-term results of radioiodine (131I) therapy in 331 patients with Graves' disease.
Topics: Autoantibodies; Cholesterol; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radio | 1980 |
Patterns of change in the early (20-minute) radioiodine uptake during carbimazole treatment for Graves' disease and their relationship to outcome.
Topics: Adult; Carbimazole; Female; Graves Disease; Humans; Iodine Radioisotopes; Kinetics; Male; Middle Age | 1981 |
Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
Topics: Adenoma; Carcinoma; Dithiothreitol; Graves Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Th | 1981 |
Thyroid suppression and stimulation testing: The place of scanning in the evaluation of nodular thyroid disease.
Topics: Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hypertrophy; Radionuclide Imaging; | 1981 |
High serum gastrin levels in thyrotoxic patients.
Topics: Adolescent; Adult; Aged; Allergy and Immunology; Autoantibodies; Female; Gastric Acid; Gastrins; Goi | 1981 |
Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol.
Topics: Female; Graves Disease; Humans; Ipodate; Kinetics; Male; Propranolol; Propylthiouracil; Thyroxine; T | 1981 |
Thyroid function tests during carbimazole therapy.
Topics: Adolescent; Adult; Carbimazole; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Fu | 1980 |
The relationships between surgical histometry, outcome and pre-treatment in Graves' disease.
Topics: Adult; Aged; Carbimazole; Epithelium; Female; Graves Disease; Humans; Iodine; Lymphocytes; Male; Mid | 1981 |
Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged | 1981 |
Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism.
Topics: Adult; Blood Pressure; Body Weight; Female; Graves Disease; Humans; Ipodate; Kinetics; Male; Middle | 1982 |
Thyroid hormone formation catalyzed by human thyroid peroxidase: a new and physiological measurement of thyroid peroxidase.
Topics: Diiodotyrosine; Graves Disease; Humans; In Vitro Techniques; Iodide Peroxidase; Methimazole; Methods | 1982 |
[Clinical evaluation of serum free T4 in patients with low Ts syndrome and pregnant patients with thyroid diseases (author's transl)].
Topics: Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Pregnancy; Pregnancy Complications; | 1982 |
[Serum free thyroxine after 131I therapy for Graves' disease (author's transl)].
Topics: Graves Disease; Humans; Iodine Radioisotopes; Prognosis; Thyrotropin; Thyroxine; Triiodothyronine | 1981 |
Triiodothyronine thyrotoxicosis complicating primary hypothyroidism in a patient with autoimmune thyroiditis.
Topics: Autoimmune Diseases; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Thy | 1982 |
Anterior mediastinal mass in a patient with Graves' disease.
Topics: Adolescent; Female; Graves Disease; Humans; Propylthiouracil; Thymus Gland; Thyroxine; Triiodothyron | 1982 |
[Relation between hypoxia and thyroid function].
Topics: Altitude; Animals; Graves Disease; Humans; Hypoxia; Oxygen Consumption; Rats; Space Flight; Thyroid | 1982 |
Serum levels of calcium and parathyroid hormone after subtotal thyroid resection for Graves' disease.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Proteins; Calcium; Female; Graves Disease; Humans; Ma | 1982 |
Early remission in thyrotoxicosis produced by short courses of treatment.
Topics: Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Male; Thyroxine; Ti | 1982 |
Sequential deiodination of thyroxine in human thyroid gland.
Topics: Diiodothyronines; Graves Disease; Humans; Hydrogen-Ion Concentration; Iodide Peroxidase; Iodine; Kin | 1982 |
[Clinical study of Basedow's disease with T4 toxicosis].
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Thyroid Function Te | 1982 |
Pupillary analyses in Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Light; Male; Middle Aged; Pupil; | 1982 |
[Unusual concentrations of triiodothyronine in the serum due to anti-T3 autoantibodies].
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperlipidemias; Male; Middle Aged; Triiodoth | 1982 |
[A long term follow-up study of patients with Graves' disease: the correlation between thyroid functions and histological findings].
Topics: Follow-Up Studies; Graves Disease; Humans; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; | 1982 |
Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease.
Topics: Adolescent; Adult; Autoimmune Diseases; Cell Count; Female; Graves Disease; Hemolytic Plaque Techniq | 1982 |
[Fundamental and clinical evaluation of enzyme-linked immunosorbent assay for serum triiodothyronine concentration (author's transl)].
Topics: Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Immunoenzyme Techniques; Triiodot | 1982 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
Productivity of thyroglobulin and thyroid hormone on human thyroid cell in collagen gel culture.
Topics: Adenoma; Adult; Carcinoma, Papillary; Child; Collagen; Culture Techniques; Female; Gels; Graves Dise | 1995 |
[Hyperthyroidism].
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Radionuclide Imaging; Thyroid Function | 1994 |
Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Topics: Adult; Cell Adhesion Molecules; Cohort Studies; E-Selectin; Enzyme-Linked Immunosorbent Assay; Femal | 1995 |
Graves' disease in severe combined immunodeficient mice.
Topics: Adult; Animals; Autoantibodies; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay | 1995 |
Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Prognos | 1995 |
Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Blotting, Western; Female; Graves Disease; HSP70 Heat-Sh | 1995 |
Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Methimazole; M | 1995 |
Immunogenic and non-immunogenic hyperthyroidism. Recent trends in prealpine Switzerland and in coastal Poland.
Topics: Adenoma; Adult; Age Factors; Aged; Graves Disease; Humans; Hyperthyroidism; Incidence; Middle Aged; | 1995 |
Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment.
Topics: Adult; Algorithms; Female; Fetal Diseases; Graves Disease; Heart Rate, Fetal; Humans; Pregnancy; Pre | 1995 |
Transient hypothyroidism after iodine-131 therapy for Grave's disease.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Life Tables; Male; Middle Aged | 1995 |
Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
Topics: Adult; Aged; Exophthalmos; Eye Diseases; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-St | 1995 |
CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease.
Topics: Adult; Aged; Antigens, CD; Autoantibodies; Autoimmune Diseases; B-Lymphocytes; CD4-Positive T-Lympho | 1993 |
Reducing effect of nadolol on serum levels of free thyroid hormones in hyperthyroidism.
Topics: Adolescent; Adult; Blood Pressure; Female; Graves Disease; Humans; Male; Middle Aged; Nadolol; Thyro | 1994 |
The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
Topics: Adult; Aged; Antibodies, Monoclonal; CD11 Antigens; CD8-Positive T-Lymphocytes; Diabetes Mellitus, T | 1995 |
Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Immunoradiometric Assay; Puerperal D | 1994 |
[Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease].
Topics: Creatinine; Diagnosis, Differential; Graves Disease; Humans; Iodine; Thyroiditis; Thyroxine; Triiodo | 1994 |
Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Topics: Adenylyl Cyclases; Animals; Cattle; Graves Disease; Hyperthyroidism; Hypophysectomy; Hypothyroidism; | 1995 |
The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.
Topics: Adolescent; Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyr | 1994 |
Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease.
Topics: Adult; Amidohydrolases; Autoantibodies; Binding, Competitive; Biotin; Biotinidase; Carrier Proteins; | 1994 |
Thyroid hormone autoantibodies in patients with untreated Graves' disease: with special reference to age.
Topics: Adolescent; Adult; Aged; Aging; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle | 1993 |
Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Iodide Peroxidase; Male; Methimazole; Propylt | 1994 |
Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese.
Topics: Adolescent; Adult; Disease Susceptibility; Female; Genetic Predisposition to Disease; Graves Disease | 1994 |
Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
Topics: Adult; Biomarkers; CD4 Antigens; CD8 Antigens; Female; Graves Disease; Humans; Immunity, Cellular; L | 1994 |
Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stim | 1993 |
The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Perchlorates; Thyroi | 1994 |
Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.
Topics: Animals; Female; Graves Disease; Humans; Iodine Radioisotopes; Methimazole; Mice; Middle Aged; Radio | 1993 |
Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Aging; Child; Female; Graves Disease; Humans; Lymphocyte Subsets; Male; Met | 1994 |
Anti-cardiolipin antibodies in autoimmune thyroid diseases.
Topics: Adult; Antibodies, Anticardiolipin; Autoimmune Diseases; Female; Graves Disease; Humans; Immunoglobu | 1994 |
Modulation of the IL-2 production defect in vitro in Graves' disease.
Topics: Cell Adhesion; Cells, Cultured; Dose-Response Relationship, Drug; Graves Disease; Humans; Interleuki | 1994 |
[The association of Graves' disease with serum soluble interleukin 2 receptor].
Topics: Adolescent; Adult; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Ma | 1993 |
Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease.
Topics: Adult; Autoantibodies; Body Weight; Female; Graves Disease; Heart Rate; Humans; Ipodate; Male; Methi | 1993 |
N-glycans modulate in vivo and in vitro thyroid hormone synthesis. Study at the N-terminal domain of thyroglobulin.
Topics: Chromatography, Affinity; Chromatography, Gel; Endocytosis; Glycoconjugates; Glycopeptides; Graves D | 1995 |
In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil.
Topics: Adult; Dose-Response Relationship, Drug; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hyp | 1995 |
Separation of autonomous function from cell density in non-immunogenic hyperthyroidism. I. Quantification by double-isotope parametric scintigraphy.
Topics: Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Radioimmunoa | 1995 |
Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Topics: Animals; Antithyroid Agents; Cell Line; CHO Cells; Cricetinae; Epitopes; Goiter; Graves Disease; Hum | 1996 |
Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Maternal-Fetal | 1996 |
Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.
Topics: Adult; Autoantibodies; Carbon Dioxide; Carbon Radioisotopes; Cells, Cultured; Citrate (si)-Synthase; | 1996 |
Decreased secretion of gonadotropins in a patient with Graves' disease.
Topics: Antithyroid Agents; Body Weight; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotrop | 1996 |
Is there one successful antithyroid regimen for Graves' disease?
Topics: Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Immune Tolerance | 1996 |
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.
Topics: Animals; Antigen-Antibody Reactions; Cattle; Cyclic AMP; Female; Graves Disease; Histocompatibility | 1996 |
The many causes of subclinical hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Mal | 1996 |
The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging.
Topics: Autoantibodies; Female; Graves Disease; HLA Antigens; Humans; Middle Aged; Radionuclide Imaging; Rec | 1996 |
Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
Topics: Acute Disease; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Immunologic Techniques; Male; | 1997 |
Plasma selectin levels in patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; E-Selectin; Female; Graves Disease; Humans; L-Selectin; M | 1996 |
Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Collagen; Collagen Type I; | 1996 |
Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Receptors, Thyrotropin; Thyroid Gland; Thyroi | 1996 |
Action of peripheral or intrathyroidal lymphocytes on autologous thyrocytes cultured in follicles in collagen gel.
Topics: Adult; Cell Communication; Cells, Cultured; Coculture Techniques; Collagen; Cyclic AMP; Cytokines; F | 1997 |
[Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease].
Topics: Adult; Age Factors; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Male; M | 1997 |
Cholesterol 7 alpha-hydroxylase activity in hypothyroidism and hyperthyroidism in humans.
Topics: Adenoma; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, HDL; Cholesterol, | 1997 |
[Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Developmental Disabilities; | 1997 |
Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
Topics: Adult; Aged; Female; Goiter; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Mid | 1997 |
Total thyroidectomy for Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Re | 1997 |
Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma.
Topics: Adenoma; Ethanol; Follow-Up Studies; Graves Disease; Humans; Injections, Intralesional; Male; Middle | 1997 |
Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Blood Loss, Surgical; Female; Graves Disease | 1997 |
Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
Topics: Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Humans; Immunoglobulins, Thyroi | 1997 |
Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
Topics: Adult; CD4-Positive T-Lymphocytes; Cells, Cultured; Female; Graves Disease; Humans; Integrin beta1; | 1997 |
Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety.
Topics: Adult; Female; Granulocyte Colony-Stimulating Factor; Graves Disease; Humans; Iodine Radioisotopes; | 1997 |
Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Topics: Adenoma; Adult; Aged; Biomarkers; Collagen; Collagen Type I; Diagnosis, Differential; Female; Goiter | 1997 |
Alteration of platelet aggregation in patients with thyroid disorders.
Topics: Adenosine Diphosphate; Adult; Female; Graves Disease; Humans; Hypothyroidism; In Vitro Techniques; M | 1997 |
Serum androgen levels in hyperthyroid women.
Topics: Adult; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Dihydrotestosterone; Female; | 1997 |
Recent trends in the management of Graves' hyperthyroidism in Japan: opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone.
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Japan; Societies, Medical; Su | 1997 |
[How I study Basedow's disease: from classic clinical examination to radioimmunologic diagnosis].
Topics: Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Physical Examination; Radioimmunodetec | 1997 |
Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients.
Topics: Adolescent; Adult; Aged; Autoantibodies; Biomarkers; Female; Follow-Up Studies; Graves Disease; Huma | 1997 |
Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, | 1998 |
Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type.
Topics: Adolescent; Adult; Autoimmune Diseases; Female; Gastrins; Gastritis; Graves Disease; Humans; Immunog | 1998 |
[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Topics: Administration, Oral; Antithyroid Agents; Female; Graves Disease; Half-Life; Humans; Iodine Radioiso | 1998 |
[Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Child; Female; Graves Disease; Human | 1998 |
Spuriously high free thyroxine with the Access free T4 assay.
Topics: Artifacts; Dandy-Walker Syndrome; Graves Disease; Humans; Immunoenzyme Techniques; Luminescent Measu | 1998 |
Prevalence and significance of steatorrhea in patients with active Graves' disease.
Topics: Absorption; Adult; Antithyroid Agents; Body Mass Index; Carbimazole; Case-Control Studies; Celiac Di | 1998 |
Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
Topics: Adult; B-Lymphocytes; CD40 Antigens; CD8 Antigens; Female; Graves Disease; Humans; Interleukin-4; Le | 1998 |
Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease.
Topics: Adolescent; Adult; Antigens, CD; Autoantibodies; B-Lymphocytes; Female; Graves Disease; Humans; Immu | 1998 |
Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autonomic Nervous System; Female; Graves Dis | 1998 |
Quantitative measurements for type 1 deiodinase messenger ribonucleic acid in human peripheral blood mononuclear cells: mechanism of the preferential increase of T3 in hyperthyroid Graves' disease.
Topics: Gene Expression Regulation; Graves Disease; Humans; Iodide Peroxidase; Leukocytes, Mononuclear; Reve | 1998 |
[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; Child; Female; Graves Disease; Humans; Iodine Radio | 1998 |
Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Topics: Adolescent; Adult; Eye Diseases; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, T | 1998 |
Normal serum concentrations of sex hormone binding-globulin in patients with hyperthyroidism due to subacute thyroiditis.
Topics: Adenoma; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Reference Values | 1998 |
Serum cytokines in thyrotoxicosis.
Topics: Adult; Antithyroid Agents; Carbimazole; Cytokines; Female; Goiter, Nodular; Graves Disease; Humans; | 1999 |
T3-release from autonomously functioning thyroid nodules in vitro.
Topics: Adult; Goiter; Graves Disease; Humans; Immunoglobulins; In Vitro Techniques; Middle Aged; Thyroid Gl | 1998 |
Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.
Topics: Adult; Autoantibodies; Biopsy, Needle; Female; Graves Disease; Humans; Hypothyroidism; Immunoglobuli | 1999 |
Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Topics: Adenoma; Aged; Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid- | 1999 |
Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.
Topics: Adult; Antithyroid Agents; Autoantibodies; Biopsy, Needle; Female; Goiter; Graves Disease; Humans; I | 1999 |
A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease.
Topics: Alanine Transaminase; Antibodies, Antinuclear; Autoantibodies; Female; Goiter; Graves Disease; Hepat | 1999 |
Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Immunoglobulin A; Immunogl | 1999 |
Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism.
Topics: Adult; Female; Gestational Age; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Parathyroid | 1999 |
Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients.
Topics: Adult; Antithyroid Agents; Case-Control Studies; Female; Graves Disease; Growth Hormone; Growth Horm | 1999 |
Familial dysalbuminemic hypertriiodothyroninemia in a Japanese kindred.
Topics: Female; Graves Disease; Humans; Middle Aged; Pedigree; Serum Albumin; Thyrotropin; Thyroxine; Triiod | 2000 |
[T3-thyrotoxicosis: incidence, significance and correlation with iodine intake].
Topics: Graves Disease; Humans; Hungary; Iodine; Thyrotoxicosis; Thyroxine; Triiodothyronine | 2000 |
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report.
Topics: Autoantibodies; Biomarkers; Graves Disease; Humans; Male; Middle Aged; Oculomotor Muscles; Thyroidit | 2000 |
Seasonal changes in calcium homeostasis affect the incidence of postoperative tetany in patients with Graves' disease.
Topics: Adult; Alkaline Phosphatase; Calcifediol; Calcitriol; Calcium; Female; Graves Disease; Homeostasis; | 2000 |
A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.
Topics: Adult; Antithyroid Agents; Carcinoma, Papillary; Granuloma; Graves Disease; Humans; Lymphatic Metast | 2000 |
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Interferon beta-1a; Interferon beta-1b; Inter | 2000 |
Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
Topics: Antithyroid Agents; Autoantibodies; Cholesterol, HDL; Cholesterol, LDL; Female; Graves Disease; Huma | 2000 |
Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
Topics: Antithyroid Agents; Autoantibodies; Child; Exophthalmos; Female; Graves Disease; Humans; Immunoglobu | 2000 |
An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Biomarkers; Female; Goiter; Goiter, | 2000 |
Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Goiter, Nodular; Graves Disease; Humans; Int | 2000 |
Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Topics: Adipose Tissue; Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobul | 2000 |
Increased levels of serum interleukin-18 in Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Interleukin-18; Male; M | 2000 |
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antithyroid Agents; Autoantibodies; Biomarkers; Bone and B | 2000 |
Spuriously high serum concentrations of TSH due to the use of an automatic pipetting device.
Topics: Artifacts; Automation; Female; Goiter; Graves Disease; Humans; Hypothyroidism; Radioimmunoassay; Thy | 2000 |
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Carbimazole; Chi-Square Distribution; F | 2001 |
[Hyperthyroidism: a cause of serum ferritin elevation].
Topics: Autoantibodies; Erythrocytes; Ferritins; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; | 2000 |
Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglob | 2000 |
Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Thyrotoxico | 1998 |
Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients.
Topics: Adult; Antithyroid Agents; Erythrocytes; Female; Glutathione; Graves Disease; Humans; Male; Nitric O | 2001 |
Graves' disease presenting as hemiparkinsonism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Diagnosis, Diff | 2001 |
Triiodothyronine predominant Graves' disease in a South-East Asian population: prevalence and clinical significance.
Topics: Asia, Southeastern; Graves Disease; Humans; Thyroxine; Triiodothyronine | 2001 |
[Graves' disease. Clinical features and treatment results].
Topics: Antithyroid Agents; Disease-Free Survival; Female; Graves Disease; Humans; Iodine Radioisotopes; Mal | 2001 |
Hyperthyroidism is associated with lengthening of ventricular repolarization.
Topics: Adrenergic beta-Antagonists; Adult; Electrocardiography, Ambulatory; Electrolytes; Female; Follow-Up | 2001 |
A case of pulmonary metastatic thyroid cancer complicated with Graves' disease.
Topics: Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimula | 2001 |
Detection of antipituitary antibodies in patients with autoimmune thyroid disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Autoantigens; Blotting, Western; Enzyme | 2001 |
Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Topics: Acidosis, Respiratory; Adult; Anesthetics; Antithyroid Agents; Carbon Dioxide; Creatine Kinase; Dant | 2001 |
Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Topics: Adult; Analysis of Variance; Antithyroid Agents; Epitopes; Female; Graves Disease; Humans; Immunoglo | 2001 |
Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Female; Goiter; Graves Disease; Hemodynamics; Humans; Hyperthyroidis | 2001 |
Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
Topics: Aged; Antithyroid Agents; Carbimazole; Female; Goiter, Nodular; Graves Disease; Humans; Iodine Radio | 2001 |
Association between lithium use and thyrotoxicosis caused by silent thyroiditis.
Topics: Adult; Antimanic Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Lithium Carbonate; Ma | 2001 |
Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease.
Topics: Adult; Antibodies; Cryopreservation; Graves Disease; Humans; Hypothyroidism; Iodide Peroxidase; Male | 2002 |
Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
Topics: Adult; Aged; Animals; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglob | 2002 |
Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism.
Topics: Adipose Tissue; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Interleukin-6; Leptin; Pl | 2002 |
Prevalence of hypergastrinemia in patients with hyper- and hypothyroidism: impact for calcitonin?
Topics: Aged; Calcitonin; Female; Gastrins; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; M | 2002 |
Accelerated production of nucleosome in cultured human mononuclear cells in untreated Graves' disease.
Topics: Adult; Apoptosis; Caspase 3; Caspases; Cytochrome c Group; DNA; Fas Ligand Protein; fas Receptor; Fe | 2002 |
Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Diagnosis, Differential; Eo | 2002 |
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Hyperplasia; Immunoglobulin G; Immunoglobulins, T | 1978 |
Stimulation with thyrotrophin-releasing hormone (TRH) during antithyroid treatment.
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Goiter, Nodular; Graves Disease; Humans; Male; Middl | 1975 |
Hormonal pattern of relapse in hyperthyroidism.
Topics: Carbimazole; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Radioimmunoassay; Recurrenc | 1975 |
Serum triiodothyronine 7-15 years after fractionated low dose radioiodine therapy of thyrotoxicosis.
Topics: Adult; Aged; Cholesterol; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; M | 1975 |
Value of routine serum-triiodothyronine estimation in diagnosis of thyrotoxicosis.
Topics: Evaluation Studies as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Male; Radioimmunoassay | 1975 |
Intentional radioiodine ablation in Graves' disease.
Topics: Administration, Oral; Adult; Aged; Evaluation Studies as Topic; Follow-Up Studies; Graves Disease; H | 1975 |
Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine; Thyroid Gland; Thyrox | 1975 |
Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Methimazole; Middle Age | 1976 |
Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; In Vitro Techniques; Iodine R | 1977 |
Diagnosis of hyperthyroidism when serum-thyroxine alone is raised.
Topics: Adult; Aged; Delirium; False Negative Reactions; Female; Follow-Up Studies; Gastroenteritis; Graves | 1977 |
Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
Topics: Administration, Oral; Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; | 1977 |
[Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
Topics: Adult; Chronic Disease; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Function Tests; T | 1977 |
[Management of patients with thyrotoxicosis of childbearing age (author's transl)].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antithyroid Agents; Female; Graves Diseas | 1977 |
Thyroid function.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Pregnancy; Radio | 1978 |
Closer correlation between serum triiodothyronine and basal metabolic rate during antithyroid drug treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Basal Metabolism; Female; Graves Disease; Humans; Male; Methi | 1978 |
Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
Topics: Adult; Autoimmune Diseases; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism | 1978 |
Long term antithyroid drug therapy for intractable cases of Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Recurrence; Thyroxine; | 1978 |
T3/T4 ratio in thyroid disease.
Topics: Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1978 |
[Follow up studies of the antithyroid drug therapy for hyperthyroidism with special emphasis on the clinical usefulness of TRH and T3-suppression tests during treatment (author's transl)].
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Follow-Up Studies; Graves Disease; Humans; Mal | 1978 |
[Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Thyroid Hormones; Thyrotr | 1979 |
T3/T4 ratio in thyroid disease.
Topics: Diagnosis, Differential; False Negative Reactions; Female; Graves Disease; Humans; Hyperthyroidism; | 1979 |
[Practical experiences with the TRH rapid test in the diagnosis of thyroid function].
Topics: Graves Disease; Hyperthyroidism; Hypothyroidism; In Vitro Techniques; Radionuclide Imaging; Thyroid | 1979 |
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
Topics: Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; | 1979 |
[Early histological changes of the thyroid gland sway the prognosis of juvenile thyrotoxicosis treated with antithyroid therapy (author's transl)].
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Female; Graves Disease; Humans; Male; Progn | 1979 |
Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 131I and antithyroid drugs.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Iodides; Iodine Radioisotopes; | 1979 |
[Effect of propranolol on the index of triiodothyronine binding in Graves' disease].
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Middle Aged; Propranolol; Thyroxine-Binding | 1978 |
[Hyperthyroidism: diagnosis (author's transl)].
Topics: Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Radionuclide Imaging; Thyroid Function Tes | 1978 |
Spectrum of pituitary alterations with mild and severe thyroid impairment.
Topics: Adult; Aged; Cholesterol; Female; Graves Disease; Growth Hormone; Humans; Hydrocortisone; Hypoglycem | 1978 |
[Value of the oral TRH test for the evaluation of thyroid function in impaired TSH reserve. Preliminary report].
Topics: Administration, Oral; Adult; Aged; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenous; | 1979 |
Exclusion of dysthyroid eye disease as a cause of unilateral proptosis.
Topics: Diagnosis, Differential; Graves Disease; Humans; Skull; Thyroid Function Tests; Thyrotropin; Thyrotr | 1979 |
Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.
Topics: Adolescent; Adult; Child; Female; Graves Disease; Humans; Iodides; Iodine Radioisotopes; Male; Middl | 1978 |
The long-acting thyroid stimulatory: is it of importance in Graves' disease.
Topics: Animals; Cyclic AMP; Female; Graves Disease; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulato | 1975 |
[Recent developments in the etiology and diagnosis of Basedow's disease].
Topics: Adenylyl Cyclases; Graves Disease; Humans; Immunoglobulins; Receptors, Cell Surface; Thyrotropin; Tr | 1976 |
[Pathophysiology of the thyroid gland. Some newer aspects (author's transl)].
Topics: Binding, Competitive; Exophthalmos; Graves Disease; Humans; Immunoglobulin G; Receptors, Cell Surfac | 1977 |
[A comparison of various indicators of murine thyroid stimulation by LATS (author's transl)].
Topics: Adenylyl Cyclases; Animals; Biological Assay; Cyclic AMP; Graves Disease; Humans; Immunoglobulin G; | 1979 |
The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism.
Topics: Adolescent; Adult; Body Weight; Drug Evaluation; Female; Graves Disease; Humans; Ipodate; Male; Midd | 1978 |
Thyrotoxicosis: relations between clinical state and biochemical changes during carbimazole treatment.
Topics: Adult; Carbimazole; Female; Graves Disease; Humans; Male; Middle Aged; Sex Hormone-Binding Globulin; | 1977 |
Graves' disease associated with familial deficiency of thyroxine-binding globulin.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Pedigree; Serum Globulins; Thyroxine; Thyr | 1977 |
The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; Pro | 1977 |
Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.
Topics: Adolescent; Adult; Female; Graves Disease; Haploidy; Histocompatibility Antigens; HLA Antigens; Huma | 1977 |
[Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)].
Topics: Adolescent; Adult; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid | 1978 |
[Study of the thyroid function by the I-M TRH test (2 mg) (author's transl)].
Topics: Adult; Evaluation Studies as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Male; Thyroid D | 1978 |
[Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease].
Topics: Graves Disease; Humans; Pituitary Gland, Anterior; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing | 1978 |
Transient recurrence of hyperthyroidism after delivery in Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Microsomes; | 1977 |
Ophthalmic Graves's disease: natural history and detailed thyroid function studies.
Topics: Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Syndrome; Thyroid Function Tests; Th | 1977 |
Outcome of long-term antithyroid treatment of graves' disease in relation to iodine intake.
Topics: Adult; Aged; Carbimazole; Diet; Female; Follow-Up Studies; Graves Disease; Humans; Iodine; Male; Mid | 1977 |
Lack of indomethacin effect on thyroid function in man.
Topics: Adult; Graves Disease; Humans; Indomethacin; Iodine Radioisotopes; Male; Middle Aged; Prostaglandins | 1977 |
Iodinating activity of thyroid tissue in toxic diffuse goiter.
Topics: Adult; Female; Graves Disease; Guaiacol; Humans; Iodide Peroxidase; Iodine; Male; Methimazole; Middl | 1977 |
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Male; Middle Aged; Propranolol; Thyroxine; | 1977 |
Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
Topics: Graves Disease; Humans; Infant; Methimazole; Propylthiouracil; Thyroid Hormones; Thyrotropin; Thyrox | 1977 |
Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Topics: Drug Therapy, Combination; Graves Disease; Humans; Iodides; Iodine; Methimazole; Propranolol; Propyl | 1977 |
Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Male; Middle Aged; Thyroxine; | 1977 |
Reduction of plasma triiodothyronine (T3) induced by propranolol.
Topics: Adult; Female; Graves Disease; Humans; Male; Propranolol; Thyroxine; Time Factors; Triiodothyronine | 1977 |
T3 toxicosis in children.
Topics: Child; Female; Graves Disease; Humans; Hyperthyroidism; Propylthiouracil; Thyroid Function Tests; Th | 1977 |
Combination drug therapy for treatment of hyperthyroid Grave's disease.
Topics: Adult; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1977 |
[Retrobulbular tissue changes following TSH administration and influence of various drugs in rats].
Topics: Animals; Graves Disease; Hydrocortisone; Male; Methionine; Rats; Thyroid Gland; Thyrotropin; Thyroxi | 1977 |
[Therapy of hyperthyroidism, compiled according to the recommendations of the section on thyroid gland of the German Endocrinological Society. 2. Control of therapy, therapy of endocrine ophthalmopathies, therapy during pregnancy and in childhood].
Topics: Adrenal Cortex Hormones; Child; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Prognosi | 1977 |
Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Middle Aged; Thy | 1977 |
[Diagnostic value and indication of the suppression test within the scope of thyroid-function diagnostics].
Topics: Adenoma; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Thyroid Function Tests; Thyr | 1977 |
[Long term follow-up after thyroidectomy].
Topics: Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Recurrence; Thyroid Neoplasms; Thyroidec | 1978 |
Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
Topics: Child, Preschool; Female; Graves Disease; Humans; Potassium Iodide; Propylthiouracil; Thyroglobulin; | 1978 |
Chemical determination of iodinated compounds in human thyroid.
Topics: Adult; Aged; Animals; Diiodotyrosine; Female; Graves Disease; Humans; Iodine; Male; Methods; Middle | 1978 |
T4-thyrotoxicosis.
Topics: Adult; Graves Disease; Humans; Male; Thyroxine; Triiodothyronine | 1978 |
[Critical study of the value of serum triiodothyronine (T3) determination in Basedow's disease].
Topics: Adult; Evaluation Studies as Topic; Graves Disease; Humans; Middle Aged; Thyroid Function Tests; Tri | 1978 |
[Value of the assay of plasma triiodothyronine level for the diagnosis of hyperthyroidism and hypothyroidism].
Topics: Adult; Aged; Contraceptives, Oral; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; | 1978 |
Thyroid function tests simulating Graves' disease in alcoholic hepatitis.
Topics: Adult; Diagnosis, Differential; Graves Disease; Hepatitis, Alcoholic; Humans; Liver; Male; Thyroid F | 1978 |
[Hyperthyroidism in older patients].
Topics: Aged; Cardiovascular Diseases; Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hyp | 1978 |
Prevention and management of hyperthyroid storm.
Topics: Adrenal Glands; Graves Disease; Humans; Hyperthyroidism; Propylthiouracil; Sympatholytics; Thyroid C | 1978 |
[Thyrotoxicosis occurring after the Werner test in Graves-Basedow disease].
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Triiodothyronine | 1978 |
Time and tides in Graves's disease: their implications in predicting outcome of treatment.
Topics: Carbimazole; Graves Disease; Humans; Iodine; Periodicity; Prognosis; Triiodothyronine | 1979 |
Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Female; Graves Disease; Humans; Iodine; Male; Methimazo | 1979 |
[Three cases of multinodular toxic goiter (author's transl)].
Topics: Adolescent; Adult; Female; Goiter, Nodular; Graves Disease; Humans; Radionuclide Imaging; Thyroid Gl | 1978 |
Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulator; Male; | 1979 |
[Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
Topics: Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes | 1979 |
Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy.
Topics: Adult; Aged; Drug Evaluation; Female; Graves Disease; Humans; Male; Middle Aged; Premedication; Prop | 1979 |
Alkaline phosphatase isoenzyme patterns in hyperthyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Female; Graves Disease; Humans; Hyperthyroidism; Isoe | 1979 |
Plasma dopamine-beta-hydroxylase activity and thyroid suppressibility in Graves' disease.
Topics: Dopamine beta-Hydroxylase; Graves Disease; Humans; Iodine; Thyroid Gland; Thyroxine; Triiodothyronin | 1979 |
Serum thyroglobulin in patients with toxic and non-toxic goitres compared to sex- and age-matched control subjects.
Topics: Adenoma; Adult; Age Factors; Aged; Female; Goiter; Goiter, Nodular; Graves Disease; Humans; Male; Mi | 1979 |
A radioimmunoassay for measurement of 3,5-diiodothyronine.
Topics: Amniotic Fluid; Diiodothyronines; Female; Fetal Blood; Graves Disease; Humans; Hyperthyroidism; Hypo | 1979 |
Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.
Topics: Graves Disease; Humans; Hyperthyroidism; Ipodate; Kinetics; Male; Reference Values; Thyroiditis, Aut | 1978 |
The regulation of thyrotrophin secretion by exogenous thyroxine and triiodothyronine.
Topics: Carbimazole; Graves Disease; Humans; Male; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronin | 1979 |
Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.
Topics: Adenoma; Adenylyl Cyclases; Adult; Aged; Enzyme Activation; Female; Graves Disease; Humans; Hyperthy | 1979 |
[Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part. I. Solid-state radioimmunoassy for human serum TSH and its clinical application (author's transl)].
Topics: Animals; Cushing Syndrome; Goiter, Nodular; Graves Disease; Humans; Hypothyroidism; Rabbits; Radioim | 1975 |
[Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part II. Development of rapid radioimmunoassay for triiodothyronine (author's transl)].
Topics: Adult; Animals; Female; Graves Disease; Humans; Hypothyroidism; Male; Rabbits; Radioimmunoassay; Thy | 1975 |
[Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treate
Topics: Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Thyroiditis, Autoimmune; Thyrotropi | 1975 |
Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations.
Topics: Acromegaly; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Thyrotr | 1976 |
[Clinical significance in radioimmunologic determination of triiodothyronine].
Topics: Adenoma; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Gland; T | 1975 |
Thyroid-stimulating immunoglobulins and the control of thyroid function.
Topics: Adult; Biological Assay; Female; Graves Disease; Humans; Immunoglobulins; Iodine Radioisotopes; Male | 1976 |
Insufficient TSH stimulation after successful treatment for hyperthyroidism.
Topics: Follow-Up Studies; Graves Disease; Humans; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Tr | 1976 |
Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Iodine Radioisotopes; Lithium; Male; Thyroglobuli | 1976 |
[Serum T4 and T3 levels during administration of Lugol's solution in Basedow's disease].
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; Solutions; Thyroxine; Triiod | 1976 |
[T3 inhibition test and daily urinary excretory volume of iodine].
Topics: Female; Graves Disease; Humans; Iodine; Triiodothyronine | 1976 |
[Clinical significance of compensated autonomic thyroid-gland adenoma].
Topics: Adenoma; Graves Disease; Humans; Radionuclide Imaging; Thyroid Neoplasms; Thyrotropin; Triiodothyron | 1976 |
[Blood triiodothyronine values in pregnant women with hypothyroidism, Basedow's disease or with normal thyroid function].
Topics: Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy Complications; | 1976 |
Hyperthyroidism.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Methimazole; Propylthiouracil; Thyroi | 1976 |
[Hyperthyroidism resulting from excess triiodotyronin i. e., T-3 thyreotoxicosis (author's transl)].
Topics: Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Triiodothyronine | 1975 |
Serum triiodothyronine concentration in the diagnosis of hyperthyroidism.
Topics: Adenoma; Carbimazole; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Radioimmunoassa | 1975 |
Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Topics: Adult; Aged; Animals; Biological Assay; Carbimazole; Female; Graves Disease; Humans; Iodine Radioiso | 1975 |
[Determination of serum triiodothyronine by radioimmunoassay].
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Diseases; Thyroxi | 1975 |
Acute effects of corticosteroids on thyroid activity in Graves' disease.
Topics: Adolescent; Adult; Dexamethasone; Female; Graves Disease; Humans; Male; Middle Aged; Thyroglobulin; | 1975 |
Triiodothyronine-induced thyrotoxicosis in ophthalmic Graves disease.
Topics: Bendroflumethiazide; Female; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Prednisone; Propy | 1975 |
Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Topics: Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyrotropin; Thyroxine; Triiodothyronine | 1975 |
Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
Topics: Adult; Dexamethasone; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; Thyroxine; | 1975 |
T3 release from thyroid slices as an assay for thyroid stimulators.
Topics: Animals; Biological Assay; Cattle; Dose-Response Relationship, Drug; Graves Disease; Humans; Long-Ac | 1975 |
[Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmop
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Stimulation, Chemical; Thyroid Gland; | 1975 |
[T-3-toxicosis as the framework of 1st appearance of the Basedow-Graves disease].
Topics: Female; Graves Disease; Humans; Middle Aged; Time Factors; Triiodothyronine | 1975 |
[Clinical studies on autoimmune mechanisms of the thyroid. Part 2. Studies on measurements of serum thyroblobulin concentrations in patients with various thyroid diseases (author's transl)].
Topics: Antibodies; Chromatography, Affinity; Cross Reactions; Graves Disease; Humans; Thyroglobulin; Thyroi | 1975 |
Thyroxine-binding globulin variant (TBG-Kumamoto): identification of a point mutation and genotype analysis of its family.
Topics: Adult; Base Sequence; Codon; Electrophoresis, Agar Gel; Exons; Female; Genotype; Graves Disease; Hum | 1992 |
Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Immunor | 1992 |
Spin echo nuclear magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy.
Topics: Adult; Autoantibodies; Carbimazole; Erythrocytes; Female; Glutathione; Graves Disease; Humans; Immun | 1992 |
Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Child; Colloids; Epithelium; Female; Graves Disease; Humans; Hyperplasia; Male; M | 1992 |
Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment.
Topics: Adult; Atrial Fibrillation; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Iodine; | 1992 |
Refractoriness at peripheral and pituitary receptors in general and pituitary types of thyroid hormone resistance.
Topics: Child; Cholesterol; Female; Graves Disease; Humans; Male; Pituitary Diseases; Pituitary Gland; Recep | 1992 |
Thyroid ultrasonography related to clinical and laboratory findings in patients with silent thyroiditis.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Thyroglobulin; Thyroid Gland; Thyroiditis, | 1992 |
The possible etiological role of psychological disturbances in Graves' disease.
Topics: Adult; Anxiety; Autoantibodies; CD4-CD8 Ratio; Depression; Female; Graves Disease; Humans; Leukocyte | 1992 |
Radioimmunoassay of thyrotropin-releasing hormone in euthyroid subjects and in patients with thyroid diseases.
Topics: Circadian Rhythm; Graves Disease; Humans; Hypothyroidism; Male; Radioimmunoassay; Reference Values; | 1992 |
Increased concentrations of type IV (7 S) collagen in sera of hyperthyroid patients with Graves disease.
Topics: Adolescent; Adult; Collagen; Female; Graves Disease; Humans; Hyperthyroidism; Liver Function Tests; | 1992 |
Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease?
Topics: Adult; Antibodies; Autoimmune Diseases; CD4-CD8 Ratio; Female; Graves Disease; Humans; Lymphocytes; | 1992 |
Alteration of renal function in hyperthyroidism: increased tubular secretion of creatinine and decreased distal tubule delivery of chloride.
Topics: Adult; Blood Urea Nitrogen; Chlorides; Creatinine; Female; Graves Disease; Humans; Kidney; Kidney Fu | 1992 |
Serum levels of free and bound testosterone in hyperthyroidism.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Luteinizing Hormone; Male; | 1992 |
Increased serum concentration of type IV collagen peptide and type III collagen peptide in hyperthyroidism.
Topics: Collagen; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1992 |
Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.
Topics: Adult; Eye Diseases; Female; Graves Disease; Humans; Male; Middle Aged; Predictive Value of Tests; P | 1992 |
A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life.
Topics: Adolescent; Adult; Aged; Amniotic Fluid; Carrier Proteins; Dose-Response Relationship, Drug; Female; | 1992 |
The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.
Topics: Adolescent; Adult; Autoantibodies; Drug Therapy, Combination; Eye Diseases; Female; Graves Disease; | 1992 |
Transplacental passage of autoantibodies to triiodothyronine.
Topics: Adolescent; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Infant, Newborn; Mate | 1992 |
Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Topics: Adolescent; Child; Child, Preschool; Female; Graves Disease; Humans; Hyperthyroidism; Hypothalamo-Hy | 1992 |
[Neonatal hyperthyroidism secondary to Basedow's disease in the mother].
Topics: Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, Thyro | 1991 |
Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Immunogl | 1991 |
Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease.
Topics: Adult; Aged; Autoantibodies; Enzyme-Linked Immunosorbent Assay; Female; Goiter, Nodular; Graves Dise | 1991 |
Antithyroid drug therapy for Graves' hyperthyroidism: is long-term administration of a small maintenance dose necessary?
Topics: Adult; Autoantibodies; Drug Administration Schedule; Female; Graves Disease; Humans; Immunoglobulins | 1991 |
Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves' disease.
Topics: Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; I | 1991 |
Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
Topics: Autoantibodies; Biopsy, Needle; Blood Sedimentation; C-Reactive Protein; Female; Graves Disease; Hum | 1991 |
Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cholesterol; Europe; Female; Graves Disease; H | 1991 |
A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.
Topics: Adult; Antibodies, Monoclonal; Autoantibodies; Dose-Response Relationship, Drug; Female; Graves Dise | 1991 |
Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
Topics: Adult; Autoantibodies; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunoglobulins, T | 1991 |
Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes.
Topics: Adenylyl Cyclases; Autoantibodies; Autoimmunity; Cross Reactions; Dose-Response Relationship, Immuno | 1991 |
Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Autoantibodies; Child; Female; Graves Disea | 1990 |
[The course of diffuse hyperthyroidism in Basedow disease].
Topics: Adult; Antithyroid Agents; Combined Modality Therapy; Female; Follow-Up Studies; Graves Disease; Hum | 1990 |
Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
Topics: Adult; Antithyroid Agents; Female; Goiter, Nodular; Graves Disease; Humans; Incidence; Iodine Radioi | 1991 |
Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hypothyroidism; Male; Prognosis; Reference Value | 1991 |
Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism.
Topics: Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methimazol | 1991 |
Thyroid stimulating antibodies in patients with Graves' ophthalmopathy.
Topics: Adolescent; Adult; Antibodies; Cyclic AMP; Eye Diseases; Female; Graves Disease; Humans; In Vitro Te | 1991 |
[Evaluation of a logistic regression model in predicting the prognosis of Graves' disease treated by antithyroid drugs].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Logistic Models; Male; | 1991 |
Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; | 1991 |
[Mitral valve prolapse associated with Basedow's disease and active hyperthyroidism. Preliminary report].
Topics: Adult; Body Weight; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Mitral Valve | 1990 |
Evaluation of a new chemiluminescence technique for human thyrotropin (BeriLux hTSH): diagnostic value of five immunometric assay methods.
Topics: Adult; Evaluation Studies as Topic; Female; Graves Disease; Humans; Immunoassay; Immunoenzyme Techni | 1991 |
A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays.
Topics: Adult; Follow-Up Studies; Graves Disease; Humans; Methimazole; Middle Aged; Recurrence; Remission In | 1991 |
Changes in serum thyroid hormone autoantibody concentrations during pregnancy: a case report.
Topics: Adult; Autoantibodies; Female; Fetal Blood; Graves Disease; Humans; Immunoglobulin G; Immunoglobulin | 1991 |
Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Topics: Adult; Autoantibodies; Cell Membrane; Cytosol; Enzyme-Linked Immunosorbent Assay; Female; Graves Dis | 1991 |
Soluble interleukin-2 receptor in sera of patients with Graves' disease.
Topics: Adult; Autoantibodies; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gra | 1991 |
[Diffuse hyperthyroid goiter treated with I131, papillary carcinoma occurring after iodine radioisotope treatment, and thyroxine malabsorption. A clinical case].
Topics: Carcinoma, Papillary; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid Neopl | 1991 |
Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
Topics: Autoantibodies; Carbimazole; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Thyroxine | 1991 |
Hyperthyroidism in the geriatric population.
Topics: Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Goiter, Nodular; Graves Disease; | 1991 |
Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months.
Topics: Adolescent; Adult; Aged; Carbonic Anhydrases; Erythrocytes; Graves Disease; Humans; Middle Aged; Pre | 1991 |
High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Antigens, Differentiation, T-Lymphocyte; CD8 Antigens; Enzyme-Link | 1991 |
Treatment of hyperthyroidism with potassium iodide.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Potassium Iodide; Thyrotropin; Thyroxi | 1991 |
Dynamic changes in soluble interleukin-2 receptor levels during treatment of Graves' disease. Correlation with disease activity.
Topics: Adult; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Midd | 1991 |
Evaluation of the ratio of T3 release stimulating antibodies to TSH-binding inhibiting antibodies during the course of Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; M | 1990 |
Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.
Topics: Adult; Autoantibodies; Combined Modality Therapy; Dexamethasone; Female; Graves Disease; Humans; Imm | 1990 |
The effect of pre-operative potassium iodide therapy on antibody production.
Topics: Antibody Formation; Autoantibodies; B-Lymphocytes; Carbimazole; Enzyme-Linked Immunosorbent Assay; F | 1990 |
The prognostic value of thyrotropin receptor antibody (TRAb) levels in Graves' disease.
Topics: Antibodies; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Prognosis; | 1990 |
Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
Topics: Adult; Autoantibodies; Eye Diseases; Female; Graves Disease; Humans; Hyaluronic Acid; Immunoglobulin | 1990 |
[Importance of investigating the function of the thyroid gland in patients with chronic atrial fibrillation].
Topics: Atrial Fibrillation; Chronic Disease; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Thyroid | 1991 |
The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion.
Topics: Animals; Autoantibodies; Bone Marrow Transplantation; Disease Models, Animal; Enzyme-Linked Immunoso | 1991 |
Two cases of Graves' disease with antithyroid hormone antibodies: implication on the role of thyroglobulin as an antigen.
Topics: Adenoma; Antibodies, Monoclonal; Autoantibodies; Autoantigens; Female; Graves Disease; Humans; Middl | 1990 |
[Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Male; Methimazole; Middle A | 1990 |
Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Graves Disease; Humans; Middle Aged; Thyroid Gland; Thyroidectomy; Thyrotro | 1990 |
Plasma atrial natriuretic peptide in patients with Graves' disease.
Topics: Age Factors; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Female; Graves Disease; Heart Ra | 1990 |
Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring.
Topics: Birth Weight; Carbimazole; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Disea | 1990 |
Serum soluble interleukin 2 receptor in hyperthyroid Graves' disease and effect of carbimazole therapy.
Topics: Adult; Carbimazole; Female; Graves Disease; Humans; Lymphocyte Activation; Male; Receptors, Interleu | 1990 |
Studies on the T3 suppression test with reference to the thyroidal 123I uptake in Graves' disease: comparison of 24-hour and 3-hour uptake.
Topics: Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Predictive Value of Tests; | 1990 |
Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Graves Disease; Humans; Lipopr | 1990 |
The measurement of the serum sex-hormone binding globulin in various thyroid diseases.
Topics: Biomarkers; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Methimazole; R | 1990 |
[The significance of serum fructosamine measurement in patients with thyroid diseases].
Topics: Creatine Kinase; Female; Fructosamine; Glycated Hemoglobin; Graves Disease; Hexosamines; Humans; Hyp | 1990 |
Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism.
Topics: Adult; Aged; Female; Graves Disease; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinet | 1990 |
[Radioimmunologic research in the complex assessment of thyroid status in primary hypothyroidism].
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; R | 1990 |
Normalization of thyroid blood flow in Graves' hyperthyroidism following radioactive iodine therapy.
Topics: Aged; Aged, 80 and over; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Re | 1990 |
[Observation of the outcome of 112 cases with Graves' disease treated by short-term antithyroid drug therapy for one year].
Topics: Adolescent; Adult; Child; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Prospectiv | 1990 |
Factors influencing the outcome of thyrostatic drug therapy in Graves' disease.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Goiter; Graves Disease; HLA Antigens; H | 1990 |
Trial of thyroid autotransplantation in patients with Graves' disease whose remnant thyroid has unintentionally been made too small at subtotal thyroidectomy.
Topics: Adult; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Male | 1990 |
Clinical management of patients with hyperthyroidism.
Topics: Adenoma; Adolescent; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Child; Female; Goiter, | 1985 |
Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
Topics: Amides; Antibodies; Antithyroid Agents; Follow-Up Studies; Graves Disease; Humans; Physical Examinat | 1986 |
Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases.
Topics: Adenocarcinoma; Goiter; Graves Disease; Humans; Immunoenzyme Techniques; Staining and Labeling; Thyr | 1986 |
Unaltered glucose-induced thermogenesis in Graves' disease.
Topics: Adult; Antithyroid Agents; Body Temperature Regulation; Energy Metabolism; Female; Glucose; Graves D | 1986 |
Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Female; Graves Disease; Humans; Iodine Radioisot | 1986 |
Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
Topics: Antibodies; Antithyroid Agents; Female; Fetal Blood; Fetal Diseases; Fetus; Graves Disease; Humans; | 1986 |
Studies on suppressor T lymphocyte function in Graves' disease by 3H-thymidine interpolation.
Topics: Adolescent; Adult; Antithyroid Agents; Graves Disease; Humans; Middle Aged; T-Lymphocytes, Regulator | 1987 |
Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immun | 1988 |
[Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug trea
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; Immunoglobulin G; Immu | 1988 |
[Treatment of T3-predominant Graves' disease].
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Prognosis; Thyroxine; Triiodothyron | 1988 |
Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobu | 1988 |
Studies on peripheral T lymphocyte subsets in patients with autoimmune thyroid diseases.
Topics: Adult; Antibodies, Monoclonal; Female; Graves Disease; Humans; Male; Middle Aged; T-Lymphocytes; T-L | 1989 |
Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
Topics: Adult; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Immunoglobulin G; Immunog | 1989 |
Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy.
Topics: Adult; Aged; Cyclic AMP; Cyclosporins; Exophthalmos; Female; Graves Disease; Humans; Immunoglobulin | 1989 |
The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease.
Topics: Adult; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunoglobulin G; Imm | 1989 |
Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Cell Line; Cyclic AMP; Enzyme-Linked Immunosorbent A | 1989 |
Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Topics: Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; | 1989 |
Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.
Topics: Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Middle Aged; M | 1989 |
Free radicals and Graves' disease: the effects of therapy.
Topics: Adult; Carbimazole; Ceruloplasmin; Female; Free Radicals; Graves Disease; Humans; Iodine Radioisotop | 1989 |
Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomy.
Topics: Adult; Body Weight; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Preanesthetic Medica | 1989 |
Immunological aspects of Graves' disease patients in different clinical stages.
Topics: Adult; Antibodies, Monoclonal; Antibody Formation; Antigen-Antibody Complex; Female; Graves Disease; | 1989 |
Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy.
Topics: Female; Graves Disease; Humans; Middle Aged; Radioimmunoassay; Thyroid Function Tests; Thyroid Hormo | 1989 |
A case of Graves' disease associated with polymyositis.
Topics: Adult; Female; Graves Disease; Humans; Muscles; Myositis; Radioimmunoassay; Thyroid Function Tests; | 1989 |
Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease.
Topics: Adult; Antigens, Differentiation; Female; Fluorescent Antibody Technique; Graves Disease; Humans; Ly | 1989 |
Measurement of anti-thyroglobulin IgG in serum by novel and sensitive immune complex transfer enzyme immunoassay.
Topics: Adult; Aged; Chromatography, Affinity; Cross Reactions; Dinitrophenols; Female; Graves Disease; Huma | 1989 |
Insulin secretion and sensitivity in hyperthyroidism.
Topics: Administration, Oral; C-Peptide; Female; Glucose; Graves Disease; Humans; Hyperthyroidism; Insulin; | 1989 |
Effect of 8-anilino-1-naphthalene sulfonic acid (ANS) on the interaction between thyroid hormone and anti-thyroid hormone antibodies.
Topics: Anilino Naphthalenesulfonates; Antibodies; Antigen-Antibody Reactions; Dose-Response Relationship, D | 1989 |
A comparative evaluation of the surgical and radioiodine treatments for Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid | 1989 |
Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts.
Topics: Cells, Cultured; Connective Tissue; Dexamethasone; Eye; Fibroblasts; Glycosaminoglycans; Graves Dise | 1989 |
Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Graves Disease; Humans; | 1989 |
Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Prospective Studies; Thyr | 1989 |
Functional properties of human thyroid follicles cultured within collagen gel.
Topics: Cells, Cultured; Collagen; Cyclic AMP; Graves Disease; Humans; Kinetics; Methimazole; Propylthiourac | 1988 |
Angiotensin-converting enzyme and anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Weight; Female; Graves Disease; Humans; Hypothyroidism; Ma | 1988 |
Spectrum of thyroid function abnormalities in gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications; | 1988 |
Prediction of the course of Graves' disease after medical antithyroid treatment.
Topics: Adolescent; Adult; Aged; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobuli | 1985 |
Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
Topics: Adolescent; Adult; Carbimazole; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, T | 1985 |
Gamma-glutamyltranspeptidase and alkaline phosphatase serum activities: their relation to the outcome of Graves' disease.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Child, Preschool; Female; gamma-Glutamyltransferase; | 1985 |
Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graves Disease; Humans; Im | 1985 |
T3 releasing activity by Graves' sera from Graves' thyroid in vitro.
Topics: Adult; Biological Assay; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulat | 1986 |
Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1986 |
Prediction of outcome in Graves' disease after carbimazole treatment.
Topics: Adult; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Histocompatibility Antigens C | 1986 |
Similar triiodothyronine releasing activity of thyroid stimulating antibodies in human and porcine thyroid slices.
Topics: Adult; Animals; Culture Techniques; Dose-Response Relationship, Drug; Female; Graves Disease; Humans | 1986 |
Juvenile Graves disease: usefulness and limitations of thyrotropin receptor antibody determinations.
Topics: Adolescent; Adult; Antibodies; Child; Child, Preschool; Female; Graves Disease; Humans; Immunoglobul | 1987 |
Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunity, Cellular; Immunoglobulin G; Immun | 1987 |
Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?
Topics: Adolescent; Adult; Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Immunoglobulin G; | 1987 |
Prediction of remission after antithyroid drug treatment in Graves' disease.
Topics: Adolescent; Adult; Antibodies; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; HLA A | 1988 |
Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
Topics: Adult; Aged; Eye Diseases; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroi | 1988 |
Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglob | 1988 |
T-lymphocyte subsets in pregnant women with Graves' disease.
Topics: Adolescent; Adult; Antibodies; Female; Graves Disease; Humans; Leukocyte Count; Microsomes; Pregnanc | 1987 |
Thyroid hormones affect serum angiotensin I converting enzyme levels.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; | 1985 |
Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.
Topics: Adolescent; Adult; Aged; Female; Goiter, Endemic; Goiter, Nodular; Graves Disease; Humans; Hyperthyr | 1985 |
Catecholamine, vasoactive intestinal peptide and thyrotrophin-dependent cAMP levels display a different sensitivity to iodothyronines in both normal and pathological human thyroid cells in culture.
Topics: Adult; Catecholamines; Cells, Cultured; Cyclic AMP; Female; Graves Disease; Humans; Male; Middle Age | 1985 |
The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Topics: Cyclic AMP; Genetic Linkage; Graves Disease; Histocompatibility Antigens Class II; HLA-DR Antigens; | 1986 |
Specific stimulatory effects of Graves' IgG on the release of triiodothyronine from the patients' own thyroids.
Topics: Adolescent; Adult; Culture Media; Cyclic AMP; Female; Graves Disease; Humans; Immunoglobulin G; Male | 1986 |
[Changes in the hormone profile, central hemodynamics and tissue blood flow in patients with thyrotoxic goiter during treatment with lithium carbonate].
Topics: Adult; Female; Graves Disease; Hemodynamics; Humans; Lithium; Lithium Carbonate; Male; Microcirculat | 1986 |
A case of total thyroxine-binding globulin deficiency with Graves' disease: fluctuations of plasma triiodothyronine/thyroxine ratio.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Methimazole; Thyroid Hormones; | 1986 |
[Value of the triiodothyronine suppression test with serum T4 and thyroid 131I uptake as indexes in judging the prognosis of Graves' disease].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Pr | 1986 |
Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Topics: Adult; Autoantibodies; DNA; Female; Graves Disease; HLA-DR Antigens; Humans; Lymphocytes; Male; Meth | 1988 |
[Evaluation of T3 suppression and TRH stimulation tests in the diagnosis of ophthalmic Graves' disease].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Function Tests; | 1987 |
Long term thyroid function after subtotal thyroidectomy for Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Gland; Thyroidec | 1988 |
Amelioration of Graves' disease during pregnancy.
Topics: Adolescent; Female; Graves Disease; Humans; Pregnancy; Pregnancy Complications; Radioimmunoassay; Th | 1988 |
Differential immunosuppressive action of carbimazole and propylthiouracil.
Topics: Adult; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Immunosuppressive Agents; Male; | 1988 |
Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Autoantibodies; Female; Graves Disease; Humans; Iodide Peroxidase; Iodine; Iodine | 1988 |
Pharmacokinetics of propylthiouracil in children and adolescents with Graves' disease in the hyperthyroid and euthyroid states.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Kinetics; Male; Propylthiouracil; Thyroid Functio | 1988 |
Adenomatous goiter with hyperthyroidism.
Topics: Adenoma; Adolescent; Adult; Child; Female; Follow-Up Studies; Goiter; Graves Disease; Humans; Hypert | 1988 |
Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
Topics: Adolescent; Adult; DNA; Female; Graves Disease; HLA Antigens; Humans; Hyperthyroidism; Male; Methima | 1988 |
Changes in sex steroid and gonadotrophin concentrations during treatment of Graves' thyrotoxicosis in males.
Topics: Adult; Gonadal Steroid Hormones; Gonadotropins; Graves Disease; Humans; Luteinizing Hormone; Male; M | 1988 |
Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease.
Topics: Antibodies, Antinuclear; Autoimmune Diseases; Female; Goiter; Graves Disease; Humans; Lupus Erythema | 1987 |
[Determination of thyroid volume using computerized ultrasonography and its clinical application].
Topics: Adolescent; Adult; Aged; Animals; Anthropometry; Body Height; Female; Graves Disease; Humans; Male; | 1986 |
Factors predicting the course of diabetes mellitus in hyperthyroid patients.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Disease Susceptibility; Female; Glucose Toleran | 1986 |
[Application of personal computer for interpretation system of clinical pathophysiology in patients with Graves' disease].
Topics: Computers; Diagnosis, Computer-Assisted; Graves Disease; Humans; Microcomputers; Thyroid Function Te | 1986 |
Autoantibodies to thyroid hormones: association with falsely low hormone levels measured by 'Amerlex' assay.
Topics: Adult; Autoantibodies; False Negative Reactions; Female; Graves Disease; Humans; Immunosorbent Techn | 1986 |
Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Female; Graves Disease; Humans; Hypothyroidism; Iodine; Mal | 1987 |
Measurement of thyroid hormone concentrations in human placenta.
Topics: Abortion, Spontaneous; Female; Fetal Blood; Graves Disease; Humans; Obstetric Labor, Premature; Plac | 1987 |
Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain.
Topics: Animals; Biological Assay; Cell Line; Dose-Response Relationship, Drug; Graves Disease; Humans; Rats | 1987 |
A case of thyroxine thyrotoxicosis.
Topics: Autoantibodies; Female; Graves Disease; Humans; Middle Aged; Protein Binding; Thyroxine; Triiodothyr | 1987 |
Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy.
Topics: Autoantibodies; Child; Female; Graves Disease; Humans; Methimazole; Middle Aged; Prednisolone; Propy | 1986 |
A new type of albumin with predominantly increased binding affinity for 3,3',5-triiodothyronine in a patient with Graves' disease.
Topics: Adult; Binding Sites; Female; Graves Disease; Humans; Protein Binding; Radioimmunoassay; Serum Album | 1987 |
[Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease].
Topics: Graves Disease; Humans; Thyroid Gland; Thyroxine; Triiodothyronine | 1987 |
[A case of familial hypercholesterolemia associated with Basedow's disease].
Topics: Adult; Graves Disease; Humans; Hyperlipoproteinemia Type II; Male; Probucol; Thyroxine; Triiodothyro | 1987 |
[Thyroid biological evaluation: critical study].
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Function Tests; T | 1987 |
Highly sensitive immunoradiometric assay for TSH and thyroid radioiodine uptake as predictors of thyroid suppression test.
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thioamides; Th | 1987 |
Goitre size and outcome of medical treatment of Graves' disease.
Topics: Adult; Aged; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans; Male; Methimazole; | 1986 |
Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Prognosis; Thyroxine; Triiodothyronine | 1986 |
Changes in plasma fibronectin levels in thyroid diseases.
Topics: Adolescent; Adult; Aged; Female; Fibronectins; Goiter; Graves Disease; Humans; Hypothyroidism; Male; | 1986 |
Fatal thyrotoxic crisis.
Topics: Adult; Death, Sudden; Female; Graves Disease; Humans; Myocardium; Thyroid Crisis; Thyroid Gland; Thy | 1986 |
Effects of betamethasone on serum iodothyronines and thyroid hormone-binding proteins in Graves' disease.
Topics: Adult; Aged; Betamethasone; Carrier Proteins; Female; Graves Disease; Humans; Male; Middle Aged; Thy | 1986 |
Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
Topics: Antibodies; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Ipodate; Thyroid Gland | 1987 |
Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
Topics: Animals; Graves Disease; Humans; Iodide Peroxidase; Kidney; Kinetics; Liver; Long-Acting Thyroid Sti | 1987 |
A comparison of the effects of propylthiouracil and methimazol on circulating thyroid hormones and various measures of peripheral thyroid hormone effects in thyrotoxic patients.
Topics: Achilles Tendon; Adult; Basal Metabolism; Female; Graves Disease; Humans; Male; Methimazole; Middle | 1985 |
Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Male; Potassium Iodide; Thyroid Hormones; Thyroxine; | 1985 |
Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
Topics: Catalysis; Chemical Phenomena; Chemistry; Chromatography, Gel; Graves Disease; Humans; Hydrogen-Ion | 1985 |
Characterization of microheterogeneity of human thyroglobulin from different thyroid disorders.
Topics: Adenoma; Densitometry; Electrophoresis, Polyacrylamide Gel; Goiter; Graves Disease; Humans; Iodine; | 1985 |
Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter.
Topics: Adult; Boston; Dose-Response Relationship, Drug; Environment; Female; Graves Disease; Humans; Hypoth | 1985 |
Computer simulation for hormones related to primary thyropathy.
Topics: Computers; Graves Disease; Humans; Hyperthyroidism; Hypothalamo-Hypophyseal System; Hypothyroidism; | 1985 |
Study of glucose and lipid metabolism by continuous indirect calorimetry in Graves' disease: effect of an oral glucose load.
Topics: Adult; Blood Glucose; Calorimetry, Indirect; Fasting; Female; Glucose; Glucose Tolerance Test; Grave | 1985 |
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Radioimmunoassay; Thyroid Dis | 1985 |
[Review of the clinical usefulness of triiodothyronine uptake values].
Topics: Female; Graves Disease; Humans; Pregnancy; Pregnancy Complications; Radioimmunoassay; Thyroid Diseas | 1985 |
A case of Graves' disease with anti-triiodothyronine antibodies.
Topics: Antibodies, Anti-Idiotypic; Antibody Specificity; Female; Graves Disease; Humans; Immunoglobulin G; | 1985 |
Clinical and laboratory assessment of thyroid abnormalities.
Topics: Autoantibodies; Blood Proteins; Graves Disease; Humans; Iodine Radioisotopes; Palpation; Radionuclid | 1985 |
Detection of familial dysalbuminaemic hyperthyroxinaemia.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Serum A | 1985 |
Long term treatment of Graves' hyperthyroidism with sodium ipodate.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Long-Term Care; Male; Middle Aged; Thyroxine; Triiod | 1985 |
Alterations in circulating thyroid hormones and thyrotropin in euthyroid patients with Graves' disease after total thyroidectomy: comparison between responders and nonresponders to TSH-releasing hormone.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Hormones; Thyroidectomy; Thyrotrop | 1985 |
Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Iodine Radi | 1970 |
Thymic hyperplasia in Graves' disease.
Topics: Adult; Antithyroid Agents; Autoradiography; Culture Techniques; Female; Graves Disease; Humans; Long | 1971 |
[Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
Topics: Antithyroid Agents; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyrotropin; Triiodothyr | 1970 |
Increased peripheral oxygen delivery in thyrotoxicosis: role of red cell 2, 3-diphosphoglycerate.
Topics: Adult; Antithyroid Agents; Erythrocytes; Female; Glycerophosphates; Graves Disease; Hemoglobins; Hum | 1970 |
Failure of pituitary response to thyrotrophin-releasing hormone in euthyroid Graves' disease.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidis | 1971 |
Metabolic clearance rate of L-triiodothyronine in man: a comparison of results by single-injection and constant infusion methods.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenous; Kinetics; Male; Metabolic C | 1971 |
Radioimmunoassay for measurement of triiodothyronine in human serum.
Topics: Animals; Antithyroid Agents; Binding Sites; Cross Reactions; Graves Disease; Humans; Hyperthyroidism | 1971 |
Thyroxine derivatives in amniotic fluid. Fetal outcome in three patients with thyroid problems.
Topics: Adult; Amniocentesis; Amniotic Fluid; Female; Fetal Diseases; Graves Disease; Humans; Hypothyroidism | 1971 |
Clinical and laboratory observations in cases of triiodothyronine toxicosis confirmed by radioimmunoassay.
Topics: Adenoma; Adult; Aged; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Male; Method | 1972 |
Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
Topics: Adult; Aged; Body Height; Body Weight; Chromatography, Ion Exchange; Graves Disease; Half-Life; Huma | 1972 |
Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Topics: Chromatography, Ion Exchange; Female; Graves Disease; Humans; Immune Sera; Immunoelectrophoresis; Im | 1972 |
[Current aspects of thyroid function diagnostics. Serum T 3 level and TRH stimulation test with radioimmunologic TSH determination].
Topics: Diagnosis, Differential; Goiter; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypothala | 1972 |
Lymphoid infiltration in toxic goitres studied with fine needle aspiration biopsy.
Topics: Adolescent; Adult; Age Factors; Aged; Antibodies; Antibody Formation; Biopsy, Needle; Complement Fix | 1972 |
Pretibial myxedema and nonthyrotoxic thyroid disease.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Bone Diseases; Diabetes Complications; Exophthalmos; Fem | 1973 |
Advances in the laboratory diagnosis of thyroid disease. II.
Topics: Child; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Metabolism, Inborn Errors; Radioimmu | 1973 |
Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Long-Acting Thyroid Sti | 1972 |
[Biological investigation in hyperthyroidism].
Topics: Cholesterol; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Iodine; Iodine Isotopes; Iodi | 1972 |
[Hyperthyroidism of a single thyroid lobe. Apropos of 3 cases].
Topics: Adult; Diagnosis, Differential; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Io | 1973 |
[Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Hyperthyro | 1973 |
Total and free triiodothyronine and thyroxine levels in thyroid storm and recurrent hyperthydroidism.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Postoperative Complicati | 1973 |
T3 toxicosis in adolescence: presentation as recurrent hyperthyroidism.
Topics: Adolescent; Diagnosis, Differential; Female; Graves Disease; Growth Hormone; Humans; Hyperthyroidism | 1973 |
[Clinical significance of serum triiodothyronine].
Topics: Arrhythmias, Cardiac; Diagnosis, Differential; Goiter; Goiter, Nodular; Graves Disease; Humans; Hype | 1973 |
[Significance and reliability of various tests of thyroid function in medical practice (author's transl)].
Topics: Adenoma; Estrogens; Evaluation Studies as Topic; Goiter; Graves Disease; Humans; Hyperthyroidism; Hy | 1973 |
Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs.
Topics: Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Male; Radioimmunoassay; Thyroid Functi | 1973 |
[Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Hypothalamus; Iodine Radioisotopes; | 1973 |
Drug treatment in thyroid disease.
Topics: Antithyroid Agents; Female; Goiter; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypoth | 1974 |
[Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
Topics: Antithyroid Agents; Graves Disease; Humans; Radioimmunoassay; Thyrotropin-Releasing Hormone; Thyroxi | 1974 |
Five years' experience with iodine-125 therapy of Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Dose-Response Relationship, Radiation; Drug Therapy, Combination; E | 1974 |
Laboratory examination of the thyroid. 1. In vitro tests.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Pregnancy; Protein Binding; R | 1974 |
Iodine-induced toxic diffuse goitre.
Topics: Adult; Female; Graves Disease; Humans; Iodine; Seaweed; Thyroid Function Tests; Thyrotropin; Thyroxi | 1974 |
Thyroid physiology and functional tests.
Topics: Achilles Tendon; Basal Metabolism; Calcitonin; Goiter; Graves Disease; Humans; Hyperthyroidism; Iodi | 1974 |
Treatment of thyrotoxicosis with lithium carbonate.
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyr | 1974 |
[Proceedings: T3 suppression test and TSH and prolactin reactions to TRH in patient with Basedow's disease under treatment with thyroid antagonists].
Topics: Antithyroid Agents; Graves Disease; Humans; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; T | 1974 |
[Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
Topics: Antithyroid Agents; Follow-Up Studies; Graves Disease; Humans; Triiodothyronine | 1974 |
306 cases of toxic adenoma: clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology; results of 131-I and surgical treatment.
Topics: Adenoma; Chromatography, Paper; Follow-Up Studies; Graves Disease; Humans; Iodine Isotopes; Iodine R | 1967 |
Treatment of thyrotoxicosis based on thyroidal suppressiblity.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Thyroid Function Tests; Thyroid Gland; | 1967 |
Occurrence of hyperthyroidism in patients receiving thyroid hormone.
Topics: Adolescent; Adult; Alopecia; Antithyroid Agents; Fatigue; Female; Goiter; Graves Disease; Humans; Hy | 1967 |
[Action of 1-triiodothyronine in euthyroid subjects and in hyperthyroidism due to toxic adenoma or exophthalmic goiter: the induced hypoiodinemia (PBI-127) test].
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Function Tests; Triiodothyronine | 1967 |
[The diencephalic-hypophyseal and orbital x-ray therapy in endocrine edematous progressive exophthalmos (100 clinical cases)].
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Hydrocortisone; Hyperthyroidism; Hypothyroidism; | 1967 |
Emotion and non-specific infection as possible aetiological factors in Graves' disease. Their relation to thyroid suppressibility.
Topics: Adult; Antithyroid Agents; Emotions; Female; Graves Disease; Humans; Hyperthyroidism; Infections; Ma | 1968 |
Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Long-Acting Thyroid Stimulator; Propylthio | 1968 |
Thyroid suppression by triiodothyronine before and after treatment for Graves' disease.
Topics: Graves Disease; Humans; Iodine; Iodine Isotopes; Iodine Radioisotopes; Thyroid Function Tests; Thyro | 1969 |
The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Topics: Exophthalmos; Graves Disease; Humans; Immunoglobulin G; Immunoglobulin M; Long-Acting Thyroid Stimul | 1969 |
[The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
Topics: Adolescent; Adult; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Hyperthyroidism; | 1968 |
Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Topics: Antithyroid Agents; Depression, Chemical; Graves Disease; Humans; Imidazoles; Iodine; Iodine Radiois | 1970 |
Ophthalmic Graves' disease. Diagnosis and pathogenesis.
Topics: Adult; Aged; Antibodies; Autoantibodies; Eye Manifestations; Female; Fluorescent Antibody Technique; | 1970 |
Post-treatment hypothyroidism. Simplified detection and follow-up system using the achilles reflex time.
Topics: Adolescent; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; | 1970 |
[Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
Topics: Antithyroid Agents; Betamethasone; Dextrothyroxine; Eye Diseases; Graves Disease; Humans; Hyperthyro | 1967 |
Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Topics: Adult; Aged; Animals; Basal Metabolism; Biological Assay; Female; Graves Disease; Humans; Hyperthyro | 1970 |
A thyroid suppression test using a single dose of L-thyroxine.
Topics: Administration, Oral; Cholesterol; Graves Disease; Humans; Iodine Radioisotopes; Pulse; Reflex; Slee | 1970 |
The response in toxic diffuse goitre to a short course of antithyroid therapy.
Topics: Antithyroid Agents; Carbimazole; Graves Disease; Humans; Imidazoles; Thyroid Function Tests; Thyroid | 1970 |
Diagnosis of hyperthyroidism. Statistical evaluation of laboratory and clinical criteria.
Topics: Adenoma; Cholesterol; Diagnosis, Computer-Assisted; Diagnosis, Differential; Glucosephosphate Dehydr | 1970 |
Evaluation of the triiodothyronine suppression test in the treatment of Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Goiter; Graves Disease; Huma | 1970 |
Recurrence of hyperthyroidism shortly after return of normal suppressibility by triiodothyronine.
Topics: Adult; Antithyroid Agents; Arrhythmias, Cardiac; Emotions; Female; Graves Disease; Humans; Imidazole | 1970 |
L.A.T.S. and Graves' disease.
Topics: Animals; Biological Assay; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Long-Acting Thy | 1970 |
Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Male; Middle Aged; Thyroid Func | 1973 |
Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Topics: Adult; Aged; Dexamethasone; Female; Graves Disease; Humans; Hypothalamus; Iodine Radioisotopes; Long | 1973 |
[TRH stimulation test. II. Evaluation of thyroid response].
Topics: Chemical Phenomena; Chemistry; Diagnosis, Differential; Graves Disease; Humans; Hypopituitarism; Hyp | 1973 |
[TRH stimulation test. II. Evaluation of thyroid response].
Topics: Diagnosis, Differential; Graves Disease; Humans; Hypopituitarism; Hypothyroidism; Radioimmunoassay; | 1973 |
Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
Topics: Adult; Aged; Chromatography, Gel; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle | 1974 |
Normal serum triiodothyronine concentration and the lack of TSH response to TRH in patients with euthyroid Graves' disease.
Topics: Adult; Antibodies; Female; Graves Disease; Hemagglutination Tests; Humans; Immunoglobulin G; Iodine | 1973 |
[Interglandular relations in so-called extinctive thyroid nodules].
Topics: 17-Ketosteroids; Female; Follicle Stimulating Hormone; Goiter, Nodular; Graves Disease; Growth Hormo | 1973 |
[Endocrine opthalmopathy-- new physiopathological viewpoints through the determination of T3, T4 and TSH following TRH stimulation].
Topics: Graves Disease; Humans; Stimulation, Chemical; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1974 |
The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism.
Topics: Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Perchlorates; Radioimmu | 1971 |
Inhibitory action of thyroid hormone of the activation of adenyl cyclase-cyclic AMP system by thyroid-stimulating hormone in human thyroid tissues from euthyroid subjects and thyrotoxic patients.
Topics: Adenylyl Cyclases; Adipose Tissue; Cyclic AMP; Enzyme Activation; Epididymis; Graves Disease; Humans | 1974 |
Medical approach to ophthalmopathy of Graves' disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Diagnosis, Differ | 1972 |
Serum L-triiodothyronine radioimmunoassay: measurements in normal subjects and in thyroid patients.
Topics: Adenoma; Adult; Graves Disease; Humans; Hyperthyroidism; Myxedema; Radioimmunoassay; Thyroid Disease | 1974 |
Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Topics: Animals; Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Iodine; Iodine Ra | 1974 |
[Incorporation of labelled triiodothyronine into the blood erythrocytes in diffuse toxic goiter under the influence of treatment with artificial arsenous mineral baths].
Topics: Arsenicals; Baths; Chronic Disease; Erythrocytes; Female; Graves Disease; Humans; In Vitro Technique | 1974 |
The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Topics: Carbimazole; Graves Disease; Humans; Immune Adherence Reaction; Iodine; Iodine Radioisotopes; Propyl | 1974 |
[Acute coronary failure during triiodothyronine inhibition test for thyroid iodine uptake].
Topics: Acute Disease; Electrocardiography; Female; Graves Disease; Humans; Middle Aged; Myocardial Infarcti | 1974 |
[Effect of neomycin on certain indicators of carbohydrate and cortisol metabolism and level of thyroid hormones in toxic goiter].
Topics: 17-Hydroxycorticosteroids; Adult; Carbohydrate Metabolism; Citrates; Female; Graves Disease; Humans; | 1974 |
[Proceedings: Clinical importance of serum triiodothyronine].
Topics: Arrhythmias, Cardiac; Goiter; Graves Disease; Humans; Hyperthyroidism; Triiodothyronine | 1974 |
[Proceedings: Blood T3-T4 ratio in various states of thyroid function].
Topics: Graves Disease; Humans; Thyroiditis, Autoimmune; Thyroxine; Triiodothyronine | 1974 |
[Proceedings: Thyroid stimulating substances in man. (1). New findings concerning autoregulation of the thyroid gland of man: increases of adenyl cyclase caused by TSH administration and their inhibition by T3 and T4 in the thyroid of normal individuals a
Topics: Adenylyl Cyclases; Graves Disease; Humans; In Vitro Techniques; Thyroid Gland; Thyrotropin; Thyroxin | 1974 |
[Proceedings: Evaluation of triiodothyronine levels in Hashimoto's disease with Basedow's disease].
Topics: Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Thyroiditis, Autoimmune; Triiodothyr | 1974 |
[Behavior of TSH and RIA-T3 following subtotal struma resection in hyperthyroidism with endocrine ophthalmopathy].
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroidectomy; Thyrotropin; Triiodothyronine | 1974 |
Hypothyroidism after thyroidectomy for Graves's disease: a search for an explanation.
Topics: Autoantibodies; Complement Fixation Tests; Female; Fluorescent Antibody Technique; Graves Disease; H | 1974 |
Competitive ligand-binding assay for measurement of thyronine-binding globulin (TBG).
Topics: Animals; Binding Sites; Cattle; Chromosome Aberrations; Chromosome Disorders; Dogs; Female; Graves D | 1972 |
Recurrent hyperthyroidism presenting as triiodothyronine toxicosis.
Topics: Adenoma; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Radioimmun | 1972 |
Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
Topics: Administration, Oral; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenou | 1973 |
Effect of synthetic thyrotrophin releasing hormone (TRH) in man.
Topics: 11-Hydroxycorticosteroids; Adult; Aged; Brain Neoplasms; Female; Follicle Stimulating Hormone; Grave | 1972 |
[Triiodothyronine-thyrotoxicosis].
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Protein Binding; Recurrence; Thyroglobulin | 1972 |
[Familial Basedow's disease in 3 generations].
Topics: Adolescent; Adult; Age Factors; Aged; Body Height; Female; Graves Disease; Hemagglutination Tests; H | 1972 |
Thyroxine and triiodothyronine in the human thyroid.
Topics: Adenocarcinoma; Autopsy; Binding, Competitive; Chromatography, Thin Layer; Goiter; Graves Disease; H | 1973 |
Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
Topics: Autoantibodies; Chronic Disease; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Long-Acting T | 1973 |
Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease.
Topics: Feces; Female; Graves Disease; Humans; Iodine Isotopes; Kinetics; Liver; Male; Phenobarbital; Radioi | 1973 |
[Value of a beta-blocking drug in prolonged treatment of hyperthyroidism and in the triiodothyronine inhibition assay].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Pindolo | 1973 |
Comparison of alterations in circulating thyroglobulin, triiodothyronine and thyroxine in response to exogenous (bovine) and endogenous (human) thyrotropin.
Topics: Adenoma; Adolescent; Adult; Animals; Cattle; Female; Graves Disease; Humans; Hypothyroidism; Male; T | 1973 |
Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results.
Topics: Adult; Diet; Female; Graves Disease; Humans; Iodine; Male; Methimazole; Middle Aged; Propylthiouraci | 1973 |
[Evaluation of the pituitary-thyroid axis by the triiodothyronine test].
Topics: Acromegaly; Adult; Graves Disease; Humans; Hypopituitarism; Middle Aged; Pituitary Function Tests; P | 1973 |
Sequential assessment during drug treatment of thyrotoxicosis.
Topics: Adult; Age Factors; Aged; Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyro | 1973 |
The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease.
Topics: Graves Disease; Humans; Iodine Radioisotopes; Kinetics; Liver; Liver Function Tests; Male; Thyroxine | 1970 |
Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
Topics: Administration, Oral; Chromatography, Paper; Electrophoresis; Female; Graves Disease; Humans; Hypert | 1971 |
"Triiodothyronine (T 3 ) toxicosis". Its role in Graves' disease.
Topics: Adult; Aged; Basal Metabolism; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Mid | 1971 |
[Long-term treatment of hyperthyroidism using antithyroid substances in combination with synthetic thyroid hormones].
Topics: Drug Synergism; Goiter; Graves Disease; Humans; Hyperthyroidism; Imidazoles; Long-Term Care; Sulfhyd | 1971 |
[Basedow coma and diabetic ketoacidosis in a 13-year-old girl].
Topics: Adolescent; Diabetic Ketoacidosis; Female; Graves Disease; Humans; Hypokalemia; Insulin; Iodine; Met | 1971 |
Premature craniosynostosis associated with hyperthyroidism in 4 children with reference to 5 further cases in the literature.
Topics: Bone Development; Child; Child, Preschool; Craniosynostoses; Female; Graves Disease; Growth; Humans; | 1972 |
Clinical experience with assays for triiodothyronine.
Topics: Animals; Antibodies; Chromatography, Paper; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism | 1972 |
Hyperthyroidism.
Topics: Eye Manifestations; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Iodides; Iodin | 1972 |
Iodoamino acid composition of the thyroglobulin of normal and diseased thyroid glands. Comparison with in vitro iodinated thyroglobulin.
Topics: Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Diiodotyrosine; Goiter; Graves Disease; | 1972 |
Congenital goiter due to maternal ingestion of iodides.
Topics: Apgar Score; Bone Diseases, Developmental; Cesarean Section; Electroencephalography; Female; Fetus; | 1972 |
Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Methimazole; Methylthiouracil; Propylthiouracil; Rad | 1972 |
The physiological role of triiodothyronine.
Topics: Goiter, Endemic; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Isotopes; Radioimmu | 1972 |
[Treatment of hyperthyroidism in Grave's disease with low doses of radioactive iodine].
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine Isotopes; Male; Methimazole; Middle Aged; Radiot | 1971 |
[Relation between Basedow's disease and Hashimoto thyroiditis].
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Imm | 1971 |
Application of the radioiodine uptake to the clinical evaluation of thyroid disease.
Topics: Body Weight; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidis | 1971 |
Recurrent thyrotoxicosis after subtotal thyroidectomy.
Topics: Autoantibodies; Gastric Mucosa; Graves Disease; Humans; Immunoglobulin G; Iodine Radioisotopes; Long | 1971 |
Bilateral exophthalmic ophthalmoplegia. A case report.
Topics: Acid Phosphatase; Biopsy; Clinical Enzyme Tests; Electromyography; Glucosyltransferases; Graves Dise | 1969 |
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.
Topics: Acetates; Adult; Basal Metabolism; Chemical Precipitation; Chlorine; Female; Graves Disease; Humans; | 1970 |
Development of Graves' disease in a patient with an autonomous thyroid nodule.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Radiography; Radionucl | 1970 |
Thyroid gland in Graves' disease: victim or culprit?
Topics: Adolescent; Adult; Aged; Analysis of Variance; Graves Disease; Humans; Immunoglobulin G; Iodine Radi | 1970 |
Abnormalities in thyroid hormone production and metabolism in hyperthyroidism.
Topics: Diiodotyrosine; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Monoiodotyrosine; Thyroi | 1970 |
[The thyroid gland suppression test with triiodothyronine].
Topics: Adenoma; Adolescent; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine | 1967 |
[Basedowian ophthalmopathies. Pathogenic role of 1-triiodothyronine and LATS. Therapeutic role of 1-thyroxine, d-thyrosine and corticoids].
Topics: Adrenal Cortex Hormones; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyroxine; Triiodot | 1967 |
[The diagnostic value of the triiodothyronine-suppression-tes in thyroid gland diagnosis with radioactive iodine].
Topics: Adult; Age Factors; Goiter; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Middle Ag | 1967 |
Iodine kinetics in man--a model.
Topics: Computers; Graves Disease; Humans; Hyperthyroidism; Hypophysectomy; Hypothyroidism; Iodides; Iodine; | 1968 |
Long acting thyroid stimulator (LATS) and iodo-amino acids in localized pretibial myxeodema.
Topics: Adult; Blood Proteins; Diiodotyrosine; Female; Graves Disease; Humans; Iodine; Long-Acting Thyroid S | 1968 |
[Efficiency of muscular work of healthy young men before and during oral administration of triiodothyronine].
Topics: Adult; Basal Metabolism; Efficiency; Graves Disease; Humans; Male; Oxygen Consumption; Triiodothyron | 1968 |
[Clinical and instrumental study of thyroid diseases in relation to the indications for surgical treatment. VI. The dynamic study of thyroid function with the L-triiodothyronine blocking rest in a group of subjects thyroidectomized for hyperfunctioning sy
Topics: Adolescent; Adult; Aged; Female; Goiter; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; | 1968 |
Investigation of endocrine exophthalmos.
Topics: Antibodies; Graves Disease; Humans; Iodine Radioisotopes; Long-Acting Thyroid Stimulator; Thyroid Fu | 1969 |
[Test of inhibition of thyroid uptake of radioiodine by means of triiodothyronine in patients with Basedow's disease in clinical remission].
Topics: Female; Graves Disease; Humans; Male; Thyroid Function Tests; Triiodothyronine | 1965 |